≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Oesophageal varices

DOID EFO Endpoint Browser PheWeb

I9_VARICVEOES

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — I85
  • Hospital discharge: ICD-9 — 456[0-1]
  • Hospital discharge: ICD-8 — 4560
  • Cause of death: ICD-10 — I85
  • Cause of death: ICD-9 — 456[0-1]
  • Cause of death: ICD-8 — 4560

2 out of 7 registries used, show all original rules.

1647

4. Check minimum number of events

None

1647

5. Include endpoints

None

1647

6. Filter based on genotype QC (FinnGen only)

1598

Control definitions (FinnGen only)

Control exclude
I9_DISVEINLYMPH

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
I80-I89
Name in latin
Varices oesophagi

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 15571 4582 10653
Only index persons 9567 3029 6538
Unadjusted period prevalence (%)
Whole population 0.25 0.13 0.30
Only index persons 0.21 0.11 0.25
Median age at first event (years)
Whole population 59.23 62.25 57.96
Only index persons 60.61 62.62 59.68

-FinnGen-

Key figures

All Female Male
Number of individuals 1598 567 1031
Unadjusted period prevalence (%) 0.38 0.20 0.47
Median age at first event (years) 63.62 64.50 63.14

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1646
Matched controls
16460
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K70.4
ICD-10 Finland
Alcoholic hepatic failure
89.7
308.1
162
20
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
2076.9
307.7
452
*
K92.1
ICD-10 Finland
Melaena
12.0
307.7
426
466
C03CA01
ATC
furosemide; systemic
7.2
307.7
1095
3557
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
177.0
307.7
720
72
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
41.2
307.7
347
106
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
57.5
307.7
211
42
Z94.4
ICD-10 Finland
Liver transplant status
175.6
307.7
173
11
A06AD11
ATC
lactulose; oral
7.7
307.7
719
1503
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
11.4
307.7
631
851
C07AA05
ATC
propranolol; systemic
8.0
307.7
817
1799
R18
ICD-10 Finland
Ascites
57.7
307.7
484
118
K92.0
ICD-10 Finland
Haematemesis
30.6
307.7
395
168
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
8.8
307.7
708
1297
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
4503599627370496.0
307.7
1396
*
C03DA01
ATC
spironolactone; oral
18.6
307.7
997
1254
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
20.8
307.7
266
151
A07AA11
ATC
rifaximin; oral
164.1
307.7
176
12
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
21.7
307.7
1397
3377
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
+∞
307.7
506
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
155.3
307.7
684
75
C07AG02
ATC
carvedilol; oral
13.2
307.7
505
534
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
40.2
276.6
170
47
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
24.0
267.4
196
92
A05AA02
ATC
ursodeoxycholic acid; oral
27.7
238.9
165
66
127
Kela drug reimbursment
Transplant complication
19.5
224.6
180
103
K70.1
ICD-10 Finland
Alcoholic hepatitis
46.2
223.1
132
31
D97
ICPC
Liver disease NOS
56.7
213.8
121
23
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
11.6
207.8
227
223
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
55.2
207.4
118
23
D64.9
ICD-10 Finland
Anaemia, unspecified
5.5
196.0
480
1150
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
57.2
180.6
102
19
L04AA06
ATC
mycophenolic acid; systemic
14.3
175.6
165
127
K72.9
ICD-10 Finland
Hepatic failure, unspecified
49.4
175.2
102
22
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
5.9
164.2
345
713
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
36.7
154.9
97
28
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
12.0
153.0
160
146
JJC00
NOMESCO Finland
Allogenic transplantation of liver
244.2
152.9
155
7
L04AD02
ATC
tacrolimus; systemic
22.2
152.7
114
55
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.6
146.3
319
678
I81
ICD-10 Finland
Portal vein thrombosis
+∞
131.0
124
*
A10AB05
ATC
insulin aspart; parenteral
5.1
128.2
311
721
K76.9
ICD-10 Finland
Liver disease, unspecified
16.1
125.7
109
72
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
11.3
124.8
135
129
A10AE04
ATC
insulin glargine; parenteral
4.3
117.9
366
1028
JN3AD
NOMESCO Finland
Abdominal CT examination
3.9
117.7
434
1379
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.2
116.5
272
608
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
8.7
115.8
154
194
K74.3
ICD-10 Finland
Primary biliary cirrhosis
35.8
114.3
72
21
K83.0
ICD-10 Finland
Cholangitis
12.7
114.3
114
96
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
18.6
111.9
90
51
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
7.8
111.7
163
229
K29.6
ICD-10 Finland
Other gastritis
14.2
110.0
102
76
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
154.4
109.7
115
8
WW500
NOMESCO Finland
Blood transfusion
6.6
109.2
189
319
UJF32
NOMESCO Finland
Coloscopy
3.2
109.0
685
3023
L04AD01
ATC
ciclosporin; systemic
10.7
108.2
121
121
103
Kela drug reimbursment
Diabetes, insulin-treated
3.1
107.9
748
3486
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
41.6
105.7
64
16
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
9.9
104.3
124
135
K72.1
ICD-10 Finland
Chronic hepatic failure
183.0
99.5
103
6
K70.0
ICD-10 Finland
Alcoholic fatty liver
15.8
96.2
84
56
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.0
95.9
672
3108
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
10.0
92.2
108
115
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
7.1
90.4
143
219
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
90.2
508
2069
K29.7
ICD-10 Finland
Gastritis, unspecified
6.4
88.7
155
263
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.9
88.2
301
893
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
11.0
87.3
95
91
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.7
87.1
145
234
TK800
NOMESCO Finland
Hemodialysis
8.2
86.3
118
153
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
10.6
85.6
96
96
UJD02
NOMESCO Finland
Gastroscopy
5.2
83.9
186
394
P15
ICPC
Chronic alcohol abuse
6.2
81.1
146
255
N02AX02
ATC
tramadol; systemic, rectal
2.7
80.9
933
5437
F10.20
ICD-10 Finland
Alcohol dependence currently independent
8.4
80.8
108
136
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
80.7
495
2096
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
9.4
78.5
96
108
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.7
78.3
642
3154
K76.7
ICD-10 Finland
Hepatorenal syndrome
207.3
76.9
79
*
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
31.5
75.0
49
16
B18.2
ICD-10 Finland
Chronic viral hepatitis C
13.7
74.5
70
53
A02BC02
ATC
pantoprazole; systemic
3.0
73.1
1310
9285
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.7
72.4
261
798
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
13.9
71.9
67
50
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
71.8
1021
6433
T90
ICPC
Diabetes non-insulin dependent
2.6
71.0
624
3142
JCA32
NOMESCO Finland
Endoscopic injection in oesophagus
100.9
70.5
77
8
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
70.5
532
2485
K74.0
ICD-10 Finland
Hepatic fibrosis
34.7
69.2
44
13
F10.25
ICD-10 Finland
Alcohol dependence continuous use
7.6
69.2
101
141
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.5
67.1
136
265
K76.6
ICD-10 Finland
Portal hypertension
663.7
65.4
64
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.1
65.3
332
1251
A10BA02
ATC
metformin; oral
2.4
64.9
682
3697
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
5.1
64.6
143
301
45499
ICD-8 Finland
Varicose veins of lower extremities, Other and unspecified, without ulcer
+∞
64.0
61
*
A10BH01
ATC
sitagliptin; oral
3.2
63.0
285
1002
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
8.3
62.6
84
106
JDA42
NOMESCO Finland
Other endoscopic haemostatic procedure in stomach or pylorus
25.1
62.3
44
18
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.0
62.1
332
1285
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.5
61.4
159
381
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
20.1
60.9
47
24
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
6.3
60.9
105
175
I86.4
ICD-10 Finland
Gastric varices
+∞
60.8
58
*
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
5.8
60.4
115
211
WX892
NOMESCO Finland
Monitored bed care
3.5
59.8
227
714
WX002
NOMESCO Finland
Sedation and analgesia
2.6
59.2
439
2009
ZX120
NOMESCO Finland
Intravenous
3.3
58.8
246
823
JN4AD
NOMESCO Finland
Body CT examination
2.9
58.3
320
1253
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
95.1
58.3
64
7
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
14.4
58.1
53
38
J01MA02
ATC
ciprofloxacin; systemic
2.3
57.8
787
4709
Z2446
NOMESCO Finland
Social worker
3.8
57.6
189
539
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.0
56.5
288
1081
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
11.5
56.4
59
53
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
15.1
56.4
50
34
Z51.5
ICD-10 Finland
Palliative care
3.2
56.3
261
927
F10.24
ICD-10 Finland
Alcohol depence active use
7.2
55.9
85
124
JN4CD
NOMESCO Finland
Very extensive body CT
4.7
55.8
136
310
JCA20
NOMESCO Finland
Ligature of oesophageal varices
+∞
55.5
53
*
JJ5AT, ,
NOMESCO Finland
122.3
55.2
59
5
A10AC01
ATC
insulin (human); parenteral
3.5
53.1
204
645
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
51.9
297
1184
R4110
NOMESCO Finland
Physiotherapy
2.3
51.8
580
3166
K65.0
ICD-10 Finland
Acute peritonitis
10.0
51.2
59
61
UJF30
NOMESCO Finland
Ileoscopy through colon
3.0
50.9
265
1003
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
9.7
50.0
59
63
I85
ICD-10 Finland
Oesophageal varices
+∞
49.2
47
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
5.3
47.8
99
196
4560A
ICD-9 Finland
Varicose veins of other sites, Oesophageal varices with bleeding
+∞
47.1
45
*
A10AE05
ATC
insulin detemir; parenteral
3.7
45.7
157
460
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
16.9
45.4
38
23
TKC20
NOMESCO Finland
Catheterisation of bladder
3.3
44.5
188
628
K22.6
ICD-10 Finland
Gastro-oesophageal laceration-haemorrhage syndrome
13.0
44.4
43
34
PHD99
NOMESCO Finland
Resection of other vein
231.2
44.1
45
*
N07BB01
ATC
disulfiram; oral
3.9
43.4
133
360
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.7
42.6
81
148
K83.1
ICD-10 Finland
Obstruction of bile duct
6.8
42.3
67
102
L04AX01
ATC
azathioprine; systemic
4.3
41.8
112
274
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
16.0
41.8
36
23
A10BB12
ATC
glimepiride; oral
3.1
41.8
191
668
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.4
41.4
161
511
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.8
40.9
133
375
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.7
40.7
77
140
SPAT1262
SPAT
Handing over of treatment supplies
2.3
40.7
386
1937
Z2221
NOMESCO Finland
Medical doctor
2.1
39.1
491
2750
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.8
39.0
123
339
H02AB04
ATC
methylprednisolone; systemic
2.5
38.9
295
1339
A41.8
ICD-10 Finland
Other specified sepsis
5.7
38.7
74
136
PC2DE
NOMESCO Finland
Ultrasound examination of liver vasculature with Doppler method
+∞
38.7
37
*
UJK02
NOMESCO Finland
ERCP
4.9
38.6
87
185
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.5
38.6
270
1180
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
38.5
345
1686
PHD76
NOMESCO Finland
Resection of long saphenous vein
386.1
38.2
38
*
R50.9
ICD-10 Finland
Fever, unspecified
2.4
38.1
324
1546
C10AC01
ATC
colestyramine; oral
5.1
38.1
81
164
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.3
37.9
156
512
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
8.5
37.8
49
59
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.2
37.6
374
1906
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
6.4
37.5
63
102
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
3.3
37.2
153
502
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
6.1
37.0
65
110
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
36.8
344
1707
ZXD05
NOMESCO Finland
Urgent procedure
2.0
36.8
548
3256
4549X
ICD-9 Finland
Varicose veins of lower extremities, Without mention of ulcer or inflammation
+∞
36.6
35
*
A46
ICD-10 Finland
Erysipelas
2.4
36.4
306
1451
K70.2
ICD-10 Finland
Alcoholic fibrosis and sclerosis of liver
61.5
36.3
42
7
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
7.7
36.2
51
68
B80
ICPC
Iron deficiency anaemia
5.3
35.8
74
146
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
11.4
35.4
37
33
JN4BD
NOMESCO Finland
Extensive body CT
2.6
35.1
238
1022
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
5.4
34.7
70
135
G93.4
ICD-10 Finland
Encephalopathy, unspecified
40.1
34.5
43
11
AA1AD
NOMESCO Finland
CT of head and brain
2.0
34.4
577
3557
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
10.5
34.3
38
37
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.1
34.0
96
244
N02AA05
ATC
oxycodone; systemic
2.1
33.9
393
2119
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
6.5
33.9
56
89
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
6.8
33.7
53
80
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.4
33.5
124
380
JDA32
NOMESCO Finland
Endoscopic injection in stomach or pylorus
39.2
33.5
42
11
K86.1
ICD-10 Finland
Other chronic pancreatitis
8.1
33.3
45
57
WX882
NOMESCO Finland
High dependency care
4.2
33.2
90
222
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
33.1
595
3743
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.9
32.7
168
625
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.3
32.6
131
423
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
32.4
590
3721
N05CF01
ATC
zopiclone; oral
1.9
32.3
580
3642
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
6.5
31.7
52
82
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
37.2
31.6
40
11
P16
ICPC
Acute alcohol abuse
5.5
31.3
61
114
XW000
NOMESCO Finland
Bone marrow biopsy
3.4
30.7
116
360
3AC01, ,
NOMESCO Finland
8.7
30.6
39
46
R60.0
ICD-10 Finland
Localized oedema
2.4
30.5
247
1146
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
11.2
30.3
32
29
D50.8
ICD-10 Finland
Other iron deficiency anaemias
6.3
30.2
51
83
UJF92
NOMESCO Finland
Capsular endoscopy
4.9
30.1
67
141
K73.80
ICD-10 Finland
Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)
11.7
30.1
31
27
B82
ICPC
Anaemia other/unspecified
4.0
29.7
88
232
D25
ICPC
Abdominal distension
5.2
29.6
61
120
A40.8
ICD-10 Finland
Other streptococcal sepsis
7.1
29.3
44
63
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
29.2
570
3651
A10BH05
ATC
linagliptin; oral
3.0
29.1
138
491
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.8
29.0
158
606
5611
FHL
Vena saphena Magna and / or swarm of nodule and possible local emissions
297.0
28.9
29
*
Z3231
NOMESCO Finland
Registered nurse
1.9
28.7
494
3035
J01MA12
ATC
levofloxacin; systemic
2.0
28.5
369
2057
A41.9
ICD-10 Finland
Sepsis, unspecified
3.7
28.5
94
267
160
Kela drug reimbursment
exenatide
4.9
28.4
64
136
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
6.7
27.7
44
67
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
7.0
27.6
42
61
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
6.3
27.6
47
77
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
7.8
27.3
38
50
UJC12
NOMESCO Finland
Flexible oesophagoscopy
7.5
27.2
39
53
5712A
ICD-9 Finland
Chronic liver disease and cirrhosis, Alcoholic cirrhosis of liver
+∞
27.2
26
*
N05BA04
ATC
oxazepam; oral
1.9
27.1
450
2725
ZXE00
NOMESCO Finland
One hour or less
1.8
27.0
641
4333
E87.5
ICD-10 Finland
Hyperkalaemia
5.0
26.8
58
119
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
275.4
26.8
27
*
ZX108
NOMESCO Finland
Inhalation
8.7
26.7
34
40
R60.9
ICD-10 Finland
Oedema, unspecified
3.0
26.7
122
425
B01AB05
ATC
enoxaparin; parenteral
1.8
26.6
520
3312
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.5
26.4
38
52
K26.9
ICD-10 Finland
Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation
7.2
26.3
39
55
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
5.4
26.2
52
99
198
Kela drug reimbursment
Sorafenib
23.6
26.2
37
16
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.1
25.8
112
378
Z3226
NOMESCO Finland
Physiotherapist
2.0
25.8
330
1825
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
4.6
25.6
62
140
K29.3
ICD-10 Finland
Chronic superficial gastritis
3.5
25.4
88
258
D64.8
ICD-10 Finland
Other specified anaemias
4.6
25.3
60
133
L04AA01
ATC
[U] ciclosporin
6.5
25.2
41
64
SPAT1265
SPAT
Breathalyser
6.9
25.1
39
58
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
59.0
25.1
29
5
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.3
24.9
97
307
S97
ICPC
Chronic ulcer skin
2.7
24.8
138
534
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.9
24.6
122
444
JCA42
NOMESCO Finland
Other endoscopic procedure for hemostasis
43.6
24.6
30
7
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.7
24.6
145
578
TJA10
NOMESCO Finland
Laparocentesis
22.3
24.4
35
16
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
24.3
300
1636
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
4.7
24.2
56
122
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
6.3
24.2
41
67
Z72.1
ICD-10 Finland
Alcohol use
5.3
24.0
48
92
M04AA01
ATC
allopurinol; systemic
2.1
24.0
279
1489
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.7
23.9
132
509
A02BC01
ATC
omeprazole; systemic
1.8
23.9
464
2934
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
6.3
23.7
40
65
JDA22
NOMESCO Finland
Endoscopic ligature of varices of stomach
47.4
23.4
28
6
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.4
23.3
59
138
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
6.6
23.1
37
57
K86.3
ICD-10 Finland
Pseudocyst of pancreas
9.2
23.0
28
31
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.8
22.8
123
468
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
3.9
22.8
68
180
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
4.0
22.8
66
171
WVA20
NOMESCO Finland
Medicine administration
3.6
22.7
76
218
WX872
NOMESCO Finland
Intensive care
2.7
22.7
130
511
SPAT1255
SPAT
Intravenous administration of medicine
2.5
22.4
143
593
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
22.2
273
1482
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
22.1
667
4748
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
29.5
21.9
29
10
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.0
21.8
99
343
SPAT1088
SPAT
Blood transfusion
18.7
21.8
33
18
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
5.2
21.7
45
89
R41.0
ICD-10 Finland
Disorientation, unspecified
3.3
21.6
82
255
N06AX11
ATC
mirtazapine; oral
1.7
21.5
557
3802
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
4.1
21.3
59
148
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
23.5
21.3
30
13
R04.0
ICD-10 Finland
Epistaxis
2.4
21.2
160
716
J94.8
ICD-10 Finland
Other specified pleural conditions
4.7
21.1
49
107
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.2
21.0
199
979
A28
ICPC
Limited function/disability NOS
1.9
21.0
330
1944
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.5
21.0
140
592
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.6
21.0
129
525
S42.2
ICD-10 Finland
Fracture of upper end of humerus
2.9
21.0
101
362
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
60.8
20.9
24
*
D73.1
ICD-10 Finland
Hypersplenism
60.8
20.9
24
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.4
20.8
155
690
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
20.8
196
963
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
20.7
298
1705
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
20.7
443
2863
WZC00
NOMESCO Finland
Treatment plan or consultation
1.7
20.7
603
4236
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
4.3
20.5
53
126
N05CD07
ATC
temazepam; oral
2.1
20.5
222
1149
UJD10, ,
SPAT
3.6
20.5
68
194
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
18.6
20.4
31
17
E87.6
ICD-10 Finland
Hypokalaemia
3.1
20.4
87
291
K22.1
ICD-10 Finland
Ulcer of oesophagus
4.3
20.3
53
127
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.8
20.3
105
391
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.3
20.1
78
246
E66.00
ICD-10 Finland
Metabolic syndrome
2.6
20.1
119
475
JDA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in stomach or pylorus
27.4
20.1
27
10
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.6
19.9
67
193
K29.1
ICD-10 Finland
Other acute gastritis
5.4
19.7
39
74
K70
ICD-10 Finland
Alcoholic liver disease
106.3
19.6
21
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.0
19.5
239
1293
N17.8
ICD-10 Finland
Other acute renal failure
5.2
19.3
40
79
A10BX04
ATC
[U] exenatide
5.8
19.3
35
61
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
31.7
19.3
25
8
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.9
19.2
42
87
K42.0
ICD-10 Finland
Umbilical hernia with obstruction, without gangrene
5.4
19.2
38
72
RS220, ,
NOMESCO Finland
5.4
19.2
38
72
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
5.6
19.2
36
65
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
6.8
19.2
30
45
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.1
19.1
195
986
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
6.1
19.1
33
55
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
4.9
18.8
41
85
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.0
18.8
53
135
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
28.2
18.7
25
9
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
6.0
18.7
33
56
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.1
18.7
81
273
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
70.7
18.7
21
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
7.8
18.7
26
34
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
7.4
18.7
27
37
K25.3
ICD-10 Finland
Gastric ulcer, Acute without haemorrhage or perforation
6.1
18.6
32
53
1324
FHL
Esophagoscopy and sclerotherapy
192.1
18.6
19
*
C10AA07
ATC
rosuvastatin; oral
0.5
18.4
276
4433
177
Kela drug reimbursment
Insulin glargine 300 U / ml
3.9
18.3
54
142
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
3.7
18.3
57
156
A10AD05
ATC
insulin aspart; parenteral
4.2
18.2
48
116
F10.09
ICD-10 Finland
Alcohol intoxication UNS
3.7
18.1
58
162
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.3
18.0
67
206
A10BG03
ATC
pioglitazone; oral
3.4
17.8
64
193
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.5
17.7
141
2790
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
17.7
467
3171
PHM76
NOMESCO Finland
Endovenous obliteration of v.saphena magna
181.9
17.5
18
*
Z94.0
ICD-10 Finland
Kidney transplant status
5.2
17.5
36
71
ZXD35
NOMESCO Finland
Usual procedure
3.2
17.4
70
226
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
17.4
348
2192
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.3
17.2
66
207
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.8
17.2
86
315
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.6
17.2
105
426
K26.0
ICD-10 Finland
Duodenal ulcer, acute with haemorrhage
5.8
17.1
31
54
A98
ICPC
Health maint/preventive medicine
0.6
17.1
1335
14555
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
7.2
17.0
25
35
A10BD07
ATC
metformin and sitagliptin; systemic
2.6
16.9
100
399
N19
ICD-10 Finland
Unspecified kidney failure
2.8
16.8
87
324
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.8
16.8
85
313
J01FF01
ATC
clindamycin; systemic
1.7
16.8
434
2927
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
16.6
129
584
UJK12
NOMESCO Finland
Peroral cholangioscopy
27.8
16.5
22
8
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.9
16.5
80
288
K29.2
ICD-10 Finland
Alcoholic gastritis
12.3
16.3
29
24
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
14.4
16.3
27
19
V03AE01
ATC
polystyrene sulfonate; oral
4.4
16.2
41
96
OAB43, ,
SPAT
0.4
16.2
100
2186
K55.0
ICD-10 Finland
Acute vascular disorders of intestine
7.1
16.1
24
34
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
16.1
309
1921
K65.8
ICD-10 Finland
Other peritonitis
13.7
16.0
27
20
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
21.2
16.0
23
11
A10BB01
ATC
glibenclamide; oral
2.8
16.0
83
310
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.4
16.0
57
171
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
6.9
15.7
24
35
4561A
ICD-9 Finland
Varicose veins of other sites, Oesophageal varices without mention of bleeding
+∞
15.6
15
*
R4190
NOMESCO Finland
Nutritional therapy
2.7
15.6
85
325
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
15.5
133
627
JCA35
NOMESCO Finland
Endoscopic contact coagulation in oesophagus
161.5
15.5
16
*
JAH00
NOMESCO Finland
Laparotomy
3.1
15.5
66
221
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
4.5
15.5
37
83
G62.1
ICD-10 Finland
Alcoholic polyneuropathy
12.5
15.4
27
22
M10.9
ICD-10 Finland
Gout, unspecified
2.1
15.1
150
749
WX402
NOMESCO Finland
General anaesthesia
1.7
15.1
368
2436
WX730
NOMESCO Finland
Conventional respirator
4.1
15.0
41
102
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
15.0
578
4264
K85
ICD-10 Finland
Acute pancreatitis
3.8
14.9
46
125
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
6.0
14.8
26
44
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.7
14.7
80
306
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
13.3
14.7
25
19
A10BJ02
ATC
liraglutide; parenteral
3.1
14.7
60
196
L01XE05
ATC
[U] sorafenib
21.3
14.7
21
10
K75.4
ICD-10 Finland
Autoimmune hepatitis
21.3
14.7
21
10
I86.8
ICD-10 Finland
Varicose veins of other specified sites
80.8
14.6
16
*
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
14.5
119
551
A10BX07
ATC
[U] liraglutide
4.4
14.3
36
84
WW200, ,
SPAT
0.6
14.3
233
3710
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
3.7
14.2
45
125
A10AE06
ATC
insulin degludec; parenteral
2.7
14.1
76
290
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.2
13.9
55
176
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
30.3
13.9
18
6
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
13.8
125
602
N06AB04
ATC
citalopram; systemic
1.7
13.8
314
2035
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
11.5
13.8
25
22
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.5
13.7
87
359
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
3.6
13.7
45
128
L28
ICPC
Limited function/disability (L)
1.7
13.7
312
2024
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.6
13.7
78
306
K85.2
ICD-10 Finland
Alcohol-induced acute pancreatitis
6.5
13.7
22
34
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
3.9
13.6
40
105
205
Kela drug reimbursment
Chronic hypertension
1.6
13.6
472
3386
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.0
13.6
148
765
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
75.8
13.6
15
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
4.5
13.6
33
75
5716A
ICD-9 Finland
Chronic liver disease and cirrhosis, Biliary cirrhosis[CIRRHOSIS BILIARIS PRIMARIA]
+∞
13.6
13
*
N05BA01
ATC
diazepam; systemic, rectal
1.8
13.5
209
1215
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
16.4
13.5
21
13
K76.89
ICD-10 Finland
Other specified diseases of liver
16.4
13.5
21
13
WX419
NOMESCO Finland
Other general anesthesy
5.6
13.4
25
45
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
26.0
13.4
18
7
K08.3
ICD-10 Finland
Retained dental root
2.0
13.4
152
798
SPAT1254
SPAT
Administration of medicine
1.8
13.3
231
1389
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
13.3
552
4114
K80.3
ICD-10 Finland
Calculus of bile duct with cholangitis
5.4
13.3
26
49
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
13.3
213
3416
B01AB10
ATC
tinzaparin; parenteral
1.9
13.2
177
983
K55.8
ICD-10 Finland
Other vascular disorders of intestine
11.1
13.0
24
22
T89
ICPC
Diabetes insulin dependent
2.5
13.0
80
326
JJA21
NOMESCO Finland
Laparoscopic biopsy of liver
28.6
13.0
17
6
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
3.7
13.0
40
109
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
3.9
12.9
38
100
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
4.5
12.9
31
70
M01AH05
ATC
etoricoxib; oral
0.7
12.9
643
8008
A08
ICPC
Swelling
2.3
12.8
97
435
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.2
12.7
108
508
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.3
12.7
32
75
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
2.6
12.7
73
288
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
12.7
435
3106
N05AH04
ATC
quetiapine; oral
1.7
12.7
260
1638
1508
Kela drug reimbursment
Lenvatinib
70.4
12.6
14
*
3019
Kela drug reimbursment
Lenvatinib
70.4
12.6
14
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.6
12.6
72
283
XCK10
NOMESCO Finland
Photography of fundus of eye
1.9
12.6
169
939
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.3
12.5
98
445
K74.2
ICD-10 Finland
Hepatic fibrosis with hepatic sclerosis
+∞
12.5
12
*
I98.2
ICD-10 Finland
Oesophageal varices without bleeding in diseases classified elsewhere
+∞
12.5
12
*
I82.0
ICD-10 Finland
Budd-Chiari syndrome
+∞
12.5
12
*
ZXA00
NOMESCO Finland
Right side
1.6
12.5
412
2916
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
5.7
12.4
23
41
A02BA03
ATC
famotidine; systemic
2.6
12.4
74
297
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
2.9
12.4
59
211
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
12.3
362
2492
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
12.3
77
316
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
5.4
12.3
24
45
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.9
12.2
173
977
A07AA09
ATC
vancomycin; oral
4.0
12.2
34
86
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
12.2
221
1344
K63.5
ICD-10 Finland
Polyp of colon
2.9
12.2
56
196
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
16.0
12.1
19
12
K55.2
ICD-10 Finland
Angiodysplasia of colon
6.1
12.1
21
35
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.4
12.1
82
350
A40.9
ICD-10 Finland
Streptococcal sepsis, unspecified
18.2
12.1
18
10
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
2.9
12.0
55
192
WX213
NOMESCO Finland
Lower leg blockade
5.3
12.0
24
46
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
12.0
562
4271
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
3.0
12.0
51
171
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
12.0
231
1430
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
4.0
11.9
33
83
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
4.0
11.9
33
83
N18.8
ICD-10 Finland
Other chronic renal failure
3.0
11.9
53
182
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.0
11.8
52
178
A02BC03
ATC
lansoprazole; oral
1.5
11.8
442
3209
N05AB01
ATC
dixyrazine; systemic
4.1
11.7
32
80
K65.9
ICD-10 Finland
Peritonitis, unspecified
16.5
11.7
18
11
3A422, ,
NOMESCO Finland
30.3
11.6
15
5
162
Kela drug reimbursment
liraglutide
4.1
11.6
31
76
H02AB09
ATC
hydrocortisone; systemic
3.1
11.5
48
159
E0000UV, ,
ATC
1.5
11.5
589
4548
L04AA10
ATC
[U] sirolimus
120.8
11.4
12
*
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
2.5
11.4
71
291
K07
ICPC
Swollen ankles/oedema
2.4
11.4
81
353
R53
ICD-10 Finland
Malaise and fatigue
1.5
11.3
363
2544
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
15.1
11.3
18
12
UJF02
NOMESCO Finland
Peroral enteroscopy
8.4
11.3
24
29
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
9.7
11.2
22
23
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
11.2
155
868
B01AB04
ATC
dalteparin; parenteral
2.3
11.2
82
362
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.3
11.2
82
362
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
4.8
11.2
25
53
Z71.4
ICD-10 Finland
Alcohol abuse counselling and surveillance
5.6
11.2
21
38
ZXE90
NOMESCO Finland
More than 22 hours
5.6
11.2
21
38
J01DB01
ATC
cefalexin; oral
1.5
11.1
1275
11410
K51.5
ICD-10 Finland
Left sided colitis
2.9
11.1
51
179
D69.5
ICD-10 Finland
Secondary thrombocytopenia
11.2
11.0
20
18
S76
ICPC
Skin infection other
2.2
11.0
91
423
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.1
11.0
112
565
F10.4
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium
14.0
11.0
18
13
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.1
11.0
46
153
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
10.9
207
1273
W19
ICD-10 Finland
Unspecified fall
1.8
10.8
161
923
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
2.2
10.8
90
420
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
10.8
291
1959
R94.5
ICD-10 Finland
Abnormal results of liver function studies
4.3
10.8
27
63
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
9.7
10.8
21
22
R40.2
ICD-10 Finland
Coma, unspecified
4.5
10.7
26
59
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
28.2
10.7
14
5
I78.8
ICD-10 Finland
Other diseases of capillaries
21.6
10.7
15
7
B02AA02
ATC
tranexamic acid; systemic
1.8
10.7
167
973
RS120, ,
NOMESCO Finland
13.0
10.6
18
14
N03AX16
ATC
[U] pregabalin
1.5
10.6
344
2412
N05BA02
ATC
chlordiazepoxide; systemic
2.8
10.6
54
200
OAA67, ,
SPAT
0.4
10.6
48
1206
130
Kela drug reimbursment
Malignant tumour
1.8
10.6
169
990
I50
ICD-10 Finland
Heart failure
2.7
10.5
54
201
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
10.5
309
2120
D45
ICD-10 Finland
Polycythaemia vera
4.5
10.5
25
56
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
14.3
10.5
17
12
JJA20
NOMESCO Finland
Open biopsy of liver
14.3
10.5
17
12
E000001, ,
ATC
1.6
10.4
268
1782
PH3YT
NOMESCO Finland
Insertion of catheter from portal vein to liver vein (TIPS)
+∞
10.4
10
*
K31.7
ICD-10 Finland
Polyp of stomach and duodenum
7.8
10.4
23
30
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
16.1
10.4
16
10
A12BA01
ATC
potassium chloride; oral
2.3
10.3
75
330
K86.2
ICD-10 Finland
Cyst of pancreas
4.3
10.3
26
61
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
2.3
10.3
81
369
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.0
10.3
115
600
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
4.1
10.2
28
70
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
3.1
10.2
42
138
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
3.8
10.2
30
79
A10BK03
ATC
empagliflozin; oral
1.7
10.2
197
1219
3A064, ,
NOMESCO Finland
13.2
10.2
17
13
D05AX52
ATC
calcipotriol, combinations; topical
2.1
10.1
93
451
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.6
10.1
57
223
K29.8
ICD-10 Finland
Duodenitis
4.5
10.0
24
54
C10AA05
ATC
atorvastatin; oral
0.7
10.0
467
5995
TPH04, ,
SPAT
4.1
10.0
27
67
R11
ICD-10 Finland
Nausea and vomiting
1.9
9.9
134
745
K02.9
ICD-10 Finland
Dental caries, unspecified
3.2
9.9
38
120
XX4BW, ,
NOMESCO Finland
16.8
9.9
15
9
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
12.3
9.9
17
14
R06.0
ICD-10 Finland
Dyspnoea
1.5
9.9
426
3166
R02
ICPC
Shortness of breath/dyspnoea
1.7
9.8
213
1357
RS221, ,
NOMESCO Finland
3.7
9.8
31
86
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
26.2
9.8
13
5
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
4.7
9.8
22
47
B01AA03
ATC
warfarin; systemic
1.6
9.7
283
1936
H26.3
ICD-10 Finland
Drug-induced cataract
7.4
9.7
22
30
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
9.7
242
1598
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.4
9.7
65
277
A10BJ01
ATC
exenatide; parenteral
4.2
9.6
25
60
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.7
9.6
52
199
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.6
9.6
234
3427
JAF30
NOMESCO Finland
Repair of umbilical hernia using prosthetic material
2.7
9.6
51
194
N05CF02
ATC
zolpidem; oral
1.6
9.6
246
1635
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
4.8
9.5
21
44
D50
ICD-10 Finland
Iron deficiency anaemia
3.1
9.5
39
128
Z53.0
ICD-10 Finland
Procedure not carried out because of contraindication
15.1
9.5
15
10
K74
ICD-10 Finland
Fibrosis and cirrhosis of liver
100.6
9.4
10
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.8
9.4
47
173
4520A
ICD-9 Finland
Portal vein thrombosis[THROMBOSIS VENAE PORTAE]
+∞
9.4
9
*
K86.01
ICD-10 Finland
Late effects of pancreatitis caused by alcohol
12.4
9.4
16
13
SPAT1263
SPAT
Sampling
1.4
9.3
580
4599
K29.4
ICD-10 Finland
Chronic atrophic gastritis
3.1
9.3
38
125
A02BD07
ATC
lansoprazole, amoxicillin and clarithromycin; systemic
2.1
9.2
85
414
A07EC02
ATC
mesalazine; oral, rectal
2.1
9.1
85
415
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.1
9.1
81
389
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
4.8
9.1
20
42
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
9.1
9.0
18
20
L01EX08
ATC
lenvatinib; oral
36.9
9.0
11
*
J01DA01
ATC
[U] cefalexin
1.4
9.0
893
7627
A10BJ06
ATC
semaglutide; parenteral
2.0
9.0
99
515
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
2.6
8.9
51
201
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
3.5
8.9
30
87
JAF10
NOMESCO Finland
Repair of umbilical hernia
2.6
8.9
52
207
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
7.5
8.9
20
27
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.6
8.9
204
1317
C10AX09
ATC
ezetimibe; oral
0.6
8.9
135
2223
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
8.0
8.9
19
24
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.5
8.8
21
47
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
6.8
8.8
21
31
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.1
8.8
35
113
H02AB06
ATC
prednisolone; systemic
1.4
8.8
711
5868
SPAT1104
SPAT
Monitoring of emergency patient
1.9
8.8
105
561
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.3
8.7
68
309
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
3.5
8.7
29
84
K26.3
ICD-10 Finland
Duodenal ulcer, acute without haemorrhage or perforation
7.7
8.6
19
25
I50.0
ICD-10 Finland
Congestive heart failure
1.8
8.6
122
689
H02AB07
ATC
prednisone; oral
1.6
8.6
196
1264
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
4.6
8.6
20
44
OAA80, ,
SPAT
0.3
8.6
24
762
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.6
8.6
236
3376
L01EX02
ATC
sorafenib; oral
16.4
8.6
13
8
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.0
8.5
37
126
D07AC01
ATC
betamethasone; topical
1.4
8.5
528
4170
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
2.0
8.5
97
511
S01.0
ICD-10 Finland
Open wound of scalp
1.7
8.5
144
859
K92.9
ICD-10 Finland
Disease of digestive system, unspecified
7.4
8.4
19
26
S82.6
ICD-10 Finland
Fracture of lateral malleolus
1.9
8.4
98
519
N06AB10
ATC
escitalopram; oral
1.5
8.4
253
1739
JJA44
NOMESCO Finland
Laparoscopic destruction of lesion of liver
90.5
8.4
9
*
SPAT1122
SPAT
Ascites puncture
90.5
8.4
9
*
A11CC03
ATC
alfacalcidol; systemic
2.6
8.4
46
178
TJC00
NOMESCO Finland
Insertion of ballon tube for tamponade of oesophageal varices
+∞
8.3
8
*
5612
FHL
Local excisions and / or perforations of relapsing varicose veins
+∞
8.3
8
*
B18.8
ICD-10 Finland
Other chronic viral hepatitis
+∞
8.3
8
*
45600
ICD-8 Finland
Varicose veins of other sites, Of oesophagus
+∞
8.3
8
*
ZXE20
NOMESCO Finland
More than three and less than five hours
1.6
8.3
214
1420
P19
ICPC
Drug abuse
8.6
8.3
17
20
E86
ICD-10 Finland
Volume depletion
2.5
8.3
49
197
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
7.1
8.3
19
27
E88.0
ICD-10 Finland
Disorders of plasma-protein metabolism, not elsewhere classified
14.5
8.2
13
9
P01AB01
ATC
metronidazole; oral, rectal
1.4
8.2
536
4264
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.1
8.2
74
358
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
7.6
8.2
18
24
K26.4
ICD-10 Finland
Duodenal ulcer, chronic or unspecified with haemorrhage
7.6
8.2
18
24
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
8.2
112
627
L40.9
ICD-10 Finland
Psoriasis, unspecified
3.1
8.1
33
108
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.6
8.1
44
169
TQW80
NOMESCO Finland
Local dermatologic skincare
2.7
8.1
42
158
WX004
NOMESCO Finland
Patient-controlled sedation
8.2
8.1
17
21
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
33.5
8.1
10
*
L01BB01, ,
ATC
33.5
8.1
10
*
D23
ICPC
Hepatomegaly
33.5
8.1
10
*
A07EA06
ATC
budesonide; oral, local oral
2.3
8.1
57
249
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.2
8.0
69
327
GD1AD
NOMESCO Finland
Thorax CT examination
1.8
8.0
112
630
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
22.1
8.0
11
5
SPAT1247
SPAT
Outpatient detoxication and monitoring
7.3
8.0
18
25
R60.1
ICD-10 Finland
Generalized oedema
7.3
8.0
18
25
A10BB07
ATC
glipizide; oral
3.5
8.0
27
79
0092A
ICD-9 Finland
Ill-defined intestinal infections, Infectious diarrhoea
4.3
7.9
20
47
A10AB06
ATC
insulin glulisine; parenteral
3.7
7.9
24
65
A10AB04
ATC
insulin lispro; parenteral
2.4
7.9
52
220
S22.4
ICD-10 Finland
Multiple fractures of ribs
2.6
7.9
43
166
A02BC05
ATC
esomeprazole; systemic
1.4
7.9
592
4809
V03AA01, ,
ATC
2.9
7.8
36
127
323
Kela drug reimbursment
Sorafenib
10.8
7.8
14
13
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
9.4
7.8
15
16
Z10.0
ICD-10 Finland
Occupational health examination
0.3
7.8
22
693
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
3.7
7.7
24
66
G92
ICD-10 Finland
Toxic encephalopathy
45.2
7.7
9
*
2BB01, ,
NOMESCO Finland
45.2
7.7
9
*
Q44.29
ICD-10 Finland
Atresia of bile ducts
45.2
7.7
9
*
Q44.21
ICD-10 Finland
Atresia of extrahepatic bile ducts
45.2
7.7
9
*
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.3
7.7
57
254
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.4
7.7
49
204
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.5
7.7
48
198
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
2.3
7.7
56
248
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
7.5
7.7
17
23
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
7.5
7.7
17
23
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
7.7
139
845
D05AX02
ATC
calcipotriol; topical
2.2
7.6
63
294
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
7.6
389
2963
D73.5
ICD-10 Finland
Infarction of spleen
18.4
7.6
11
6
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.1
7.6
71
348
D77
ICPC
Malignant digestive neopl other/NOS
6.7
7.6
18
27
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.8
7.6
117
679
A41.2
ICD-10 Finland
Sepsis due to unspecified staphylococcus
25.1
7.6
10
*
TJA00
NOMESCO Finland
Puncture of peritoneum
25.1
7.6
10
*
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
7.6
306
2233
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
8.9
7.5
15
17
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
2.6
7.5
41
159
A10
ICPC
Bleeding/haemorrhage NOS
3.9
7.4
21
54
L04AH02
ATC
everolimus; oral
80.4
7.4
8
*
K74.4
ICD-10 Finland
Secondary biliary cirrhosis
80.4
7.4
8
*
L04AA18
ATC
[U] everolimus
80.4
7.4
8
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.4
7.4
50
214
N05BB01
ATC
hydroxyzine; systemic
2.0
7.4
81
421
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.1
7.4
71
352
N06AX16
ATC
venlafaxine; oral
1.6
7.3
182
1197
A04
ICPC
Weakness/tiredness general
1.5
7.3
210
1428
4511A
ICD-9 Finland
Phlebitis and thrombophlebitis, Of deep vessels of lower extremities
+∞
7.3
7
*
JJ9AT
NOMESCO Finland
Sampling of liver transplant under radiological guidance
+∞
7.3
7
*
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
6.9
7.3
17
25
N06AB03
ATC
fluoxetine; oral
1.6
7.3
169
1094
ND2AA, ,
SPAT
0.2
7.3
8
366
A03
ICPC
Fever
1.5
7.3
214
1463
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
4.2
7.3
19
46
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
7.3
149
936
SPAT1269
SPAT
Other puncture and/or drainage
6.3
7.2
18
29
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.9
7.2
87
467
JAH01
NOMESCO Finland
Laparoscopy
2.2
7.2
60
281
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
7.2
381
2915
B03XA02
ATC
darbepoetin alfa; parenteral
2.5
7.2
44
180
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.7
7.2
125
751
JLD12
NOMESCO Finland
Endoscopic drainage of pancreatic pseudocyst
30.1
7.1
9
*
D14
ICPC
Haematemesis/vomiting blood
20.1
7.1
10
5
PC2SC
NOMESCO Finland
Liver angiography with X-ray
20.1
7.1
10
5
WVA20, ,
SPAT
2.1
7.1
62
296
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
7.1
186
1239
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
8.0
7.1
15
19
XF612
NOMESCO Finland
Measurement of central venous pressure
12.1
7.1
12
10
A12AA04
ATC
calcium carbonate; oral
2.9
7.1
32
112
TPH00
NOMESCO Finland
Phlebotomy
5.6
7.1
19
34
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.9
7.1
87
471
IAB10
NOMESCO Finland
Psychiatric consultation concerning substance abuse
10.1
7.0
13
13
SPAT1281
SPAT
Other administrative function
1.8
7.0
111
649
D09AB01
ATC
zinc bandage without supplements; topical
2.9
7.0
31
107
JFB00
NOMESCO Finland
Partial resection of small intestine
2.9
7.0
31
107
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
7.0
7.0
16
23
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.1
7.0
67
332
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.7
6.9
118
705
A07AA02
ATC
nystatin; oral
1.9
6.9
86
467
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
5.5
6.9
19
35
EB4VA, ,
NOMESCO Finland
0.6
6.9
92
1576
NB6AA
NOMESCO Finland
Humerus X-ray examination
2.6
6.9
39
154
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.3
6.9
48
209
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
6.8
216
1499
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
6.8
152
974
D07XC01
ATC
betamethasone; topical
1.6
6.8
184
1234
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
4.1
6.8
18
44
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.7
6.8
34
126
XX9XW, ,
NOMESCO Finland
6.1
6.8
17
28
K02.2
ICD-10 Finland
Caries of cementum
1.9
6.8
84
456
OAB50, ,
SPAT
1.7
6.8
134
834
A10BK01
ATC
dapagliflozin; oral
1.7
6.8
135
842
SPAT1227
SPAT
Substance abuse rehabilitation
5.7
6.8
18
32
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
5.7
6.8
18
32
E14.8
ICD-10 Finland
Unspecified diabetes mellitus, with unspecified complications
5.7
6.8
18
32
4AA09, ,
NOMESCO Finland
40.2
6.8
8
*
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.8
6.7
95
537
D07AD01
ATC
clobetasol; topical
1.5
6.7
226
1588
L17
ICPC
Foot/toe symptom/complaint
1.4
6.7
421
3308
K90.0
ICD-10 Finland
Coeliac disease
2.5
6.7
42
174
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
6.7
181
1214
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.2
6.7
52
237
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
6.7
188
1272
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.2
6.7
57
270
R77.0
ICD-10 Finland
Abnormality of albumin
22.6
6.7
9
*
K42.1
ICD-10 Finland
Umbilical hernia with gangrene
22.6
6.7
9
*
R10.0
ICD-10 Finland
Acute abdomen
2.3
6.6
47
206
C02EA02, ,
ATC
2.0
6.6
66
332
E83.1
ICD-10 Finland
Disorders of iron metabolism
5.9
6.6
17
29
SPAT1229
SPAT
Assessment of need for aid
1.7
6.6
109
646
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
0.1
6.5
*
265
318
Kela drug reimbursment
Teriparatide
6.9
6.5
15
22
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
5.3
6.5
18
34
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.4
6.4
44
190
JKD50
NOMESCO Finland
Hepatoportoenterostomy
70.1
6.4
7
*
K76.4
ICD-10 Finland
Peliosis hepatis
70.1
6.4
7
*
Q61.1
ICD-10 Finland
Polycystic kidney, autosomal recessive
70.1
6.4
7
*
PHD78
NOMESCO Finland
Resection of communicating veins of lower leg and thigh
70.1
6.4
7
*
RS321, ,
NOMESCO Finland
70.1
6.4
7
*
N30.0
ICD-10 Finland
Acute cystitis
1.5
6.4
191
1309
R04.2
ICD-10 Finland
Haemoptysis
2.1
6.4
61
302
I78.0
ICD-10 Finland
Hereditary haemorrhagic telangiectasia
14.4
6.4
10
7
L40
ICD-10 Finland
Psoriasis
2.6
6.4
35
136
X57
ICD-10 Finland
Unspecified privation
2.5
6.4
37
148
A02BA04
ATC
nizatidine; systemic
1.7
6.4
111
668
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
6.4
116
707
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
11.1
6.3
11
10
JDA35
NOMESCO Finland
Endoscopic contact coagulation in stomach or pylorus
11.1
6.3
11
10
UJG02
NOMESCO Finland
Proctoscopy
2.5
6.3
38
155
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
6.3
400
3147
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
3.4
6.3
22
66
PHD77
NOMESCO Finland
Resection of short saphenous vein
+∞
6.3
6
*
45299
ICD-8 Finland
Portal vein thrombosis
+∞
6.3
6
*
JJC60
NOMESCO Finland
Total excision of transplanted liver
+∞
6.3
6
*
BE00A, ,
NOMESCO Finland
+∞
6.3
6
*
PHD79, ,
NOMESCO Finland
+∞
6.3
6
*
28920
ICD-8 Finland
Other disease of blood and blood-forming organs, Nonspecific mesenteric lymphadenitis
+∞
6.3
6
*
JKA20
NOMESCO Finland
Cholecystectomy
2.3
6.3
45
199
C09AA02
ATC
enalapril; systemic
1.4
6.2
302
2272
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
2.8
6.2
30
109
FFM32
NOMESCO Finland
Occlusion or excision of atrial appendage transvenously with a closing device
26.8
6.2
8
*
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
26.8
6.2
8
*
474, ,
NOMESCO Finland
26.8
6.2
8
*
I83
ICD-10 Finland
Varicose veins of lower extremities
3.5
6.2
20
57
5BA08, ,
NOMESCO Finland
6.3
6.2
15
24
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
2.1
6.1
56
273
RS122, ,
NOMESCO Finland
7.7
6.1
13
17
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.7
6.1
104
622
K94
ICPC
Phlebitis/thrombophlebitis
4.1
6.1
16
39
E51.2
ICD-10 Finland
Wernicke encephalopathy
12.6
6.1
10
8
N02BE01
ATC
paracetamol; systemic, rectal
0.7
6.1
1210
12969
K61.0
ICD-10 Finland
Anal abscess
2.8
6.1
29
105
SPAT1240
SPAT
Therapeutic discussion
1.7
6.1
112
685
K75.0
ICD-10 Finland
Abscess of liver
8.6
6.1
12
14
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
6.7
6.0
14
21
5781A
ICD-9 Finland
Gastro-intestinal haemorrhage, Melaena[MELAENA]
10.1
6.0
11
11
A10BG02
ATC
rosiglitazone; oral
2.7
6.0
30
111
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.9
6.0
72
387

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
ursodeoxycholic acid; oral
A05AA02 [21600513]
3.5e+00
3.8e+00
3.7e+00
—
3.9e+00
4.0e+00
4.0e+00
cases:5.23%
controls:0.17%
cases:5.72%
controls:0.14%
cases:2.58%
controls:0.07%
—
—
cases:2.61%
controls:0.06%
cases:7.39%
controls:0.15%
cases:8.23%
controls:0.17%
85
28
1539
16195
93
22
1532
16210
42
11
1583
16221
—
40
9
1494
16198
102
23
1278
15712
83
22
925
13133
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
2.3e+00
3.5e+00
4.9e+00
—
4.8e+00
4.0e+00
3.3e+00
cases:13.79%
controls:1.58%
cases:19.69%
controls:0.75%
cases:8.06%
controls:0.07%
—
—
cases:8.60%
controls:0.08%
cases:23.91%
controls:0.58%
cases:36.81%
controls:2.15%
224
256
1400
15967
320
121
1305
16111
131
11
1494
16221
—
132
13
1402
16194
330
91
1050
15644
371
283
637
12872
spironolactone; oral
C03DA01 [21601534]
2.1e+00
2.9e+00
3.3e+00
3.6e+00
3.7e+00
3.5e+00
3.3e+00
cases:12.93%
controls:1.78%
cases:23.45%
controls:1.59%
cases:10.52%
controls:0.44%
cases:1.11%
controls:0.03%
cases:16.10%
controls:0.48%
cases:38.62%
controls:1.89%
cases:45.83%
controls:2.91%
210
288
1414
15935
381
258
1244
15974
171
72
1454
16160
18
5
1607
16227
247
78
1287
16129
533
298
847
15437
462
383
546
12772
Other and unspecified cirrhosis of liver
K74.6 [45538546]
4.5e+00
5.4e+00
—
—
—
6.4e+00
5.3e+00
cases:6.40%
controls:0.07%
cases:12.31%
controls:0.06%
—
—
—
—
—
—
cases:23.55%
controls:0.05%
cases:27.98%
controls:0.20%
104
12
1520
16211
200
10
1425
16222
—
—
—
325
8
1055
15727
282
26
726
13129
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
3.2e+00
4.1e+00
4.5e+00
1.0e+50
—
5.1e+00
4.4e+00
cases:5.17%
controls:0.22%
cases:8.37%
controls:0.15%
cases:3.32%
controls:0.04%
cases:1.54%
controls:0.00%
—
—
cases:15.58%
controls:0.11%
cases:26.59%
controls:0.45%
84
35
1540
16188
136
25
1489
16207
54
6
1571
16226
25
0
1600
16232
—
215
18
1165
15717
268
59
740
13096
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
2.5e+00
3.4e+00
4.1e+00
—
4.3e+00
3.4e+00
2.8e+00
cases:3.57%
controls:0.30%
cases:6.46%
controls:0.23%
cases:2.52%
controls:0.04%
—
—
cases:2.74%
controls:0.04%
cases:8.84%
controls:0.34%
cases:16.27%
controls:1.16%
58
48
1566
16175
105
37
1520
16195
41
7
1584
16225
—
42
6
1492
16201
122
53
1258
15682
164
152
844
13003
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
1.2e+00
2.2e+00
3.1e+00
5.3e+00
3.2e+00
2.6e+00
2.0e+00
cases:29.68%
controls:10.95%
cases:37.72%
controls:6.25%
cases:23.02%
controls:1.36%
cases:9.85%
controls:0.06%
cases:22.56%
controls:1.14%
cases:47.25%
controls:6.29%
cases:58.73%
controls:15.76%
482
1777
1142
14446
613
1015
1012
15217
374
220
1251
16012
160
9
1465
16223
346
185
1188
16022
652
989
728
14746
592
2073
416
11082
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1.2e+00
2.2e+00
3.2e+00
4.8e+00
3.4e+00
2.7e+00
2.1e+00
cases:24.75%
controls:9.28%
cases:32.37%
controls:5.19%
cases:18.15%
controls:0.89%
cases:3.69%
controls:0.03%
cases:19.82%
controls:0.81%
cases:44.13%
controls:5.10%
cases:55.75%
controls:13.33%
402
1506
1222
14717
526
843
1099
15389
295
144
1330
16088
60
5
1565
16227
304
131
1230
16076
609
803
771
14932
562
1753
446
11402
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
3.1e+00
4.1e+00
4.9e+00
1.0e+50
—
4.2e+00
3.0e+00
cases:8.68%
controls:0.44%
cases:12.12%
controls:0.22%
cases:3.82%
controls:0.03%
cases:0.31%
controls:0.00%
—
—
cases:8.26%
controls:0.14%
cases:9.92%
controls:0.56%
141
72
1483
16151
197
36
1428
16196
62
5
1563
16227
5
0
1620
16232
—
114
22
1266
15713
100
74
908
13081
Gastroenterology
10 [38004455]
1.7e+00
2.7e+00
3.4e+00
—
4.1e+00
3.8e+00
3.0e+00
cases:23.15%
controls:5.32%
cases:25.72%
controls:2.31%
cases:12.06%
controls:0.44%
—
—
cases:22.69%
controls:0.47%
cases:52.68%
controls:2.33%
cases:57.14%
controls:6.19%
376
863
1248
15360
418
375
1207
15857
196
72
1429
16160
—
348
76
1186
16131
727
366
653
15369
576
814
432
12341
Internal Medicine
11 [38004456]
1.0e+00
1.8e+00
2.7e+00
6.4e+00
2.8e+00
2.2e+00
1.8e+00
cases:43.41%
controls:21.68%
cases:36.25%
controls:8.50%
cases:16.00%
controls:1.28%
cases:20.25%
controls:0.04%
cases:18.19%
controls:1.31%
cases:45.29%
controls:8.37%
cases:61.61%
controls:20.34%
705
3517
919
12706
589
1380
1036
14852
260
207
1365
16025
329
7
1296
16225
279
213
1255
15994
625
1317
755
14418
621
2676
387
10479
Ascites
R18 [45548949]
4.1e+00
5.1e+00
—
1.0e+50
1.0e+50
4.6e+00
4.5e+00
cases:3.26%
controls:0.06%
cases:7.26%
controls:0.05%
—
—
cases:2.28%
controls:0.00%
cases:4.04%
controls:0.00%
cases:8.48%
controls:0.09%
cases:13.29%
controls:0.17%
53
9
1571
16214
118
8
1507
16224
—
37
0
1588
16232
62
0
1472
16207
117
14
1263
15721
134
23
874
13132
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19176-7 [3015916]
3.6e+00
4.5e+00
—
1.0e+50
—
5.5e+00
4.6e+00
cases:6.22%
controls:0.18%
cases:8.43%
controls:0.10%
—
—
cases:0.43%
controls:0.00%
—
—
cases:16.16%
controls:0.08%
cases:25.79%
controls:0.36%
101
30
1523
16193
137
16
1488
16216
—
7
0
1618
16232
—
223
12
1157
15723
260
47
748
13108
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
1.6e+00
2.4e+00
3.3e+00
1.0e+50
4.0e+00
3.8e+00
3.1e+00
cases:18.66%
controls:4.31%
cases:12.37%
controls:1.27%
cases:3.45%
controls:0.13%
cases:56.74%
controls:0.00%
cases:8.08%
controls:0.17%
cases:35.00%
controls:1.23%
cases:51.49%
controls:4.43%
303
700
1321
15523
201
206
1424
16026
56
21
1569
16211
922
0
703
16232
124
27
1410
16180
483
194
897
15541
519
583
489
12572
Cholangitis
K83.0 [45552955]
2.9e+00
3.9e+00
—
1.0e+50
3.6e+00
4.1e+00
3.7e+00
cases:2.59%
controls:0.15%
cases:2.65%
controls:0.06%
—
—
cases:1.17%
controls:0.00%
cases:1.11%
controls:0.03%
cases:3.55%
controls:0.06%
cases:4.76%
controls:0.12%
42
24
1582
16199
43
9
1582
16223
—
19
0
1606
16232
17
5
1517
16202
49
10
1331
15725
48
16
960
13139
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2.1e+00
2.9e+00
4.0e+00
—
4.2e+00
2.8e+00
2.0e+00
cases:10.71%
controls:1.45%
cases:13.42%
controls:0.84%
cases:4.25%
controls:0.08%
—
—
cases:5.15%
controls:0.08%
cases:10.65%
controls:0.72%
cases:11.71%
controls:1.79%
174
235
1450
15988
218
136
1407
16096
69
13
1556
16219
—
79
13
1455
16194
147
113
1233
15622
118
236
890
12919
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
1.8e+00
2.8e+00
4.3e+00
—
4.3e+00
2.8e+00
1.9e+00
cases:10.65%
controls:1.86%
cases:12.74%
controls:0.84%
cases:3.75%
controls:0.06%
—
—
cases:5.35%
controls:0.08%
cases:10.29%
controls:0.68%
cases:13.39%
controls:2.16%
173
301
1451
15922
207
136
1418
16096
61
9
1564
16223
—
82
13
1452
16194
142
107
1238
15628
135
284
873
12871
Abdominal ultrasound examination
JN3AE [2001305555]
1.6e+00
2.8e+00
3.8e+00
1.0e+50
3.7e+00
3.1e+00
2.8e+00
cases:7.14%
controls:1.52%
cases:8.80%
controls:0.59%
cases:1.97%
controls:0.04%
cases:3.63%
controls:0.00%
cases:1.43%
controls:0.04%
cases:9.71%
controls:0.47%
cases:19.54%
controls:1.45%
116
246
1508
15977
143
96
1482
16136
32
7
1593
16225
59
0
1566
16232
22
6
1512
16201
134
74
1246
15661
197
191
811
12964
Cathetrisation of abdominal cavity with ultrasound guidance
JA3AT [2001304536]
3.5e+00
4.8e+00
1.0e+50
1.0e+50
1.0e+50
5.0e+00
4.4e+00
cases:1.72%
controls:0.06%
cases:3.57%
controls:0.03%
cases:1.78%
controls:0.00%
cases:1.72%
controls:0.00%
cases:2.35%
controls:0.00%
cases:5.58%
controls:0.04%
cases:8.83%
controls:0.12%
28
9
1596
16214
58
5
1567
16227
29
0
1596
16232
28
0
1597
16232
36
0
1498
16207
77
6
1303
15729
89
16
919
13139
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
1.9e+00
2.8e+00
4.1e+00
—
4.0e+00
2.6e+00
2.0e+00
cases:10.59%
controls:1.76%
cases:12.00%
controls:0.84%
cases:3.75%
controls:0.06%
—
—
cases:5.02%
controls:0.09%
cases:8.91%
controls:0.69%
cases:12.60%
controls:1.98%
172
286
1452
15937
195
136
1430
16096
61
10
1564
16222
—
77
15
1457
16192
123
109
1257
15626
127
260
881
12895
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
1.7e+00
2.7e+00
3.2e+00
—
4.2e+00
3.0e+00
2.7e+00
cases:10.10%
controls:2.10%
cases:12.37%
controls:0.97%
cases:4.25%
controls:0.18%
—
—
cases:6.65%
controls:0.11%
cases:14.57%
controls:0.88%
cases:27.68%
controls:2.47%
164
341
1460
15882
201
158
1424
16074
69
29
1556
16203
—
102
18
1432
16189
201
138
1179
15597
279
325
729
12830
Anaemia, unspecified
D64.9 [45600610]
1.7e+00
2.9e+00
4.5e+00
1.0e+50
3.3e+00
2.9e+00
2.0e+00
cases:5.73%
controls:1.05%
cases:6.89%
controls:0.43%
cases:3.69%
controls:0.04%
cases:3.20%
controls:0.00%
cases:2.54%
controls:0.09%
cases:8.12%
controls:0.49%
cases:11.31%
controls:1.71%
93
171
1531
16052
112
69
1513
16163
60
7
1565
16225
52
0
1573
16232
39
15
1495
16192
112
77
1268
15658
114
225
894
12930
Alcoholic cirrhosis of liver
K70.3 [45596343]
4.8e+00
—
1.0e+50
1.0e+50
—
6.3e+00
5.9e+00
cases:7.45%
controls:0.07%
—
—
cases:8.18%
controls:0.00%
cases:14.77%
controls:0.00%
—
—
cases:26.52%
controls:0.06%
cases:34.72%
controls:0.14%
121
11
1503
16212
—
133
0
1492
16232
240
0
1385
16232
—
366
10
1014
15725
350
19
658
13136
Iron deficiency anaemia, unspecified
D50.9 [45605373]
2.1e+00
3.1e+00
3.7e+00
1.0e+50
3.3e+00
2.7e+00
2.0e+00
cases:4.99%
controls:0.66%
cases:4.92%
controls:0.24%
cases:2.71%
controls:0.07%
cases:2.58%
controls:0.00%
cases:1.89%
controls:0.07%
cases:5.72%
controls:0.39%
cases:8.04%
controls:1.17%
81
107
1543
16116
80
39
1545
16193
44
11
1581
16221
42
0
1583
16232
29
11
1505
16196
79
61
1301
15674
81
154
927
13001
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
1.5e+00
2.7e+00
3.8e+00
1.0e+50
4.4e+00
2.7e+00
1.6e+00
cases:10.59%
controls:2.55%
cases:12.18%
controls:0.92%
cases:3.94%
controls:0.09%
cases:0.37%
controls:0.00%
cases:4.43%
controls:0.06%
cases:9.49%
controls:0.73%
cases:11.61%
controls:2.70%
172
414
1452
15809
198
149
1427
16083
64
15
1561
16217
6
0
1619
16232
68
9
1466
16198
131
115
1249
15620
117
355
891
12800
Haematemesis
K92.0 [45605964]
2.7e+00
4.5e+00
—
1.0e+50
1.0e+50
5.4e+00
4.0e+00
cases:2.77%
controls:0.18%
cases:4.06%
controls:0.05%
—
—
cases:8.25%
controls:0.00%
cases:2.93%
controls:0.00%
cases:6.81%
controls:0.03%
cases:9.23%
controls:0.18%
45
30
1579
16193
66
8
1559
16224
—
134
0
1491
16232
45
0
1489
16207
94
5
1286
15730
93
24
915
13131
Primary biliary cirrhosis
K74.3 [45557676]
3.6e+00
3.8e+00
—
1.0e+50
—
4.7e+00
4.4e+00
cases:2.16%
controls:0.06%
cases:2.22%
controls:0.05%
—
—
cases:1.23%
controls:0.00%
—
—
cases:3.41%
controls:0.03%
cases:3.97%
controls:0.05%
35
10
1589
16213
36
8
1589
16224
—
20
0
1605
16232
—
47
5
1333
15730
40
7
968
13148
propranolol; oral, parenteral
C07AA05 [21601670]
1.1e+00
2.0e+00
2.7e+00
—
4.2e+00
3.5e+00
3.0e+00
cases:9.61%
controls:3.41%
cases:11.45%
controls:1.71%
cases:4.49%
controls:0.33%
—
—
cases:16.95%
controls:0.30%
cases:36.38%
controls:1.76%
cases:41.87%
controls:3.49%
156
554
1468
15669
186
277
1439
15955
73
53
1552
16179
—
260
48
1274
16159
502
277
878
15458
422
459
586
12696
INR in Blood by Coagulation assay
34714-6 [3032080]
1.1e+00
1.8e+00
2.4e+00
4.4e+00
2.6e+00
2.3e+00
1.9e+00
cases:25.55%
controls:10.67%
cases:29.91%
controls:6.37%
cases:19.20%
controls:2.11%
cases:8.98%
controls:0.12%
cases:19.95%
controls:1.83%
cases:39.28%
controls:5.94%
cases:53.87%
controls:15.36%
415
1731
1209
14492
486
1034
1139
15198
312
343
1313
15889
146
20
1479
16212
306
296
1228
15911
542
935
838
14800
543
2020
465
11135
Emergency Room Visit
ER [9203]
7.5e-01
1.6e+00
2.6e+00
6.2e+00
2.1e+00
1.7e+00
1.5e+00
cases:49.88%
controls:31.90%
cases:36.86%
controls:10.73%
cases:16.68%
controls:1.43%
cases:21.42%
controls:0.06%
cases:10.30%
controls:1.39%
cases:37.90%
controls:10.29%
cases:62.80%
controls:27.67%
810
5175
814
11048
599
1742
1026
14490
271
232
1354
16000
348
9
1277
16223
158
225
1376
15982
523
1619
857
14116
633
3640
375
9515
Inpatient Hospital
21 [8717]
7.8e-01
1.5e+00
2.5e+00
6.0e+00
2.6e+00
1.7e+00
1.2e+00
cases:47.29%
controls:29.16%
cases:32.86%
controls:9.62%
cases:13.78%
controls:1.32%
cases:24.18%
controls:0.08%
cases:15.84%
controls:1.38%
cases:33.99%
controls:8.34%
cases:48.21%
controls:21.29%
768
4730
856
11493
534
1561
1091
14671
224
215
1401
16017
393
13
1232
16219
243
223
1291
15984
469
1313
911
14422
486
2801
522
10354
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]
1.9e+00
2.3e+00
3.0e+00
—
3.2e+00
3.0e+00
2.7e+00
cases:4.13%
controls:0.62%
cases:3.51%
controls:0.36%
cases:0.98%
controls:0.05%
—
—
cases:1.56%
controls:0.06%
cases:6.45%
controls:0.34%
cases:12.30%
controls:0.98%
67
100
1557
16123
57
59
1568
16173
16
8
1609
16224
—
24
10
1510
16197
89
54
1291
15681
124
129
884
13026
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2.4e+00
3.3e+00
4.8e+00
—
—
3.2e+00
2.2e+00
cases:9.91%
controls:0.99%
cases:11.94%
controls:0.49%
cases:3.63%
controls:0.03%
—
—
—
—
cases:9.28%
controls:0.40%
cases:10.42%
controls:1.22%
161
160
1463
16063
194
79
1431
16153
59
5
1566
16227
—
—
128
63
1252
15672
105
160
903
12995
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
2.3e+00
3.1e+00
3.2e+00
1.0e+50
—
4.0e+00
3.3e+00
cases:8.31%
controls:0.92%
cases:6.71%
controls:0.31%
cases:1.05%
controls:0.04%
cases:2.15%
controls:0.00%
—
—
cases:11.52%
controls:0.24%
cases:19.05%
controls:0.82%
135
149
1489
16074
109
50
1516
16182
17
7
1608
16225
35
0
1590
16232
—
159
37
1221
15698
192
108
816
13047
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
1.8e+00
2.5e+00
3.5e+00
—
3.4e+00
2.6e+00
2.1e+00
cases:11.21%
controls:2.11%
cases:14.65%
controls:1.34%
cases:5.29%
controls:0.17%
—
—
cases:5.08%
controls:0.17%
cases:15.58%
controls:1.33%
cases:24.90%
controls:4.00%
182
342
1442
15881
238
218
1387
16014
86
28
1539
16204
—
78
28
1456
16179
215
209
1165
15526
251
526
757
12629
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
1.6e+00
2.5e+00
3.5e+00
—
3.6e+00
2.6e+00
2.0e+00
cases:5.30%
controls:1.12%
cases:5.66%
controls:0.51%
cases:0.98%
controls:0.03%
—
—
cases:2.02%
controls:0.06%
cases:5.00%
controls:0.38%
cases:8.04%
controls:1.18%
86
181
1538
16042
92
82
1533
16150
16
5
1609
16227
—
31
9
1503
16198
69
60
1311
15675
81
155
927
13000
lactulose; oral
A06AD11 [21600571]
1.2e+00
2.4e+00
2.9e+00
—
3.4e+00
3.0e+00
2.8e+00
cases:6.03%
controls:1.95%
cases:10.15%
controls:0.97%
cases:4.06%
controls:0.23%
—
—
cases:8.41%
controls:0.30%
cases:18.04%
controls:1.10%
cases:26.59%
controls:2.11%
98
316
1526
15907
165
158
1460
16074
66
38
1559
16194
—
129
48
1405
16159
249
173
1131
15562
268
277
740
12878
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
7.7e-01
1.6e+00
2.7e+00
4.7e+00
2.6e+00
1.9e+00
1.4e+00
cases:35.41%
controls:20.32%
cases:42.22%
controls:12.98%
cases:26.03%
controls:2.38%
cases:10.22%
controls:0.10%
cases:24.45%
controls:2.36%
cases:51.45%
controls:13.33%
cases:62.60%
controls:28.21%
575
3296
1049
12927
686
2107
939
14125
423
386
1202
15846
166
16
1459
16216
375
383
1159
15824
710
2097
670
13638
631
3711
377
9444
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
1825-9 [3026285]
2.9e+00
4.4e+00
—
—
1.0e+50
4.9e+00
3.6e+00
cases:4.13%
controls:0.23%
cases:5.91%
controls:0.08%
—
—
—
—
cases:2.41%
controls:0.00%
cases:5.43%
controls:0.04%
cases:7.14%
controls:0.22%
67
38
1557
16185
96
13
1529
16219
—
—
37
0
1497
16207
75
7
1305
15728
72
29
936
13126
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
1.7e+00
2.5e+00
3.5e+00
—
3.4e+00
2.5e+00
2.0e+00
cases:11.15%
controls:2.29%
cases:14.71%
controls:1.46%
cases:5.17%
controls:0.17%
—
—
cases:5.22%
controls:0.19%
cases:15.29%
controls:1.45%
cases:25.99%
controls:4.45%
181
371
1443
15852
239
237
1386
15995
84
28
1541
16204
—
80
31
1454
16176
211
228
1169
15507
262
586
746
12569
Outpatient Hospital
22 [8756]
6.3e-01
1.3e+00
2.1e+00
6.0e+00
2.4e+00
1.7e+00
1.3e+00
cases:37.32%
controls:23.98%
cases:20.98%
controls:6.89%
cases:7.26%
controls:0.95%
cases:15.32%
controls:0.04%
cases:8.21%
controls:0.81%
cases:25.29%
controls:5.84%
cases:42.16%
controls:16.33%
606
3891
1018
12332
341
1119
1284
15113
118
155
1507
16077
249
7
1376
16225
126
132
1408
16075
349
919
1031
14816
425
2148
583
11007
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
1.5e+00
2.5e+00
3.8e+00
1.0e+50
4.0e+00
2.3e+00
1.4e+00
cases:12.25%
controls:3.12%
cases:13.54%
controls:1.32%
cases:4.18%
controls:0.10%
cases:0.31%
controls:0.00%
cases:4.56%
controls:0.09%
cases:9.71%
controls:1.09%
cases:13.79%
controls:3.95%
199
506
1425
15717
220
215
1405
16017
68
16
1557
16216
5
0
1620
16232
70
14
1464
16193
134
172
1246
15563
139
519
869
12636
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
1.2e+00
2.2e+00
3.4e+00
—
3.6e+00
2.7e+00
2.2e+00
cases:15.89%
controls:5.33%
cases:19.82%
controls:2.59%
cases:11.26%
controls:0.43%
—
—
cases:11.99%
controls:0.38%
cases:26.74%
controls:2.39%
cases:39.29%
controls:6.50%
258
864
1366
15359
322
421
1303
15811
183
69
1442
16163
—
184
62
1350
16145
369
376
1011
15359
396
855
612
12300
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
1.7e+00
2.4e+00
3.3e+00
—
3.4e+00
2.5e+00
2.0e+00
cases:11.76%
controls:2.47%
cases:15.26%
controls:1.55%
cases:5.17%
controls:0.19%
—
—
cases:5.28%
controls:0.19%
cases:15.87%
controls:1.60%
cases:26.39%
controls:4.64%
191
400
1433
15823
248
251
1377
15981
84
31
1541
16201
—
81
30
1453
16177
219
251
1161
15484
266
610
742
12545
Ceruloplasmin [Mass/volume] in Serum or Plasma
2064-4 [3022756]
3.2e+00
4.9e+00
—
—
1.0e+50
3.9e+00
3.3e+00
cases:3.57%
controls:0.15%
cases:4.62%
controls:0.04%
—
—
—
—
cases:1.56%
controls:0.00%
cases:1.81%
controls:0.04%
cases:2.28%
controls:0.08%
58
25
1566
16198
75
6
1550
16226
—
—
24
0
1510
16207
25
6
1355
15729
23
11
985
13144
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
1.7e+00
2.3e+00
3.5e+00
—
3.1e+00
2.6e+00
2.0e+00
cases:12.87%
controls:2.59%
cases:9.17%
controls:1.03%
cases:3.08%
controls:0.09%
—
—
cases:2.35%
controls:0.10%
cases:11.01%
controls:0.91%
cases:19.44%
controls:3.18%
209
420
1415
15803
149
167
1476
16065
50
15
1575
16217
—
36
17
1498
16190
152
143
1228
15592
196
418
812
12737
Liver Pathology biopsy report
65752-8 [40768441]
3.0e+00
3.5e+00
1.0e+50
—
1.0e+50
4.5e+00
4.2e+00
cases:1.85%
controls:0.09%
cases:1.54%
controls:0.05%
cases:0.31%
controls:0.00%
—
—
cases:0.91%
controls:0.00%
cases:3.84%
controls:0.04%
cases:8.53%
controls:0.14%
30
15
1594
16208
25
8
1600
16224
5
0
1620
16232
—
14
0
1520
16207
53
7
1327
15728
86
18
922
13137
General Surgery
2 [38004447]
5.5e-01
1.2e+00
2.3e+00
5.7e+00
2.3e+00
1.7e+00
1.4e+00
cases:26.29%
controls:17.08%
cases:14.71%
controls:4.98%
cases:7.02%
controls:0.71%
cases:13.66%
controls:0.06%
cases:6.52%
controls:0.68%
cases:21.09%
controls:4.74%
cases:38.00%
controls:13.41%
427
2771
1197
13452
239
809
1386
15423
114
116
1511
16116
222
9
1403
16223
100
111
1434
16096
291
746
1089
14989
383
1764
625
11391
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
1.8e+00
2.6e+00
3.3e+00
—
3.2e+00
2.3e+00
1.9e+00
cases:3.57%
controls:0.62%
cases:3.88%
controls:0.31%
cases:1.66%
controls:0.06%
—
—
cases:1.30%
controls:0.06%
cases:3.26%
controls:0.34%
cases:7.44%
controls:1.22%
58
100
1566
16123
63
50
1562
16182
27
10
1598
16222
—
20
9
1514
16198
45
53
1335
15682
75
160
933
12995
ferrous glycine sulfate; oral
B03AA01 [21601080]
1.9e+00
2.2e+00
2.8e+00
—
3.2e+00
2.7e+00
2.1e+00
cases:4.00%
controls:0.65%
cases:2.83%
controls:0.31%
cases:0.74%
controls:0.04%
—
—
cases:1.56%
controls:0.07%
cases:4.42%
controls:0.31%
cases:9.03%
controls:1.22%
65
105
1559
16118
46
50
1579
16182
12
7
1613
16225
—
24
11
1510
16196
61
49
1319
15686
91
160
917
12995
Chronic viral hepatitis C
B18.2 [45590846]
2.9e+00
3.5e+00
—
1.0e+50
—
4.2e+00
4.2e+00
cases:2.03%
controls:0.12%
cases:2.15%
controls:0.07%
—
—
cases:0.92%
controls:0.00%
—
—
cases:3.41%
controls:0.05%
cases:4.07%
controls:0.06%
33
19
1591
16204
35
11
1590
16221
—
15
0
1610
16232
—
47
8
1333
15727
41
8
967
13147
Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9838-4 [3003265]
2.8e+00
3.7e+00
—
—
1.0e+50
4.8e+00
3.5e+00
cases:2.77%
controls:0.18%
cases:3.69%
controls:0.09%
—
—
—
—
cases:1.76%
controls:0.00%
cases:4.35%
controls:0.04%
cases:5.75%
controls:0.18%
45
29
1579
16194
60
15
1565
16217
—
—
27
0
1507
16207
60
6
1320
15729
58
24
950
13131
furosemide; oral, parenteral
C03CA01 [21601518]
1.3e+00
1.9e+00
2.0e+00
2.8e+00
2.3e+00
2.2e+00
2.2e+00
cases:19.52%
controls:5.94%
cases:25.60%
controls:4.87%
cases:9.48%
controls:1.46%
cases:0.86%
controls:0.06%
cases:13.36%
controls:1.55%
cases:34.06%
controls:5.37%
cases:45.44%
controls:8.43%
317
963
1307
15260
416
791
1209
15441
154
237
1471
15995
14
9
1611
16223
205
251
1329
15956
470
845
910
14890
458
1109
550
12046
Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
3193-0 [3005757]
2.6e+00
3.4e+00
—
—
—
4.7e+00
3.9e+00
cases:1.23%
controls:0.09%
cases:1.97%
controls:0.07%
—
—
—
—
—
—
cases:4.20%
controls:0.04%
cases:7.24%
controls:0.16%
20
15
1604
16208
32
11
1593
16221
—
—
—
58
6
1322
15729
73
21
935
13134
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1.4e+00
2.3e+00
2.6e+00
—
3.5e+00
2.5e+00
2.1e+00
cases:5.79%
controls:1.56%
cases:7.08%
controls:0.74%
cases:2.22%
controls:0.16%
—
—
cases:3.46%
controls:0.10%
cases:8.62%
controls:0.74%
cases:15.38%
controls:2.17%
94
253
1530
15970
115
120
1510
16112
36
26
1589
16206
—
53
17
1481
16190
119
116
1261
15619
155
286
853
12869
carvedilol; oral
C07AG02 [21601700]
1.1e+00
1.7e+00
1.7e+00
1.0e+50
3.4e+00
3.3e+00
3.2e+00
cases:3.45%
controls:1.13%
cases:4.62%
controls:0.84%
cases:1.35%
controls:0.25%
cases:3.38%
controls:0.00%
cases:8.28%
controls:0.29%
cases:19.20%
controls:0.87%
cases:20.73%
controls:1.09%
56
183
1568
16040
75
137
1550
16095
22
40
1603
16192
55
0
1570
16232
127
47
1407
16160
265
137
1115
15598
209
143
799
13012
Other transluminal endoscopic operation on stomach or duodenum
JDW98 [2001304774]
1.4e+00
3.3e+00
1.0e+50
1.0e+50
—
4.9e+00
4.7e+00
cases:0.62%
controls:0.15%
cases:1.42%
controls:0.06%
cases:0.49%
controls:0.00%
cases:4.92%
controls:0.00%
—
—
cases:5.80%
controls:0.04%
cases:5.65%
controls:0.05%
10
24
1614
16199
23
9
1602
16223
8
0
1617
16232
80
0
1545
16232
—
80
7
1300
15728
57
7
951
13148
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
3.1e+00
4.1e+00
—
1.0e+50
—
4.1e+00
2.9e+00
cases:8.74%
controls:0.44%
cases:11.94%
controls:0.23%
—
—
cases:0.31%
controls:0.00%
—
—
cases:8.04%
controls:0.14%
cases:9.23%
controls:0.54%
142
72
1482
16151
194
37
1431
16195
—
5
0
1620
16232
—
111
22
1269
15713
93
71
915
13084
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
2.1e+00
2.5e+00
3.3e+00
—
2.6e+00
2.0e+00
1.7e+00
cases:7.14%
controls:0.95%
cases:5.11%
controls:0.46%
cases:1.42%
controls:0.06%
—
—
cases:1.11%
controls:0.08%
cases:3.33%
controls:0.46%
cases:6.55%
controls:1.28%
116
154
1508
16069
83
75
1542
16157
23
9
1602
16223
—
17
13
1517
16194
46
72
1334
15663
66
169
942
12986
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
1.1e+00
1.4e+00
1.6e+00
5.2e+00
2.0e+00
1.5e+00
1.2e+00
cases:18.97%
controls:7.17%
cases:13.85%
controls:3.71%
cases:3.38%
controls:0.69%
cases:5.54%
controls:0.03%
cases:4.69%
controls:0.69%
cases:15.43%
controls:4.09%
cases:25.69%
controls:9.24%
308
1163
1316
15060
225
603
1400
15629
55
112
1570
16120
90
5
1535
16227
72
112
1462
16095
213
643
1167
15092
259
1216
749
11939
Biopsy of liver with ultrasound guidance
JJ2AT [2001305254]
3.3e+00
3.6e+00
1.0e+50
—
—
4.1e+00
3.1e+00
cases:3.76%
controls:0.15%
cases:1.97%
controls:0.06%
cases:0.62%
controls:0.00%
—
—
—
—
cases:3.26%
controls:0.06%
cases:3.87%
controls:0.18%
61
24
1563
16199
32
9
1593
16223
10
0
1615
16232
—
—
45
9
1335
15726
39
24
969
13131
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
1.3e+00
2.1e+00
3.1e+00
1.0e+50
3.3e+00
2.4e+00
1.8e+00
cases:14.16%
controls:4.38%
cases:15.51%
controls:2.22%
cases:5.60%
controls:0.26%
cases:0.86%
controls:0.00%
cases:5.22%
controls:0.21%
cases:20.43%
controls:2.36%
cases:32.14%
controls:6.99%
230
711
1394
15512
252
360
1373
15872
91
43
1534
16189
14
0
1611
16232
80
34
1454
16173
282
371
1098
15364
324
920
684
12235
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
7.2e-01
1.2e+00
1.9e+00
4.6e+00
2.3e+00
1.7e+00
1.4e+00
cases:17.43%
controls:9.34%
cases:15.88%
controls:5.19%
cases:5.66%
controls:0.89%
cases:2.89%
controls:0.03%
cases:7.04%
controls:0.77%
cases:22.25%
controls:5.03%
cases:38.79%
controls:13.55%
283
1516
1341
14707
258
842
1367
15390
92
145
1533
16087
47
5
1578
16227
108
124
1426
16083
307
791
1073
14944
391
1782
617
11373
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
1.4e+00
2.7e+00
—
1.0e+50
3.9e+00
3.0e+00
2.7e+00
cases:1.66%
controls:0.41%
cases:3.32%
controls:0.23%
—
—
cases:0.37%
controls:0.00%
cases:1.50%
controls:0.03%
cases:3.26%
controls:0.17%
cases:6.85%
controls:0.49%
27
67
1597
16156
54
37
1571
16195
—
6
0
1619
16232
23
5
1511
16202
45
27
1335
15708
69
65
939
13090
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1.3e+00
2.1e+00
3.0e+00
—
3.2e+00
2.3e+00
1.8e+00
cases:21.43%
controls:7.09%
cases:23.75%
controls:3.73%
cases:9.23%
controls:0.48%
—
—
cases:9.39%
controls:0.44%
cases:27.54%
controls:3.79%
cases:41.77%
controls:10.15%
348
1151
1276
15072
386
605
1239
15627
150
78
1475
16154
—
144
71
1390
16136
380
597
1000
15138
421
1335
587
11820
magnesium hydroxide; oral
A02AA04 [21600052]
1.6e+00
2.2e+00
2.4e+00
—
2.6e+00
2.6e+00
2.3e+00
cases:2.16%
controls:0.46%
cases:2.40%
controls:0.28%
cases:0.80%
controls:0.07%
—
—
cases:1.30%
controls:0.10%
cases:3.99%
controls:0.31%
cases:6.75%
controls:0.70%
35
75
1589
16148
39
45
1586
16187
13
12
1612
16220
—
20
16
1514
16191
55
48
1325
15687
68
92
940
13063
magnesium hydroxide; oral
G04BX01 [21602658]
1.6e+00
2.2e+00
2.4e+00
—
2.6e+00
2.6e+00
2.3e+00
cases:2.16%
controls:0.46%
cases:2.40%
controls:0.28%
cases:0.80%
controls:0.07%
—
—
cases:1.30%
controls:0.10%
cases:3.99%
controls:0.31%
cases:6.75%
controls:0.70%
35
75
1589
16148
39
45
1586
16187
13
12
1612
16220
—
20
16
1514
16191
55
48
1325
15687
68
92
940
13063
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
5.8e-01
1.1e+00
2.0e+00
4.8e+00
2.4e+00
1.5e+00
1.1e+00
cases:21.18%
controls:13.12%
cases:18.58%
controls:6.92%
cases:6.52%
controls:0.90%
cases:5.78%
controls:0.05%
cases:8.41%
controls:0.80%
cases:24.71%
controls:6.64%
cases:42.36%
controls:19.41%
344
2128
1280
14095
302
1124
1323
15108
106
146
1519
16086
94
8
1531
16224
129
130
1405
16077
341
1045
1039
14690
427
2554
581
10601
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.6e+00
2.3e+00
2.9e+00
—
3.1e+00
2.0e+00
1.6e+00
cases:5.73%
controls:1.23%
cases:6.40%
controls:0.65%
cases:2.09%
controls:0.12%
—
—
cases:1.69%
controls:0.07%
cases:5.87%
controls:0.82%
cases:10.32%
controls:2.32%
93
199
1531
16024
104
106
1521
16126
34
19
1591
16213
—
26
12
1508
16195
81
129
1299
15606
104
305
904
12850
pantoprazole; oral, parenteral
A02BC02 [21600097]
7.8e-01
1.4e+00
1.7e+00
3.4e+00
2.6e+00
2.0e+00
1.6e+00
cases:31.96%
controls:17.77%
cases:31.63%
controls:10.49%
cases:10.77%
controls:2.15%
cases:2.83%
controls:0.10%
cases:23.14%
controls:2.24%
cases:47.68%
controls:10.74%
cases:56.65%
controls:21.19%
519
2883
1105
13340
514
1703
1111
14529
175
349
1450
15883
46
16
1579
16216
355
363
1179
15844
658
1690
722
14045
571
2787
437
10368
Cell count and differential, peritoneal fluid
67017004 [4281824]
1.5e+00
4.2e+00
—
—
1.0e+50
3.8e+00
3.7e+00
cases:0.80%
controls:0.18%
cases:3.26%
controls:0.05%
—
—
—
—
cases:1.17%
controls:0.00%
cases:2.32%
controls:0.05%
cases:3.77%
controls:0.10%
13
29
1611
16194
53
8
1572
16224
—
—
18
0
1516
16207
32
8
1348
15727
38
13
970
13142
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
1.5e+00
2.2e+00
3.0e+00
—
2.9e+00
2.0e+00
1.6e+00
cases:8.37%
controls:1.99%
cases:8.86%
controls:1.08%
cases:2.89%
controls:0.15%
—
—
cases:2.41%
controls:0.14%
cases:7.83%
controls:1.11%
cases:13.89%
controls:3.12%
136
323
1488
15900
144
175
1481
16057
47
24
1578
16208
—
37
23
1497
16184
108
174
1272
15561
140
411
868
12744
Left sided colitis
K51.5 [45533604]
1.7e+00
1.8e+00
3.0e+00
—
3.0e+00
1.9e+00
1.7e+00
cases:1.85%
controls:0.35%
cases:1.54%
controls:0.26%
cases:0.74%
controls:0.04%
—
—
cases:0.98%
controls:0.05%
cases:1.59%
controls:0.24%
cases:2.08%
controls:0.37%
30
57
1594
16166
25
43
1600
16189
12
6
1613
16226
—
15
8
1519
16199
22
38
1358
15697
21
49
987
13106
Bacteria identified in Isolate by Culture
43409-2 [3042936]
8.8e-01
2.0e+00
2.3e+00
1.0e+50
3.5e+00
2.4e+00
1.9e+00
cases:6.03%
controls:2.60%
cases:7.20%
controls:1.09%
cases:1.78%
controls:0.18%
cases:0.68%
controls:0.00%
cases:3.72%
controls:0.11%
cases:9.57%
controls:0.96%
cases:19.25%
controls:3.31%
98
422
1526
15801
117
177
1508
16055
29
30
1596
16202
11
0
1614
16232
57
18
1477
16189
132
151
1248
15584
194
436
814
12719
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
1.1e+00
1.5e+00
2.5e+00
—
2.5e+00
2.8e+00
2.7e+00
cases:1.60%
controls:0.54%
cases:1.35%
controls:0.31%
cases:0.43%
controls:0.04%
—
—
cases:0.78%
controls:0.07%
cases:4.35%
controls:0.29%
cases:10.12%
controls:0.74%
26
88
1598
16135
22
50
1603
16182
7
6
1618
16226
—
12
11
1522
16196
60
45
1320
15690
102
98
906
13057
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
7.0e-01
1.2e+00
1.9e+00
4.3e+00
2.1e+00
1.5e+00
1.2e+00
cases:18.90%
controls:10.34%
cases:17.60%
controls:5.88%
cases:6.28%
controls:1.03%
cases:2.58%
controls:0.04%
cases:7.11%
controls:0.93%
cases:23.19%
controls:6.13%
cases:40.18%
controls:16.18%
307
1677
1317
14546
286
955
1339
15277
102
167
1523
16065
42
6
1583
16226
109
151
1425
16056
320
964
1060
14771
405
2128
603
11027
Very extensive MRI examination of upper part of abdomen with high intensity magnet
JN1DG [2001305530]
3.5e+00
2.5e+00
—
—
—
3.4e+00
3.5e+00
cases:1.91%
controls:0.06%
cases:1.29%
controls:0.10%
—
—
—
—
—
—
cases:1.74%
controls:0.06%
cases:3.17%
controls:0.10%
31
10
1593
16213
21
17
1604
16215
—
—
—
24
9
1356
15726
32
13
976
13142
Upper gastrointestinal surgery
106 [44777669]
1.0e+00
1.7e+00
2.7e+00
—
3.0e+00
2.5e+00
2.0e+00
cases:22.60%
controls:9.63%
cases:18.40%
controls:3.97%
cases:8.55%
controls:0.61%
—
—
cases:12.06%
controls:0.68%
cases:32.10%
controls:3.74%
cases:46.13%
controls:10.85%
367
1563
1257
14660
299
644
1326
15588
139
99
1486
16133
—
185
111
1349
16096
443
588
937
15147
465
1427
543
11728
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1.2e+00
1.9e+00
2.7e+00
—
3.3e+00
2.1e+00
1.6e+00
cases:17.06%
controls:6.02%
cases:16.31%
controls:2.78%
cases:5.97%
controls:0.41%
—
—
cases:6.13%
controls:0.23%
cases:18.19%
controls:2.64%
cases:32.74%
controls:8.97%
277
977
1347
15246
265
451
1360
15781
97
67
1528
16165
—
94
38
1440
16169
251
416
1129
15319
330
1180
678
11975
Differential panel, method unspecified - Blood
69738-3 [42870588]
8.5e-01
1.4e+00
2.0e+00
3.5e+00
1.9e+00
1.6e+00
1.5e+00
cases:15.64%
controls:7.34%
cases:16.37%
controls:4.66%
cases:6.34%
controls:0.91%
cases:1.05%
controls:0.03%
cases:5.41%
controls:0.88%
cases:19.35%
controls:4.43%
cases:33.04%
controls:9.61%
254
1191
1370
15032
266
756
1359
15476
103
148
1522
16084
17
5
1608
16227
83
143
1451
16064
267
697
1113
15038
333
1264
675
11891
Emergency Medicine
93 [38004510]
4.1e-01
1.0e+00
2.0e+00
5.7e+00
1.7e+00
1.1e+00
7.4e-01
cases:20.07%
controls:14.28%
cases:18.77%
controls:7.60%
cases:7.51%
controls:1.03%
cases:8.18%
controls:0.03%
cases:5.54%
controls:1.01%
cases:21.81%
controls:8.29%
cases:38.29%
controls:22.78%
326
2317
1298
13906
305
1234
1320
14998
122
168
1503
16064
133
5
1492
16227
85
164
1449
16043
301
1305
1079
14430
386
2997
622
10158
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
JKE98 [2001305336]
2.9e+00
2.9e+00
—
—
—
3.7e+00
3.2e+00
cases:1.91%
controls:0.11%
cases:1.23%
controls:0.07%
—
—
—
—
—
—
cases:1.81%
controls:0.04%
cases:3.27%
controls:0.14%
31
18
1593
16205
20
11
1605
16221
—
—
—
25
7
1355
15728
33
18
975
13137
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
8.4e-01
1.7e+00
2.4e+00
—
3.4e+00
2.5e+00
1.8e+00
cases:5.97%
controls:2.66%
cases:6.09%
controls:1.19%
cases:1.48%
controls:0.13%
—
—
cases:3.19%
controls:0.10%
cases:10.80%
controls:0.99%
cases:17.76%
controls:3.60%
97
432
1527
15791
99
193
1526
16039
24
21
1601
16211
—
49
17
1485
16190
149
156
1231
15579
179
474
829
12681
Hepatitis E virus IgM Ab [Presence] in Serum
14212-5 [3002222]
2.4e+00
3.7e+00
—
—
1.0e+50
3.2e+00
3.4e+00
cases:1.60%
controls:0.15%
cases:2.03%
controls:0.05%
—
—
—
—
cases:1.30%
controls:0.00%
cases:1.23%
controls:0.05%
cases:2.78%
controls:0.10%
26
25
1598
16198
33
8
1592
16224
—
—
20
0
1514
16207
17
8
1363
15727
28
13
980
13142
Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
49693-5 [3029023]
2.4e+00
3.7e+00
—
—
1.0e+50
3.2e+00
3.4e+00
cases:1.60%
controls:0.15%
cases:2.03%
controls:0.05%
—
—
—
—
cases:1.30%
controls:0.00%
cases:1.23%
controls:0.05%
cases:2.78%
controls:0.10%
26
25
1598
16198
33
8
1592
16224
—
—
20
0
1514
16207
17
8
1363
15727
28
13
980
13142
Monocytes/Leukocytes in Blood
26485-3 [3019069]
7.8e-01
1.4e+00
2.0e+00
3.6e+00
1.8e+00
1.6e+00
1.4e+00
cases:20.57%
controls:10.63%
cases:22.03%
controls:6.50%
cases:8.37%
controls:1.23%
cases:1.60%
controls:0.04%
cases:7.50%
controls:1.26%
cases:25.65%
controls:6.58%
cases:39.98%
controls:14.41%
334
1724
1290
14499
358
1055
1267
15177
136
199
1489
16033
26
7
1599
16225
115
204
1419
16003
354
1035
1026
14700
403
1896
605
11259
Basophils/Leukocytes in Blood
30180-4 [3022096]
7.7e-01
1.4e+00
2.0e+00
3.6e+00
1.9e+00
1.6e+00
1.4e+00
cases:20.26%
controls:10.48%
cases:21.91%
controls:6.50%
cases:8.37%
controls:1.24%
cases:1.60%
controls:0.04%
cases:7.50%
controls:1.25%
cases:25.58%
controls:6.58%
cases:39.78%
controls:14.34%
329
1700
1295
14523
356
1055
1269
15177
136
202
1489
16030
26
7
1599
16225
115
203
1419
16004
353
1035
1027
14700
401
1886
607
11269
Basophils [#/volume] in Blood
26444-0 [3006315]
8.1e-01
1.4e+00
2.0e+00
3.5e+00
1.9e+00
1.6e+00
1.4e+00
cases:21.92%
controls:11.13%
cases:24.06%
controls:7.02%
cases:8.74%
controls:1.34%
cases:1.66%
controls:0.05%
cases:8.15%
controls:1.32%
cases:27.10%
controls:7.11%
cases:43.06%
controls:15.85%
356
1806
1268
14417
391
1140
1234
15092
142
217
1483
16015
27
8
1598
16224
125
214
1409
15993
374
1119
1006
14616
434
2085
574
11070
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
7.8e-01
1.4e+00
2.0e+00
3.6e+00
1.8e+00
1.6e+00
1.4e+00
cases:20.38%
controls:10.54%
cases:22.09%
controls:6.51%
cases:8.31%
controls:1.24%
cases:1.60%
controls:0.04%
cases:7.43%
controls:1.26%
cases:25.72%
controls:6.61%
cases:39.68%
controls:14.36%
331
1710
1293
14513
359
1056
1266
15176
135
201
1490
16031
26
7
1599
16225
114
205
1420
16002
355
1040
1025
14695
400
1889
608
11266
Thrombocytopenia, unspecified
D69.6 [45581327]
3.6e+00
3.6e+00
1.0e+50
1.0e+50
—
2.9e+00
2.4e+00
cases:2.96%
controls:0.09%
cases:2.22%
controls:0.06%
cases:0.49%
controls:0.00%
cases:0.31%
controls:0.00%
—
—
cases:1.38%
controls:0.08%
cases:2.58%
controls:0.23%
48
14
1576
16209
36
10
1589
16222
8
0
1617
16232
5
0
1620
16232
—
19
12
1361
15723
26
30
982
13125
Monocytes [#/volume] in Blood
26484-6 [3001604]
8.1e-01
1.4e+00
2.0e+00
3.4e+00
1.9e+00
1.6e+00
1.4e+00
cases:21.86%
controls:11.05%
cases:23.88%
controls:6.95%
cases:8.74%
controls:1.32%
cases:1.66%
controls:0.06%
cases:8.15%
controls:1.31%
cases:27.10%
controls:7.06%
cases:42.76%
controls:15.83%
355
1792
1269
14431
388
1128
1237
15104
142
215
1483
16017
27
9
1598
16223
125
213
1409
15994
374
1111
1006
14624
431
2083
577
11072
Hepatitis E virus Ab [Presence] in Serum
13294-4 [3006922]
2.4e+00
3.7e+00
—
—
1.0e+50
3.2e+00
3.2e+00
cases:1.72%
controls:0.15%
cases:2.15%
controls:0.06%
—
—
—
—
cases:1.30%
controls:0.00%
cases:1.23%
controls:0.05%
cases:2.98%
controls:0.13%
28
25
1596
16198
35
9
1590
16223
—
—
20
0
1514
16207
17
8
1363
15727
30
17
978
13138
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
3.8e-01
1.1e+00
2.2e+00
4.5e+00
2.3e+00
1.3e+00
7.7e-01
cases:39.41%
controls:30.73%
cases:43.08%
controls:19.87%
cases:25.97%
controls:3.88%
cases:15.02%
controls:0.20%
cases:26.53%
controls:3.65%
cases:48.84%
controls:20.23%
cases:61.71%
controls:42.77%
640
4985
984
11238
700
3226
925
13006
422
629
1203
15603
244
33
1381
16199
407
591
1127
15616
674
3183
706
12552
622
5626
386
7529
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
1.4e+00
2.1e+00
2.8e+00
1.0e+50
—
3.3e+00
2.9e+00
cases:1.79%
controls:0.44%
cases:1.85%
controls:0.23%
cases:0.49%
controls:0.03%
cases:0.68%
controls:0.00%
—
—
cases:4.93%
controls:0.18%
cases:9.13%
controls:0.57%
29
72
1595
16151
30
38
1595
16194
8
5
1617
16227
11
0
1614
16232
—
68
29
1312
15706
92
75
916
13080
Abdominal CT examination
JN3AD [2001305554]
1.1e+00
1.9e+00
3.0e+00
1.0e+50
3.0e+00
1.9e+00
1.6e+00
cases:2.71%
controls:0.92%
cases:3.82%
controls:0.59%
cases:1.29%
controls:0.07%
cases:1.66%
controls:0.00%
cases:0.98%
controls:0.05%
cases:3.55%
controls:0.57%
cases:10.42%
controls:2.22%
44
149
1580
16074
62
96
1563
16136
21
11
1604
16221
27
0
1598
16232
15
8
1519
16199
49
89
1331
15646
105
292
903
12863
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
7.3e-01
1.3e+00
2.0e+00
3.7e+00
1.8e+00
1.5e+00
1.3e+00
cases:19.89%
controls:10.69%
cases:21.48%
controls:6.71%
cases:8.25%
controls:1.24%
cases:1.54%
controls:0.04%
cases:7.17%
controls:1.30%
cases:25.43%
controls:6.80%
cases:39.19%
controls:14.60%
323
1735
1301
14488
349
1089
1276
15143
134
201
1491
16031
25
6
1600
16226
110
211
1424
15996
351
1070
1029
14665
395
1920
613
11235
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
7.1e-01
1.5e+00
2.9e+00
—
3.3e+00
2.2e+00
1.9e+00
cases:8.56%
controls:4.39%
cases:8.55%
controls:2.06%
cases:4.31%
controls:0.24%
—
—
cases:4.50%
controls:0.18%
cases:13.12%
controls:1.72%
cases:25.60%
controls:5.13%
139
712
1485
15511
139
335
1486
15897
70
39
1555
16193
—
69
29
1465
16178
181
270
1199
15465
258
675
750
12480
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
7.4e-01
1.3e+00
2.0e+00
3.6e+00
1.8e+00
1.5e+00
1.3e+00
cases:20.63%
controls:10.98%
cases:21.91%
controls:6.82%
cases:8.43%
controls:1.24%
cases:1.60%
controls:0.04%
cases:7.56%
controls:1.31%
cases:25.58%
controls:6.89%
cases:39.48%
controls:14.88%
335
1782
1289
14441
356
1107
1269
15125
137
202
1488
16030
26
7
1599
16225
116
212
1418
15995
353
1084
1027
14651
398
1957
610
11198
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
1.2e+00
1.5e+00
2.1e+00
—
2.9e+00
2.4e+00
2.2e+00
cases:2.65%
controls:0.80%
cases:2.40%
controls:0.54%
cases:0.98%
controls:0.12%
—
—
cases:1.63%
controls:0.09%
cases:5.65%
controls:0.56%
cases:12.10%
controls:1.50%
43
129
1581
16094
39
87
1586
16145
16
19
1609
16213
—
25
15
1509
16192
78
88
1302
15647
122
197
886
12958
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
7.4e-01
1.5e+00
2.7e+00
—
3.6e+00
2.1e+00
1.7e+00
cases:4.62%
controls:2.25%
cases:4.37%
controls:1.05%
cases:1.85%
controls:0.13%
—
—
cases:4.17%
controls:0.12%
cases:8.55%
controls:1.08%
cases:17.56%
controls:3.91%
75
365
1549
15858
71
170
1554
16062
30
21
1595
16211
—
64
19
1470
16188
118
170
1262
15565
177
514
831
12641
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
7.7e-01
1.4e+00
2.0e+00
3.4e+00
1.9e+00
1.6e+00
1.3e+00
cases:22.29%
controls:11.68%
cases:24.18%
controls:7.37%
cases:8.86%
controls:1.36%
cases:1.66%
controls:0.06%
cases:8.21%
controls:1.38%
cases:27.61%
controls:7.44%
cases:42.96%
controls:16.37%
362
1895
1262
14328
393
1197
1232
15035
144
221
1481
16011
27
9
1598
16223
126
224
1408
15983
381
1171
999
14564
433
2154
575
11001
Eosinophils [#/volume] in Blood
26449-9 [3013115]
7.8e-01
1.4e+00
2.0e+00
3.3e+00
1.9e+00
1.6e+00
1.4e+00
cases:22.29%
controls:11.66%
cases:24.18%
controls:7.25%
cases:9.11%
controls:1.40%
cases:1.72%
controls:0.06%
cases:8.15%
controls:1.36%
cases:27.39%
controls:7.39%
cases:44.15%
controls:16.48%
362
1892
1262
14331
393
1177
1232
15055
148
227
1477
16005
28
10
1597
16222
125
221
1409
15986
378
1163
1002
14572
445
2168
563
10987
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
7.4e-01
1.5e+00
2.8e+00
—
3.3e+00
2.1e+00
1.8e+00
cases:12.25%
controls:6.24%
cases:10.83%
controls:2.69%
cases:5.05%
controls:0.33%
—
—
cases:5.87%
controls:0.23%
cases:16.52%
controls:2.27%
cases:31.55%
controls:7.07%
199
1013
1425
15210
176
437
1449
15795
82
53
1543
16179
—
90
38
1444
16169
228
357
1152
15378
318
930
690
12225
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
1.1e+00
1.9e+00
2.7e+00
—
2.9e+00
2.0e+00
1.5e+00
cases:19.03%
controls:7.00%
cases:22.71%
controls:4.15%
cases:8.37%
controls:0.61%
—
—
cases:8.93%
controls:0.53%
cases:26.45%
controls:4.51%
cases:39.29%
controls:12.56%
309
1136
1315
15087
369
673
1256
15559
136
99
1489
16133
—
137
86
1397
16121
365
710
1015
15025
396
1652
612
11503
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
1.2e+00
1.7e+00
1.9e+00
—
2.9e+00
2.4e+00
2.0e+00
cases:8.13%
controls:2.63%
cases:7.88%
controls:1.49%
cases:1.85%
controls:0.28%
—
—
cases:3.98%
controls:0.23%
cases:11.74%
controls:1.22%
cases:23.71%
controls:3.85%
132
426
1492
15797
128
242
1497
15990
30
45
1595
16187
—
61
38
1473
16169
162
192
1218
15543
239
507
769
12648
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
8.6e-01
1.8e+00
2.9e+00
—
3.0e+00
1.9e+00
1.6e+00
cases:5.42%
controls:2.37%
cases:6.34%
controls:1.07%
cases:1.17%
controls:0.07%
—
—
cases:2.09%
controls:0.10%
cases:5.72%
controls:0.88%
cases:12.40%
controls:2.72%
88
384
1536
15839
103
174
1522
16058
19
11
1606
16221
—
32
17
1502
16190
79
138
1301
15597
125
358
883
12797
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
7.2e-01
1.3e+00
1.7e+00
3.8e+00
1.7e+00
1.5e+00
1.3e+00
cases:23.83%
controls:13.25%
cases:26.15%
controls:8.69%
cases:10.65%
controls:2.03%
cases:3.57%
controls:0.09%
cases:10.56%
controls:2.05%
cases:30.00%
controls:8.58%
cases:45.34%
controls:18.43%
387
2150
1237
14073
425
1411
1200
14821
173
330
1452
15902
58
14
1567
16218
162
333
1372
15874
414
1350
966
14385
457
2425
551
10730
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
9.7e-01
2.0e+00
3.3e+00
—
3.4e+00
1.6e+00
7.2e-01
cases:9.11%
controls:3.66%
cases:9.17%
controls:1.32%
cases:2.77%
controls:0.10%
—
—
cases:3.00%
controls:0.10%
cases:5.58%
controls:1.19%
cases:9.52%
controls:4.90%
148
593
1476
15630
149
215
1476
16017
45
17
1580
16215
—
46
16
1488
16191
77
188
1303
15547
96
644
912
12511
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
7.4e-01
1.6e+00
2.4e+00
—
3.4e+00
2.2e+00
1.8e+00
cases:2.89%
controls:1.40%
cases:2.89%
controls:0.62%
cases:0.92%
controls:0.09%
—
—
cases:1.76%
controls:0.06%
cases:5.58%
controls:0.66%
cases:11.81%
controls:2.23%
47
227
1577
15996
47
100
1578
16132
15
14
1610
16218
—
27
10
1507
16197
77
104
1303
15631
119
294
889
12861
Extensive MRI examination of upper part of abdomen with high intensity magnet
JN1CG [2001305527]
2.2e+00
2.6e+00
—
1.0e+50
—
4.1e+00
3.2e+00
cases:2.22%
controls:0.25%
cases:0.86%
controls:0.07%
—
—
cases:0.49%
controls:0.00%
—
—
cases:1.88%
controls:0.03%
cases:3.27%
controls:0.14%
36
41
1588
16182
14
11
1611
16221
—
8
0
1617
16232
—
26
5
1354
15730
33
19
975
13136
Obstruction of bile duct
K83.1 [45548173]
2.6e+00
3.1e+00
—
—
—
3.4e+00
2.8e+00
cases:0.74%
controls:0.06%
cases:0.68%
controls:0.03%
—
—
—
—
—
—
cases:0.94%
controls:0.03%
cases:2.18%
controls:0.13%
12
9
1612
16214
11
5
1614
16227
—
—
—
13
5
1367
15730
22
17
986
13138
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
9.3e-01
1.3e+00
3.2e+00
—
3.4e+00
1.9e+00
1.2e+00
cases:1.72%
controls:0.68%
cases:1.42%
controls:0.38%
cases:0.74%
controls:0.03%
—
—
cases:1.24%
controls:0.04%
cases:2.83%
controls:0.43%
cases:5.56%
controls:1.77%
28
111
1596
16112
23
61
1602
16171
12
5
1613
16227
—
19
7
1515
16200
39
68
1341
15667
56
233
952
12922
pH of Venous blood
2746-6 [3012544]
1.1e+00
1.5e+00
2.6e+00
—
3.1e+00
2.0e+00
1.6e+00
cases:4.43%
controls:1.57%
cases:3.82%
controls:0.92%
cases:2.15%
controls:0.16%
—
—
cases:2.93%
controls:0.13%
cases:7.61%
controls:1.12%
cases:15.38%
controls:3.44%
72
255
1552
15968
62
149
1563
16083
35
26
1590
16206
—
45
21
1489
16186
105
177
1275
15558
155
452
853
12703
Melaena
K92.1 [45533624]
2.1e+00
3.5e+00
—
1.0e+50
—
3.4e+00
2.9e+00
cases:3.33%
controls:0.44%
cases:4.00%
controls:0.12%
—
—
cases:6.28%
controls:0.00%
—
—
cases:5.36%
controls:0.18%
cases:10.42%
controls:0.65%
54
71
1570
16152
65
20
1560
16212
—
102
0
1523
16232
—
74
29
1306
15706
105
85
903
13070
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
1.2e+00
1.8e+00
2.4e+00
—
2.4e+00
2.2e+00
2.0e+00
cases:6.03%
controls:1.89%
cases:6.77%
controls:1.24%
cases:1.97%
controls:0.18%
—
—
cases:2.35%
controls:0.22%
cases:8.77%
controls:1.09%
cases:16.37%
controls:2.66%
98
307
1526
15916
110
202
1515
16030
32
30
1593
16202
—
36
35
1498
16172
121
172
1259
15563
165
350
843
12805
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
1.1e+00
1.5e+00
2.1e+00
—
2.6e+00
2.3e+00
2.4e+00
cases:5.42%
controls:1.89%
cases:5.29%
controls:1.29%
cases:1.72%
controls:0.22%
—
—
cases:3.32%
controls:0.25%
cases:10.51%
controls:1.21%
cases:21.33%
controls:2.49%
88
307
1536
15916
86
209
1539
16023
28
36
1597
16196
—
51
40
1483
16167
145
190
1235
15545
215
328
793
12827
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
1.1e+00
1.8e+00
2.6e+00
—
2.5e+00
2.1e+00
1.8e+00
cases:6.16%
controls:2.13%
cases:7.02%
controls:1.25%
cases:3.08%
controls:0.23%
—
—
cases:2.61%
controls:0.23%
cases:8.91%
controls:1.24%
cases:16.47%
controls:3.03%
100
346
1524
15877
114
203
1511
16029
50
38
1575
16194
—
40
37
1494
16170
123
195
1257
15540
166
398
842
12757
Normoblasts [#/volume] in Blood
715-3 [3021589]
7.1e-01
1.1e+00
2.0e+00
4.0e+00
1.8e+00
1.3e+00
9.8e-01
cases:17.12%
controls:9.20%
cases:20.00%
controls:7.80%
cases:11.57%
controls:1.80%
cases:3.20%
controls:0.06%
cases:9.97%
controls:1.75%
cases:23.70%
controls:7.98%
cases:33.13%
controls:15.67%
278
1492
1346
14731
325
1266
1300
14966
188
292
1437
15940
52
10
1573
16222
153
283
1381
15924
327
1256
1053
14479
334
2062
674
11093
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
1.1e+00
1.4e+00
2.6e+00
—
3.0e+00
2.0e+00
1.6e+00
cases:4.43%
controls:1.50%
cases:3.82%
controls:0.94%
cases:2.03%
controls:0.15%
—
—
cases:2.87%
controls:0.14%
cases:7.75%
controls:1.12%
cases:15.48%
controls:3.44%
72
243
1552
15980
62
153
1563
16079
33
25
1592
16207
—
44
23
1490
16184
107
177
1273
15558
156
452
852
12703
Stomach Pathology biopsy report
66114-0 [40768797]
1.2e+00
1.8e+00
2.1e+00
—
3.0e+00
2.0e+00
1.7e+00
cases:6.90%
controls:2.23%
cases:4.62%
controls:0.76%
cases:0.62%
controls:0.07%
—
—
cases:2.09%
controls:0.11%
cases:4.78%
controls:0.67%
cases:13.99%
controls:2.89%
112
362
1512
15861
75
123
1550
16109
10
12
1615
16220
—
32
18
1502
16189
66
106
1314
15629
141
380
867
12775
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
1.0e+00
1.4e+00
3.0e+00
—
3.1e+00
1.9e+00
1.3e+00
cases:3.33%
controls:1.20%
cases:2.89%
controls:0.72%
cases:1.85%
controls:0.09%
—
—
cases:2.15%
controls:0.10%
cases:5.36%
controls:0.83%
cases:10.22%
controls:3.00%
54
194
1570
16029
47
117
1578
16115
30
15
1595
16217
—
33
16
1501
16191
74
130
1306
15605
103
395
905
12760
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
9.1e-01
1.3e+00
3.2e+00
—
3.2e+00
1.9e+00
1.2e+00
cases:1.72%
controls:0.70%
cases:1.42%
controls:0.38%
cases:0.74%
controls:0.03%
—
—
cases:1.24%
controls:0.05%
cases:2.83%
controls:0.43%
cases:5.75%
controls:1.79%
28
114
1596
16109
23
62
1602
16170
12
5
1613
16227
—
19
8
1515
16199
39
68
1341
15667
58
236
950
12919
thiamine (vit B1); oral, parenteral
A11DA01 [21600825]
1.9e+00
2.5e+00
2.5e+00
—
—
2.7e+00
2.2e+00
cases:1.35%
controls:0.20%
cases:1.48%
controls:0.12%
cases:0.37%
controls:0.03%
—
—
—
—
cases:1.67%
controls:0.11%
cases:2.58%
controls:0.30%
22
33
1602
16190
24
20
1601
16212
6
5
1619
16227
—
—
23
18
1357
15717
26
40
982
13115
Chronic alcohol abuse
P15 [2002000811]
2.1e+00
2.6e+00
—
—
2.6e+00
2.5e+00
2.0e+00
cases:3.02%
controls:0.38%
cases:2.03%
controls:0.16%
—
—
—
—
cases:0.52%
controls:0.04%
cases:1.88%
controls:0.17%
cases:3.87%
controls:0.56%
49
61
1575
16162
33
26
1592
16206
—
—
8
6
1526
16201
26
26
1354
15709
39
74
969
13081
Base excess in Venous blood by calculation
1927-3 [3002032]
1.1e+00
1.4e+00
2.5e+00
—
3.0e+00
2.0e+00
1.7e+00
cases:4.43%
controls:1.51%
cases:3.82%
controls:0.92%
cases:1.85%
controls:0.15%
—
—
cases:2.54%
controls:0.14%
cases:7.54%
controls:1.11%
cases:15.48%
controls:3.33%
72
245
1552
15978
62
150
1563
16082
30
25
1595
16207
—
39
22
1495
16185
104
175
1276
15560
156
438
852
12717
Gastroscopy
UJD02 [2001304787]
1.7e+00
2.9e+00
—
1.0e+50
—
4.3e+00
2.8e+00
cases:1.48%
controls:0.28%
cases:0.98%
controls:0.06%
—
—
cases:2.15%
controls:0.00%
—
—
cases:2.61%
controls:0.04%
cases:4.46%
controls:0.28%
24
46
1600
16177
16
9
1609
16223
—
35
0
1590
16232
—
36
6
1344
15729
45
37
963
13118
Outpatient Visit
OP [9202]
5.6e-01
7.5e-01
9.8e-01
4.8e+00
1.5e+00
1.6e+00
1.4e+00
cases:81.40%
controls:71.37%
cases:69.11%
controls:51.38%
cases:23.51%
controls:10.34%
cases:35.75%
controls:0.47%
cases:33.64%
controls:10.25%
cases:83.70%
controls:50.86%
cases:94.15%
controls:79.29%
1322
11578
302
4645
1123
8340
502
7892
382
1679
1243
14553
581
76
1044
16156
516
1662
1018
14545
1155
8003
225
7732
949
10430
59
2725
Immunohistochemistry procedure
117617002 [4035726]
8.9e-01
1.1e+00
2.3e+00
—
3.1e+00
2.3e+00
1.8e+00
cases:3.33%
controls:1.39%
cases:1.72%
controls:0.59%
cases:0.43%
controls:0.04%
—
—
cases:0.85%
controls:0.04%
cases:3.55%
controls:0.36%
cases:6.65%
controls:1.15%
54
225
1570
15998
28
95
1597
16137
7
7
1618
16225
—
13
6
1521
16201
49
56
1331
15679
67
151
941
13004
Hepatitis A virus IgM Ab [Presence] in Serum
22314-9 [3013327]
2.5e+00
4.1e+00
—
—
—
2.5e+00
2.4e+00
cases:2.77%
controls:0.23%
cases:4.43%
controls:0.07%
—
—
—
—
—
—
cases:1.01%
controls:0.08%
cases:2.88%
controls:0.27%
45
37
1579
16186
72
12
1553
16220
—
—
—
14
13
1366
15722
29
36
979
13119
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
9.2e-01
1.3e+00
2.0e+00
1.0e+50
3.5e+00
2.1e+00
1.8e+00
cases:2.46%
controls:0.99%
cases:1.29%
controls:0.34%
cases:0.37%
controls:0.05%
cases:1.17%
controls:0.00%
cases:1.37%
controls:0.04%
cases:3.19%
controls:0.42%
cases:8.53%
controls:1.59%
40
161
1584
16062
21
56
1604
16176
6
8
1619
16224
19
0
1606
16232
21
7
1513
16200
44
66
1336
15669
86
209
922
12946
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
9.2e-01
1.4e+00
2.0e+00
1.0e+50
3.3e+00
2.1e+00
1.8e+00
cases:2.46%
controls:0.99%
cases:1.42%
controls:0.34%
cases:0.37%
controls:0.05%
cases:0.98%
controls:0.00%
cases:1.11%
controls:0.04%
cases:3.12%
controls:0.40%
cases:8.63%
controls:1.51%
40
161
1584
16062
23
55
1602
16177
6
8
1619
16224
16
0
1609
16232
17
7
1517
16200
43
63
1337
15672
87
199
921
12956
Short blood count panel - Blood
55429-5 [40758558]
7.2e-01
1.1e+00
1.7e+00
3.8e+00
1.7e+00
1.3e+00
1.2e+00
cases:10.84%
controls:5.60%
cases:8.86%
controls:3.09%
cases:3.69%
controls:0.70%
cases:1.42%
controls:0.03%
cases:3.59%
controls:0.68%
cases:10.94%
controls:3.23%
cases:20.83%
controls:7.65%
176
909
1448
15314
144
502
1481
15730
60
113
1565
16119
23
5
1602
16227
55
110
1479
16097
151
508
1229
15227
210
1006
798
12149
Psoriasis vulgaris
L40.0 [45543370]
1.5e+00
1.9e+00
2.8e+00
1.0e+50
2.1e+00
1.8e+00
1.5e+00
cases:2.40%
controls:0.56%
cases:1.97%
controls:0.31%
cases:0.80%
controls:0.05%
cases:0.31%
controls:0.00%
cases:0.46%
controls:0.06%
cases:1.96%
controls:0.33%
cases:2.68%
controls:0.63%
39
91
1585
16132
32
51
1593
16181
13
8
1612
16224
5
0
1620
16232
7
9
1527
16198
27
52
1353
15683
27
83
981
13072
Gas panel - Venous blood
24339-4 [3000991]
1.1e+00
1.3e+00
1.9e+00
—
2.9e+00
2.2e+00
2.0e+00
cases:4.06%
controls:1.34%
cases:2.83%
controls:0.75%
cases:0.98%
controls:0.14%
—
—
cases:2.22%
controls:0.13%
cases:6.38%
controls:0.76%
cases:14.48%
controls:2.27%
66
217
1558
16006
46
122
1579
16110
16
23
1609
16209
—
34
21
1500
16186
88
119
1292
15616
146
298
862
12857
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
8.6e-01
1.7e+00
2.8e+00
—
2.7e+00
1.9e+00
1.4e+00
cases:30.91%
controls:15.85%
cases:31.32%
controls:7.55%
cases:13.54%
controls:0.91%
—
—
cases:11.99%
controls:0.91%
cases:35.80%
controls:7.44%
cases:52.38%
controls:21.36%
502
2572
1122
13651
509
1226
1116
15006
220
147
1405
16085
—
184
148
1350
16059
494
1170
886
14565
528
2810
480
10345
Alcohol depence active use
F10.24 [2000501681]
2.5e+00
2.9e+00
—
—
—
2.7e+00
3.2e+00
cases:1.54%
controls:0.12%
cases:1.05%
controls:0.06%
—
—
—
—
—
—
cases:0.72%
controls:0.05%
cases:2.48%
controls:0.10%
25
20
1599
16203
17
9
1608
16223
—
—
—
10
8
1370
15727
25
13
983
13142
Coloscopy
UJF32 [2001305029]
1.1e+00
1.3e+00
2.3e+00
1.0e+50
3.3e+00
2.2e+00
1.3e+00
cases:11.08%
controls:4.18%
cases:4.25%
controls:1.24%
cases:1.17%
controls:0.12%
cases:2.34%
controls:0.00%
cases:2.61%
controls:0.10%
cases:9.93%
controls:1.22%
cases:14.48%
controls:4.52%
180
678
1444
15545
69
201
1556
16031
19
20
1606
16212
38
0
1587
16232
40
16
1494
16191
137
192
1243
15543
146
595
862
12560
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
8.5e-01
1.3e+00
3.2e+00
—
3.3e+00
1.7e+00
1.0e+00
cases:2.09%
controls:0.91%
cases:1.78%
controls:0.51%
cases:1.05%
controls:0.04%
—
—
cases:1.37%
controls:0.05%
cases:3.26%
controls:0.64%
cases:6.35%
controls:2.37%
34
147
1590
16076
29
83
1596
16149
17
7
1608
16225
—
21
8
1513
16199
45
101
1335
15634
64
312
944
12843
Hematology
82 [38004501]
1.6e+00
1.9e+00
2.4e+00
—
2.0e+00
1.8e+00
1.7e+00
cases:4.62%
controls:0.99%
cases:4.25%
controls:0.65%
cases:1.97%
controls:0.19%
—
—
cases:1.96%
controls:0.26%
cases:4.49%
controls:0.79%
cases:7.24%
controls:1.47%
75
160
1549
16063
69
105
1556
16127
32
31
1593
16201
—
30
42
1504
16165
62
124
1318
15611
73
194
935
12961
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
9.4e-01
1.4e+00
3.4e+00
—
3.4e+00
1.4e+00
8.2e-01
cases:1.91%
controls:0.75%
cases:1.60%
controls:0.42%
cases:1.05%
controls:0.04%
—
—
cases:1.30%
controls:0.04%
cases:2.32%
controls:0.58%
cases:4.27%
controls:1.93%
31
122
1593
16101
26
68
1599
16164
17
6
1608
16226
—
20
7
1514
16200
32
92
1348
15643
43
254
965
12901
Bile acid [Moles/volume] in Serum --fasting
35562-8 [3034274]
2.3e+00
2.5e+00
—
—
1.0e+50
3.0e+00
3.4e+00
cases:0.62%
controls:0.06%
cases:0.62%
controls:0.05%
—
—
—
—
cases:0.33%
controls:0.00%
cases:0.80%
controls:0.04%
cases:2.18%
controls:0.08%
10
10
1614
16213
10
8
1615
16224
—
—
5
0
1529
16207
11
6
1369
15729
22
10
986
13145
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1.0e+00
1.3e+00
1.8e+00
—
2.8e+00
2.3e+00
2.0e+00
cases:2.22%
controls:0.83%
cases:1.66%
controls:0.44%
cases:0.74%
controls:0.12%
—
—
cases:1.30%
controls:0.08%
cases:3.77%
controls:0.39%
cases:10.02%
controls:1.56%
36
134
1588
16089
27
72
1598
16160
12
19
1613
16213
—
20
13
1514
16194
52
62
1328
15673
101
205
907
12950
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
8.5e-01
1.3e+00
3.5e+00
—
3.4e+00
1.5e+00
6.7e-01
cases:1.48%
controls:0.63%
cases:1.48%
controls:0.43%
cases:1.23%
controls:0.04%
—
—
cases:1.63%
controls:0.06%
cases:2.46%
controls:0.55%
cases:4.17%
controls:2.17%
24
103
1600
16120
24
69
1601
16163
20
6
1605
16226
—
25
9
1509
16198
34
87
1346
15648
42
285
966
12870
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
9.0e-01
1.4e+00
2.5e+00
1.0e+50
2.7e+00
2.1e+00
1.7e+00
cases:5.54%
controls:2.34%
cases:3.38%
controls:0.89%
cases:0.92%
controls:0.07%
cases:2.03%
controls:0.00%
cases:1.04%
controls:0.07%
cases:5.65%
controls:0.75%
cases:12.40%
controls:2.58%
90
379
1534
15844
55
145
1570
16087
15
12
1610
16220
33
0
1592
16232
16
12
1518
16195
78
118
1302
15617
125
340
883
12815
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
8.9e-01
2.0e+00
2.4e+00
—
2.6e+00
1.8e+00
1.5e+00
cases:3.57%
controls:1.50%
cases:4.18%
controls:0.59%
cases:0.92%
controls:0.09%
—
—
cases:1.11%
controls:0.08%
cases:3.55%
controls:0.60%
cases:7.94%
controls:1.94%
58
243
1566
15980
68
96
1557
16136
15
14
1610
16218
—
17
13
1517
16194
49
94
1331
15641
80
255
928
12900
Body CT examination
JN4AD [2001310897]
9.6e-01
1.6e+00
2.3e+00
1.0e+50
2.9e+00
1.9e+00
1.5e+00
cases:2.34%
controls:0.91%
cases:3.02%
controls:0.62%
cases:1.05%
controls:0.10%
cases:1.05%
controls:0.00%
cases:0.85%
controls:0.05%
cases:3.91%
controls:0.62%
cases:7.14%
controls:1.62%
38
147
1586
16076
49
101
1576
16131
17
17
1608
16215
17
0
1608
16232
13
8
1521
16199
54
98
1326
15637
72
213
936
12942
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
9.0e-01
1.4e+00
2.2e+00
—
3.0e+00
1.9e+00
1.8e+00
cases:2.71%
controls:1.12%
cases:2.22%
controls:0.53%
cases:0.43%
controls:0.05%
—
—
cases:1.37%
controls:0.07%
cases:3.12%
controls:0.50%
cases:8.93%
controls:1.67%
44
182
1580
16041
36
86
1589
16146
7
8
1618
16224
—
21
11
1513
16196
43
79
1337
15656
90
220
918
12935
pH of Blood
11558-4 [3010421]
9.8e-01
1.8e+00
2.3e+00
—
2.4e+00
2.1e+00
1.6e+00
cases:1.17%
controls:0.44%
cases:1.11%
controls:0.19%
cases:0.62%
controls:0.06%
—
—
cases:0.39%
controls:0.04%
cases:1.30%
controls:0.17%
cases:3.57%
controls:0.71%
19
72
1605
16151
18
31
1607
16201
10
10
1615
16222
—
6
6
1528
16201
18
26
1362
15709
36
93
972
13062
Infectious Disease
44 [38004484]
7.7e-01
1.4e+00
2.6e+00
1.0e+50
2.9e+00
1.7e+00
1.7e+00
cases:3.20%
controls:1.51%
cases:2.58%
controls:0.65%
cases:0.80%
controls:0.06%
cases:0.31%
controls:0.00%
cases:1.37%
controls:0.07%
cases:3.19%
controls:0.57%
cases:8.23%
controls:1.63%
52
245
1572
15978
42
105
1583
16127
13
10
1612
16222
5
0
1620
16232
21
12
1513
16195
44
90
1336
15645
83
214
925
12941
Polycythaemia vera
D45 [45595761]
1.9e+00
2.1e+00
—
1.0e+50
2.4e+00
2.4e+00
2.3e+00
cases:0.55%
controls:0.08%
cases:0.74%
controls:0.09%
—
—
cases:0.37%
controls:0.00%
cases:0.65%
controls:0.06%
cases:1.09%
controls:0.10%
cases:1.39%
controls:0.14%
9
13
1615
16210
12
15
1613
16217
—
6
0
1619
16232
10
10
1524
16197
15
15
1365
15720
14
19
994
13136
Hepatitis A virus Ab [Presence] in Serum
20575-7 [3016650]
2.6e+00
3.9e+00
—
—
—
2.4e+00
2.2e+00
cases:3.02%
controls:0.23%
cases:4.31%
controls:0.09%
—
—
—
—
—
—
cases:0.87%
controls:0.08%
cases:2.78%
controls:0.31%
49
37
1575
16186
70
15
1555
16217
—
—
—
12
13
1368
15722
28
41
980
13114
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 [3024403]
1.5e+00
2.4e+00
—
—
3.0e+00
2.4e+00
1.8e+00
cases:1.79%
controls:0.42%
cases:1.97%
controls:0.18%
—
—
—
—
cases:0.59%
controls:0.03%
cases:2.10%
controls:0.19%
cases:3.57%
controls:0.60%
29
68
1595
16155
32
29
1593
16203
—
—
9
5
1525
16202
29
30
1351
15705
36
79
972
13076
Chronic active hepatitis, not elsewhere classified
K73.2 [45543340]
3.3e+00
—
—
—
—
3.7e+00
4.0e+00
cases:1.17%
controls:0.04%
—
—
—
—
—
—
—
—
cases:1.30%
controls:0.03%
cases:2.08%
controls:0.04%
19
7
1605
16216
—
—
—
—
18
5
1362
15730
21
5
987
13150
Iron deficiency anaemia secondary to blood loss (chronic)
D50.0 [45566697]
2.2e+00
2.8e+00
—
1.0e+50
—
3.1e+00
2.9e+00
cases:2.34%
controls:0.26%
cases:2.15%
controls:0.13%
—
—
cases:1.85%
controls:0.00%
—
—
cases:3.04%
controls:0.14%
cases:5.16%
controls:0.31%
38
42
1586
16181
35
21
1590
16211
—
30
0
1595
16232
—
42
22
1338
15713
52
41
956
13114
Gastrointestinal haemorrhage, unspecified
K92.2 [45533625]
2.0e+00
2.9e+00
—
1.0e+50
—
3.4e+00
2.7e+00
cases:1.54%
controls:0.21%
cases:1.23%
controls:0.07%
—
—
cases:1.54%
controls:0.00%
—
—
cases:2.17%
controls:0.08%
cases:3.47%
controls:0.24%
25
34
1599
16189
20
11
1605
16221
—
25
0
1600
16232
—
30
12
1350
15723
35
32
973
13123
Fatty (change of) liver, not elsewhere classified
K76.0 [45601189]
2.7e+00
2.6e+00
—
1.0e+50
—
3.2e+00
2.4e+00
cases:3.08%
controls:0.22%
cases:1.60%
controls:0.12%
—
—
cases:0.92%
controls:0.00%
—
—
cases:2.54%
controls:0.10%
cases:2.88%
controls:0.27%
50
35
1574
16188
26
19
1599
16213
—
15
0
1610
16232
—
35
16
1345
15719
29
36
979
13119
Cathetrisation of artery
TPH07 [2001309747]
5.5e-01
1.4e+00
2.6e+00
1.0e+50
3.1e+00
2.0e+00
1.8e+00
cases:2.52%
controls:1.47%
cases:1.91%
controls:0.46%
cases:0.68%
controls:0.05%
cases:1.35%
controls:0.00%
cases:0.91%
controls:0.04%
cases:2.75%
controls:0.37%
cases:8.83%
controls:1.60%
41
238
1583
15985
31
75
1594
16157
11
8
1614
16224
22
0
1603
16232
14
7
1520
16200
38
58
1342
15677
89
211
919
12944
Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11259-9 [3021125]
1.9e+00
2.9e+00
—
—
—
3.3e+00
2.8e+00
cases:0.55%
controls:0.08%
cases:0.98%
controls:0.06%
—
—
—
—
—
—
cases:1.30%
controls:0.05%
cases:2.28%
controls:0.14%
9
13
1615
16210
16
9
1609
16223
—
—
—
18
8
1362
15727
23
18
985
13137
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
3.2e-01
8.1e-01
1.9e+00
4.2e+00
2.1e+00
1.0e+00
5.6e-01
cases:43.10%
controls:35.39%
cases:47.32%
controls:28.54%
cases:27.82%
controls:5.34%
cases:15.94%
controls:0.29%
cases:30.18%
controls:5.05%
cases:53.55%
controls:29.69%
cases:65.67%
controls:52.33%
700
5742
924
10481
769
4632
856
11600
452
867
1173
15365
259
47
1366
16185
463
818
1071
15389
739
4672
641
11063
662
6884
346
6271
ECG with 12 standard connections
XF400 [2001303368]
8.3e-01
1.6e+00
2.7e+00
1.0e+50
2.3e+00
1.8e+00
1.7e+00
cases:4.31%
controls:1.94%
cases:2.95%
controls:0.62%
cases:1.11%
controls:0.07%
cases:0.68%
controls:0.00%
cases:0.59%
controls:0.06%
cases:3.26%
controls:0.56%
cases:7.24%
controls:1.42%
70
314
1554
15909
48
101
1577
16131
18
12
1607
16220
11
0
1614
16232
9
10
1525
16197
45
88
1335
15647
73
187
935
12968
Bacteria identified in Blood by Culture
600-7 [3023368]
8.0e-01
1.4e+00
2.2e+00
—
3.1e+00
1.8e+00
1.5e+00
cases:9.36%
controls:4.44%
cases:8.98%
controls:2.33%
cases:2.95%
controls:0.33%
—
—
cases:4.82%
controls:0.23%
cases:13.19%
controls:2.35%
cases:26.39%
controls:7.56%
152
720
1472
15503
146
378
1479
15854
48
53
1577
16179
—
74
38
1460
16169
182
369
1198
15366
266
994
742
12161
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
7.5e-01
1.2e+00
2.2e+00
1.0e+50
3.2e+00
1.9e+00
1.6e+00
cases:3.20%
controls:1.54%
cases:2.15%
controls:0.64%
cases:0.86%
controls:0.10%
cases:1.60%
controls:0.00%
cases:1.76%
controls:0.07%
cases:4.28%
controls:0.69%
cases:11.90%
controls:2.59%
52
250
1572
15973
35
104
1590
16128
14
16
1611
16216
26
0
1599
16232
27
12
1507
16195
59
108
1321
15627
120
341
888
12814
Base excess in Arterial blood by calculation
1925-7 [3003396]
6.9e-01
1.2e+00
2.2e+00
—
3.2e+00
1.9e+00
1.6e+00
cases:3.82%
controls:1.95%
cases:2.83%
controls:0.83%
cases:0.86%
controls:0.10%
—
—
cases:1.96%
controls:0.08%
cases:5.14%
controls:0.82%
cases:13.59%
controls:3.03%
62
317
1562
15906
46
135
1579
16097
14
16
1611
16216
—
30
13
1504
16194
71
129
1309
15606
137
398
871
12757
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
1.1e+00
1.6e+00
2.2e+00
—
2.6e+00
1.8e+00
1.4e+00
cases:5.54%
controls:1.82%
cases:4.86%
controls:1.05%
cases:1.48%
controls:0.17%
—
—
cases:1.63%
controls:0.12%
cases:6.09%
controls:1.02%
cases:11.11%
controls:3.00%
90
296
1534
15927
79
171
1546
16061
24
27
1601
16205
—
25
19
1509
16188
84
160
1296
15575
112
394
896
12761
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
3.2e-01
8.0e-01
1.9e+00
4.1e+00
2.1e+00
9.9e-01
5.4e-01
cases:43.17%
controls:35.65%
cases:47.57%
controls:28.97%
cases:28.12%
controls:5.45%
cases:15.82%
controls:0.30%
cases:30.18%
controls:5.14%
cases:53.70%
controls:30.17%
cases:65.67%
controls:52.69%
701
5784
923
10439
773
4703
852
11529
457
885
1168
15347
257
48
1368
16184
463
833
1071
15374
741
4748
639
10987
662
6932
346
6223
Oxygen saturation in Arterial blood
2708-6 [3016502]
7.2e-01
1.2e+00
2.0e+00
—
3.3e+00
1.9e+00
1.6e+00
cases:3.45%
controls:1.71%
cases:2.40%
controls:0.71%
cases:0.80%
controls:0.10%
—
—
cases:2.02%
controls:0.07%
cases:4.57%
controls:0.72%
cases:12.60%
controls:2.87%
56
277
1568
15946
39
116
1586
16116
13
17
1612
16215
—
31
12
1503
16195
63
114
1317
15621
127
377
881
12778
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
1.3e+00
1.7e+00
2.2e+00
—
2.5e+00
1.7e+00
1.5e+00
cases:3.14%
controls:0.88%
cases:2.52%
controls:0.49%
cases:0.86%
controls:0.10%
—
—
cases:1.24%
controls:0.10%
cases:3.26%
controls:0.63%
cases:6.25%
controls:1.49%
51
142
1573
16081
41
79
1584
16153
14
16
1611
16216
—
19
17
1515
16190
45
99
1335
15636
63
196
945
12959
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
7.1e-01
1.3e+00
2.1e+00
—
3.2e+00
1.9e+00
1.6e+00
cases:3.88%
controls:1.95%
cases:2.95%
controls:0.86%
cases:0.92%
controls:0.12%
—
—
cases:2.09%
controls:0.09%
cases:5.29%
controls:0.81%
cases:13.69%
controls:3.08%
63
317
1561
15906
48
139
1577
16093
15
19
1610
16213
—
32
14
1502
16193
73
128
1307
15607
138
405
870
12750
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
7.1e-01
1.3e+00
2.1e+00
—
3.2e+00
1.9e+00
1.6e+00
cases:3.88%
controls:1.95%
cases:2.95%
controls:0.86%
cases:0.92%
controls:0.12%
—
—
cases:2.09%
controls:0.09%
cases:5.29%
controls:0.81%
cases:13.69%
controls:3.09%
63
317
1561
15906
48
139
1577
16093
15
19
1610
16213
—
32
14
1502
16193
73
128
1307
15607
138
406
870
12749
Body temperature
8310-5 [3020891]
7.7e-01
1.4e+00
2.8e+00
—
3.1e+00
1.7e+00
1.0e+00
cases:1.60%
controls:0.75%
cases:1.23%
controls:0.30%
cases:0.62%
controls:0.04%
—
—
cases:1.17%
controls:0.06%
cases:1.96%
controls:0.37%
cases:3.77%
controls:1.40%
26
121
1598
16102
20
49
1605
16183
10
6
1615
16226
—
18
9
1516
16198
27
59
1353
15676
38
184
970
12971
Office Visit
OMOP4822458 [581477]
6.4e-01
1.3e+00
2.4e+00
1.0e+50
3.4e+00
1.8e+00
1.2e+00
cases:14.66%
controls:8.28%
cases:7.88%
controls:2.33%
cases:2.34%
controls:0.22%
cases:7.38%
controls:0.00%
cases:8.47%
controls:0.30%
cases:10.72%
controls:1.99%
cases:17.46%
controls:5.81%
238
1344
1386
14879
128
378
1497
15854
38
36
1587
16196
120
0
1505
16232
130
49
1404
16158
148
313
1232
15422
176
764
832
12391
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
2.1e+00
2.9e+00
—
—
—
3.2e+00
2.5e+00
cases:3.57%
controls:0.43%
cases:4.06%
controls:0.23%
—
—
—
—
—
—
cases:3.84%
controls:0.16%
cases:6.15%
controls:0.55%
58
70
1566
16153
66
38
1559
16194
—
—
—
53
25
1327
15710
62
73
946
13082
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
1.0e+00
1.4e+00
1.9e+00
—
2.5e+00
2.0e+00
1.9e+00
cases:7.20%
controls:2.69%
cases:6.71%
controls:1.79%
cases:2.03%
controls:0.31%
—
—
cases:3.39%
controls:0.28%
cases:10.87%
controls:1.62%
cases:20.83%
controls:3.72%
117
436
1507
15787
109
291
1516
15941
33
51
1592
16181
—
52
46
1482
16161
150
255
1230
15480
210
489
798
12666
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
8.7e-01
1.7e+00
2.7e+00
—
2.5e+00
1.7e+00
1.2e+00
cases:3.02%
controls:1.28%
cases:2.65%
controls:0.48%
cases:0.74%
controls:0.05%
—
—
cases:0.65%
controls:0.06%
cases:2.32%
controls:0.42%
cases:4.86%
controls:1.51%
49
208
1575
16015
43
78
1582
16154
12
8
1613
16224
—
10
9
1524
16198
32
66
1348
15669
49
198
959
12957
Supine thorax X-ray examination
GD1QA [2001303648]
9.1e-01
1.4e+00
2.6e+00
—
2.8e+00
1.6e+00
1.5e+00
cases:4.43%
controls:1.82%
cases:3.08%
controls:0.78%
cases:1.11%
controls:0.09%
—
—
cases:1.43%
controls:0.09%
cases:4.78%
controls:1.00%
cases:12.90%
controls:3.28%
72
296
1552
15927
50
126
1575
16106
18
14
1607
16218
—
22
15
1512
16192
66
158
1314
15577
130
432
878
12723
pH of Arterial blood
2744-1 [3019977]
7.3e-01
1.2e+00
2.1e+00
—
3.2e+00
1.9e+00
1.6e+00
cases:3.94%
controls:1.95%
cases:2.83%
controls:0.84%
cases:0.92%
controls:0.12%
—
—
cases:2.09%
controls:0.09%
cases:5.14%
controls:0.83%
cases:13.69%
controls:3.09%
64
316
1560
15907
46
137
1579
16095
15
19
1610
16213
—
32
14
1502
16193
71
131
1309
15604
138
406
870
12749
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
3.3e-01
8.7e-01
2.0e+00
4.0e+00
1.9e+00
1.0e+00
4.8e-01
cases:43.72%
controls:35.91%
cases:48.43%
controls:28.31%
cases:27.88%
controls:4.87%
cases:10.46%
controls:0.20%
cases:26.34%
controls:4.94%
cases:54.49%
controls:30.02%
cases:64.98%
controls:53.49%
710
5825
914
10398
787
4595
838
11637
453
791
1172
15441
170
33
1455
16199
404
800
1130
15407
752
4724
628
11011
655
7036
353
6119
Bacterial infection, unspecified
A49.9 [45590816]
9.3e-01
1.3e+00
2.8e+00
—
2.2e+00
2.0e+00
1.3e+00
cases:2.52%
controls:1.01%
cases:1.60%
controls:0.43%
cases:0.74%
controls:0.04%
—
—
cases:0.46%
controls:0.05%
cases:2.97%
controls:0.39%
cases:5.46%
controls:1.56%
41
164
1583
16059
26
70
1599
16162
12
7
1613
16225
—
7
8
1527
16199
41
62
1339
15673
55
205
953
12950
Medical doctor
Z2221 [2001311556]
5.9e-01
1.3e+00
1.8e+00
1.0e+50
2.9e+00
2.3e+00
1.7e+00
cases:8.07%
controls:4.64%
cases:4.31%
controls:1.18%
cases:1.05%
controls:0.17%
cases:6.40%
controls:0.00%
cases:1.96%
controls:0.11%
cases:8.41%
controls:0.92%
cases:11.31%
controls:2.25%
131
753
1493
15470
70
191
1555
16041
17
27
1608
16205
104
0
1521
16232
30
18
1504
16189
116
144
1264
15591
114
296
894
12859
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
9.1e-01
1.7e+00
2.6e+00
—
2.7e+00
1.5e+00
1.3e+00
cases:10.16%
controls:4.37%
cases:6.58%
controls:1.29%
cases:1.29%
controls:0.10%
—
—
cases:1.56%
controls:0.11%
cases:4.78%
controls:1.07%
cases:11.51%
controls:3.44%
165
709
1459
15514
107
210
1518
16022
21
16
1604
16216
—
24
18
1510
16189
66
169
1314
15566
116
452
892
12703
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
6.0e-01
1.3e+00
2.6e+00
—
3.0e+00
1.8e+00
1.4e+00
cases:15.15%
controls:8.90%
cases:12.62%
controls:3.92%
cases:5.91%
controls:0.48%
—
—
cases:6.65%
controls:0.36%
cases:18.19%
controls:3.45%
cases:34.03%
controls:11.05%
246
1444
1378
14779
205
636
1420
15596
96
78
1529
16154
—
102
59
1432
16148
251
543
1129
15192
343
1453
665
11702
Cathetrisation of vein
TPH04 [2001309597]
8.4e-01
1.5e+00
2.6e+00
—
2.1e+00
2.0e+00
1.5e+00
cases:6.77%
controls:3.04%
cases:4.92%
controls:1.09%
cases:1.48%
controls:0.11%
—
—
cases:1.24%
controls:0.15%
cases:6.74%
controls:0.97%
cases:14.09%
controls:3.45%
110
493
1514
15730
80
177
1545
16055
24
18
1601
16214
—
19
24
1515
16183
93
152
1287
15583
142
454
866
12701
X-ray examination of the lungs in one projection
GD1PA [2001303645]
9.5e-01
1.7e+00
2.2e+00
1.0e+50
2.5e+00
1.8e+00
1.4e+00
cases:2.40%
controls:0.94%
cases:2.15%
controls:0.39%
cases:0.49%
controls:0.06%
cases:0.86%
controls:0.00%
cases:0.78%
controls:0.06%
cases:2.75%
controls:0.48%
cases:6.35%
controls:1.62%
39
153
1585
16070
35
64
1590
16168
8
9
1617
16223
14
0
1611
16232
12
10
1522
16197
38
76
1342
15659
64
213
944
12942
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
7.2e-01
1.4e+00
1.6e+00
—
2.9e+00
2.3e+00
1.7e+00
cases:3.57%
controls:1.77%
cases:3.20%
controls:0.84%
cases:1.05%
controls:0.22%
—
—
cases:2.15%
controls:0.12%
cases:6.23%
controls:0.66%
cases:11.41%
controls:2.27%
58
287
1566
15936
52
137
1573
16095
17
35
1608
16197
—
33
20
1501
16187
86
104
1294
15631
115
299
893
12856
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
3.7e-01
7.7e-01
1.9e+00
4.2e+00
1.9e+00
9.2e-01
5.3e-01
cases:32.14%
controls:24.67%
cases:36.62%
controls:21.10%
cases:24.68%
controls:4.65%
cases:12.18%
controls:0.22%
cases:24.19%
controls:4.65%
cases:41.52%
controls:22.10%
cases:51.79%
controls:38.68%
522
4003
1102
12220
595
3425
1030
12807
401
754
1224
15478
198
35
1427
16197
371
753
1163
15454
573
3478
807
12257
522
5089
486
8066
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
8.5e-01
1.5e+00
2.0e+00
—
3.7e+00
2.5e+00
2.0e+00
cases:1.79%
controls:0.77%
cases:1.60%
controls:0.34%
cases:0.31%
controls:0.04%
—
—
cases:1.24%
controls:0.03%
cases:3.55%
controls:0.31%
cases:8.43%
controls:1.28%
29
125
1595
16098
26
56
1599
16176
5
7
1620
16225
—
19
5
1515
16202
49
49
1331
15686
85
169
923
12986
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
8.9e-01
1.2e+00
1.8e+00
2.9e+00
1.6e+00
1.3e+00
8.3e-01
cases:9.36%
controls:4.05%
cases:8.12%
controls:2.64%
cases:2.58%
controls:0.44%
cases:0.55%
controls:0.03%
cases:2.28%
controls:0.45%
cases:8.91%
controls:2.64%
cases:13.99%
controls:6.61%
152
657
1472
15566
132
429
1493
15803
42
72
1583
16160
9
5
1616
16227
35
73
1499
16134
123
416
1257
15319
141
870
867
12285
Alcohol dependence currently independent
F10.20 [2000501677]
2.1e+00
2.4e+00
—
—
—
3.1e+00
2.9e+00
cases:1.35%
controls:0.16%
cases:0.68%
controls:0.06%
—
—
—
—
—
—
cases:1.09%
controls:0.05%
cases:2.58%
controls:0.15%
22
26
1602
16197
11
10
1614
16222
—
—
—
15
8
1365
15727
26
20
982
13135
Emergency Room and Inpatient Visit
ERIP [262]
8.1e-01
1.6e+00
2.5e+00
—
2.6e+00
1.8e+00
1.3e+00
cases:9.48%
controls:4.47%
cases:12.31%
controls:2.82%
cases:4.68%
controls:0.42%
—
—
cases:4.63%
controls:0.36%
cases:15.29%
controls:3.02%
cases:29.46%
controls:10.49%
154
725
1470
15498
200
458
1425
15774
76
68
1549
16164
—
71
58
1463
16149
211
475
1169
15260
297
1380
711
11775
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
1.6e+00
2.7e+00
1.0e+50
—
—
3.6e+00
2.5e+00
cases:1.54%
controls:0.31%
cases:1.54%
controls:0.10%
cases:0.43%
controls:0.00%
—
—
—
—
cases:2.54%
controls:0.07%
cases:4.86%
controls:0.41%
25
50
1599
16173
25
17
1600
16215
7
0
1618
16232
—
—
35
11
1345
15724
49
54
959
13101
Metabolic syndrome
E66.00 [2000501500]
1.4e+00
1.7e+00
2.3e+00
—
2.4e+00
1.6e+00
1.1e+00
cases:2.77%
controls:0.70%
cases:1.60%
controls:0.30%
cases:0.55%
controls:0.06%
—
—
cases:0.59%
controls:0.06%
cases:1.52%
controls:0.32%
cases:2.88%
controls:0.99%
45
114
1579
16109
26
48
1599
16184
9
9
1616
16223
—
9
9
1525
16198
21
50
1359
15685
29
130
979
13025
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
7.2e-01
1.3e+00
2.2e+00
—
3.0e+00
1.8e+00
1.2e+00
cases:11.64%
controls:6.01%
cases:6.58%
controls:1.80%
cases:1.54%
controls:0.17%
—
—
cases:3.98%
controls:0.20%
cases:9.78%
controls:1.71%
cases:17.16%
controls:5.72%
189
975
1435
15248
107
292
1518
15940
25
28
1600
16204
—
61
32
1473
16175
135
269
1245
15466
173
752
835
12403
Examination and observation for other specified reasons
Z04.8 [45552063]
9.8e-01
1.1e+00
2.4e+00
—
2.6e+00
2.0e+00
1.2e+00
cases:3.82%
controls:1.46%
cases:1.54%
controls:0.52%
cases:0.55%
controls:0.05%
—
—
cases:0.59%
controls:0.04%
cases:2.97%
controls:0.40%
cases:5.95%
controls:1.92%
62
237
1562
15986
25
85
1600
16147
9
8
1616
16224
—
9
7
1525
16200
41
63
1339
15672
60
252
948
12903
Other specified diabetes mellitus, without complications
E13.9 [45537964]
2.2e+00
2.7e+00
—
1.0e+50
—
3.3e+00
2.1e+00
cases:0.86%
controls:0.09%
cases:0.98%
controls:0.07%
—
—
cases:0.43%
controls:0.00%
—
—
cases:1.30%
controls:0.05%
cases:0.99%
controls:0.12%
14
15
1610
16208
16
11
1609
16221
—
7
0
1618
16232
—
18
8
1362
15727
10
16
998
13139
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
3.1e-01
9.6e-01
1.4e+00
3.7e+00
1.8e+00
1.1e+00
1.0e+00
cases:19.58%
controls:15.10%
cases:17.35%
controls:7.47%
cases:4.49%
controls:1.15%
cases:1.97%
controls:0.05%
cases:5.74%
controls:1.04%
cases:20.29%
controls:7.88%
cases:41.47%
controls:20.44%
318
2450
1306
13773
282
1212
1343
15020
73
186
1552
16046
32
8
1593
16224
88
168
1446
16039
280
1240
1100
14495
418
2689
590
10466
CBC panel - Blood by Automated count
58410-2 [40761511]
2.8e-01
6.4e-01
1.9e+00
4.1e+00
2.0e+00
9.2e-01
4.4e-01
cases:40.21%
controls:33.72%
cases:36.49%
controls:23.26%
cases:22.77%
controls:4.38%
cases:11.63%
controls:0.21%
cases:23.14%
controls:4.09%
cases:43.99%
controls:23.84%
cases:56.75%
controls:45.85%
653
5471
971
10752
593
3776
1032
12456
370
711
1255
15521
189
34
1436
16198
355
663
1179
15544
607
3752
773
11983
572
6032
436
7123
Alcohol dependence continuous use
F10.25 [2000501682]
2.5e+00
3.3e+00
—
1.0e+50
—
2.6e+00
1.7e+00
cases:2.22%
controls:0.18%
cases:0.86%
controls:0.03%
—
—
cases:0.37%
controls:0.00%
—
—
cases:0.80%
controls:0.06%
cases:1.29%
controls:0.23%
36
30
1588
16193
14
5
1611
16227
—
6
0
1619
16232
—
11
9
1369
15726
13
30
995
13125
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
2.6e-01
7.1e-01
1.9e+00
4.2e+00
1.9e+00
9.1e-01
4.0e-01
cases:44.64%
controls:38.41%
cases:49.78%
controls:32.70%
cases:31.26%
controls:6.63%
cases:16.74%
controls:0.31%
cases:31.75%
controls:6.40%
cases:56.52%
controls:34.28%
cases:65.67%
controls:56.25%
725
6232
899
9991
809
5308
816
10924
508
1076
1117
15156
272
51
1353
16181
487
1037
1047
15170
780
5394
600
10341
662
7400
346
5755
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
1.6e+00
2.7e+00
1.0e+50
—
1.0e+50
3.4e+00
2.5e+00
cases:1.60%
controls:0.33%
cases:1.60%
controls:0.11%
cases:0.49%
controls:0.00%
—
—
cases:0.85%
controls:0.00%
cases:2.46%
controls:0.08%
cases:4.96%
controls:0.43%
26
53
1598
16170
26
18
1599
16214
8
0
1617
16232
—
13
0
1521
16207
34
13
1346
15722
50
56
958
13099
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
1.1e+00
1.7e+00
2.2e+00
—
2.6e+00
1.4e+00
1.1e+00
cases:8.07%
controls:2.76%
cases:9.42%
controls:1.87%
cases:2.15%
controls:0.23%
—
—
cases:2.61%
controls:0.19%
cases:8.70%
controls:2.26%
cases:21.03%
controls:8.35%
131
448
1493
15775
153
303
1472
15929
35
38
1590
16194
—
40
31
1494
16176
120
355
1260
15380
212
1099
796
12056
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
2.7e-01
7.2e-01
1.8e+00
4.1e+00
1.8e+00
8.9e-01
5.6e-01
cases:31.53%
controls:26.09%
cases:37.42%
controls:22.60%
cases:22.58%
controls:4.45%
cases:11.38%
controls:0.22%
cases:22.23%
controls:4.45%
cases:43.12%
controls:23.71%
cases:55.85%
controls:41.98%
512
4232
1112
11991
608
3669
1017
12563
367
723
1258
15509
185
35
1440
16197
341
722
1193
15485
595
3731
785
12004
563
5523
445
7632
Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32785-8 [3043405]
2.4e+00
2.6e+00
—
—
—
2.7e+00
2.4e+00
cases:1.48%
controls:0.13%
cases:0.92%
controls:0.07%
—
—
—
—
—
—
cases:0.72%
controls:0.05%
cases:1.79%
controls:0.17%
24
21
1600
16202
15
11
1610
16221
—
—
—
10
8
1370
15727
18
22
990
13133
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
4.5e-01
1.2e+00
2.7e+00
1.0e+50
3.6e+00
1.6e+00
9.2e-01
cases:0.99%
controls:0.63%
cases:1.23%
controls:0.39%
cases:1.05%
controls:0.07%
cases:0.80%
controls:0.00%
cases:1.17%
controls:0.03%
cases:2.10%
controls:0.43%
cases:4.17%
controls:1.70%
16
102
1608
16121
20
63
1605
16169
17
11
1608
16221
13
0
1612
16232
18
5
1516
16202
29
67
1351
15668
42
223
966
12932
Alcoholic fatty liver
K70.0 [45567323]
3.3e+00
—
1.0e+50
1.0e+50
—
3.1e+00
3.6e+00
cases:0.99%
controls:0.04%
—
—
cases:0.31%
controls:0.00%
cases:0.92%
controls:0.00%
—
—
cases:0.87%
controls:0.04%
cases:1.69%
controls:0.05%
16
6
1608
16217
—
5
0
1620
16232
15
0
1610
16232
—
12
6
1368
15729
17
6
991
13149
Neutrophil cytoplasmic Ab.classic [Titer] in Serum
32708-0 [3046294]
2.3e+00
3.8e+00
—
—
1.0e+50
—
4.0e+00
cases:1.48%
controls:0.15%
cases:2.40%
controls:0.06%
—
—
—
—
cases:0.85%
controls:0.00%
—
—
cases:5.36%
controls:0.11%
24
25
1600
16198
39
9
1586
16223
—
—
13
0
1521
16207
—
54
14
954
13141
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
32787-4 [3043453]
2.3e+00
3.8e+00
—
—
1.0e+50
—
4.0e+00
cases:1.48%
controls:0.15%
cases:2.40%
controls:0.06%
—
—
—
—
cases:0.85%
controls:0.00%
—
—
cases:5.36%
controls:0.11%
24
25
1600
16198
39
9
1586
16223
—
—
13
0
1521
16207
—
54
14
954
13141
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
2.0e-01
6.8e-01
1.9e+00
4.1e+00
1.9e+00
8.7e-01
3.1e-01
cases:45.69%
controls:40.89%
cases:51.38%
controls:34.81%
cases:36.49%
controls:7.63%
cases:18.34%
controls:0.36%
cases:34.49%
controls:7.44%
cases:57.97%
controls:36.67%
cases:66.07%
controls:58.70%
742
6634
882
9589
835
5650
790
10582
593
1239
1032
14993
298
58
1327
16174
529
1205
1005
15002
800
5770
580
9965
666
7722
342
5433
Platelets [#/volume] in Blood
26515-7 [3007461]
1.9e-01
6.9e-01
1.9e+00
4.1e+00
1.9e+00
8.7e-01
3.2e-01
cases:45.50%
controls:40.74%
cases:51.32%
controls:34.68%
cases:36.43%
controls:7.60%
cases:18.22%
controls:0.36%
cases:34.42%
controls:7.44%
cases:57.83%
controls:36.54%
cases:66.07%
controls:58.56%
739
6610
885
9613
834
5630
791
10602
592
1234
1033
14998
296
58
1329
16174
528
1205
1006
15002
798
5750
582
9985
666
7704
342
5451
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.9e-01
6.9e-01
1.9e+00
4.1e+00
1.9e+00
8.7e-01
3.1e-01
cases:45.57%
controls:40.89%
cases:51.45%
controls:34.78%
cases:36.49%
controls:7.63%
cases:18.28%
controls:0.36%
cases:34.42%
controls:7.43%
cases:57.97%
controls:36.64%
cases:66.07%
controls:58.72%
740
6634
884
9589
836
5645
789
10587
593
1239
1032
14993
297
58
1328
16174
528
1204
1006
15003
800
5765
580
9970
666
7725
342
5430
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.9e-01
6.9e-01
1.9e+00
4.1e+00
1.9e+00
8.6e-01
3.2e-01
cases:45.63%
controls:40.87%
cases:51.38%
controls:34.75%
cases:36.43%
controls:7.63%
cases:18.22%
controls:0.36%
cases:34.42%
controls:7.43%
cases:57.83%
controls:36.64%
cases:66.17%
controls:58.60%
741
6631
883
9592
835
5640
790
10592
592
1238
1033
14994
296
58
1329
16174
528
1204
1006
15003
798
5766
582
9969
667
7709
341
5446
MCH [Entitic mass]
28539-5 [3035941]
2.0e-01
6.9e-01
1.9e+00
4.1e+00
1.9e+00
8.6e-01
3.2e-01
cases:45.63%
controls:40.80%
cases:51.38%
controls:34.72%
cases:36.43%
controls:7.62%
cases:18.22%
controls:0.36%
cases:34.29%
controls:7.41%
cases:57.75%
controls:36.58%
cases:66.07%
controls:58.55%
741
6619
883
9604
835
5636
790
10596
592
1237
1033
14995
296
58
1329
16174
526
1201
1008
15006
797
5756
583
9979
666
7702
342
5453
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.9e-01
6.9e-01
1.9e+00
4.1e+00
1.9e+00
8.6e-01
3.2e-01
cases:45.63%
controls:40.86%
cases:51.38%
controls:34.76%
cases:36.43%
controls:7.61%
cases:18.22%
controls:0.36%
cases:34.29%
controls:7.42%
cases:57.83%
controls:36.61%
cases:66.07%
controls:58.64%
741
6629
883
9594
835
5642
790
10590
592
1236
1033
14996
296
58
1329
16174
526
1202
1008
15005
798
5761
582
9974
666
7714
342
5441
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
2.0e-01
6.8e-01
1.9e+00
4.1e+00
1.9e+00
8.6e-01
3.2e-01
cases:45.63%
controls:40.84%
cases:51.38%
controls:34.77%
cases:36.43%
controls:7.62%
cases:18.22%
controls:0.36%
cases:34.42%
controls:7.44%
cases:57.75%
controls:36.64%
cases:66.07%
controls:58.65%
741
6626
883
9597
835
5644
790
10588
592
1237
1033
14995
296
58
1329
16174
528
1205
1006
15002
797
5765
583
9970
666
7715
342
5440
Endoscopic retrograd cholangiopancreaticography
JL5SB [2001305388]
2.4e+00
2.3e+00
—
—
—
3.0e+00
2.3e+00
cases:0.80%
controls:0.07%
cases:0.49%
controls:0.05%
—
—
—
—
—
—
cases:0.72%
controls:0.04%
cases:1.09%
controls:0.11%
13
12
1611
16211
8
8
1617
16224
—
—
—
10
6
1370
15729
11
14
997
13141
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
8.5e-01
1.3e+00
1.8e+00
—
2.2e+00
2.0e+00
1.8e+00
cases:16.75%
controls:7.90%
cases:10.03%
controls:2.83%
cases:3.26%
controls:0.56%
—
—
cases:4.43%
controls:0.51%
cases:16.45%
controls:2.70%
cases:32.44%
controls:7.15%
272
1282
1352
14941
163
459
1462
15773
53
91
1572
16141
—
68
83
1466
16124
227
425
1153
15310
327
941
681
12214
Other chronic pancreatitis
K86.1 [45586743]
2.2e+00
2.2e+00
—
—
—
3.1e+00
2.6e+00
cases:0.80%
controls:0.09%
cases:0.37%
controls:0.04%
—
—
—
—
—
—
cases:0.94%
controls:0.04%
cases:1.19%
controls:0.09%
13
15
1611
16208
6
7
1619
16225
—
—
—
13
7
1367
15728
12
12
996
13143
Blood transfusion
WW500 [2001310603]
1.7e+00
2.4e+00
—
1.0e+50
—
3.0e+00
2.8e+00
cases:1.35%
controls:0.24%
cases:1.60%
controls:0.14%
—
—
cases:0.80%
controls:0.00%
—
—
cases:2.39%
controls:0.13%
cases:5.26%
controls:0.33%
22
39
1602
16184
26
23
1599
16209
—
13
0
1612
16232
—
33
20
1347
15715
53
44
955
13111
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
9.3e-01
1.4e+00
1.8e+00
1.0e+50
3.1e+00
1.5e+00
1.2e+00
cases:3.63%
controls:1.46%
cases:2.65%
controls:0.68%
cases:0.49%
controls:0.08%
cases:0.80%
controls:0.00%
cases:1.17%
controls:0.06%
cases:4.13%
controls:0.97%
cases:9.82%
controls:3.09%
59
237
1565
15986
43
110
1582
16122
8
13
1617
16219
13
0
1612
16232
18
9
1516
16198
57
152
1323
15583
99
407
909
12748
Extensive abdominal CT
JN3BD [2001305556]
1.2e+00
2.0e+00
2.6e+00
—
2.2e+00
2.2e+00
1.9e+00
cases:3.94%
controls:1.22%
cases:2.40%
controls:0.32%
cases:0.55%
controls:0.04%
—
—
cases:0.33%
controls:0.04%
cases:2.54%
controls:0.29%
cases:6.25%
controls:0.96%
64
198
1560
16025
39
52
1586
16180
9
7
1616
16225
—
5
6
1529
16201
35
46
1345
15689
63
126
945
13029
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
9.4e-01
1.4e+00
1.7e+00
1.0e+50
3.1e+00
1.4e+00
1.3e+00
cases:3.51%
controls:1.40%
cases:2.65%
controls:0.67%
cases:0.49%
controls:0.09%
cases:0.80%
controls:0.00%
cases:1.17%
controls:0.06%
cases:4.06%
controls:0.99%
cases:10.52%
controls:3.19%
57
227
1567
15996
43
108
1582
16124
8
14
1617
16218
13
0
1612
16232
18
9
1516
16198
56
155
1324
15580
106
419
902
12736
Oral Surgery
19 [38004464]
1.0e+00
1.4e+00
—
—
2.8e+00
2.3e+00
2.3e+00
cases:2.16%
controls:0.80%
cases:1.17%
controls:0.29%
—
—
—
—
cases:0.59%
controls:0.04%
cases:2.61%
controls:0.26%
cases:6.85%
controls:0.71%
35
129
1589
16094
19
47
1606
16185
—
—
9
6
1525
16201
36
41
1344
15694
69
94
939
13061
Colonoscopy Study observation
28023-0 [3022145]
8.7e-01
1.5e+00
2.2e+00
1.0e+50
2.5e+00
1.6e+00
1.1e+00
cases:4.68%
controls:2.02%
cases:3.14%
controls:0.73%
cases:0.62%
controls:0.07%
cases:0.74%
controls:0.00%
cases:0.78%
controls:0.06%
cases:3.62%
controls:0.76%
cases:7.94%
controls:2.81%
76
327
1548
15896
51
118
1574
16114
10
11
1615
16221
12
0
1613
16232
12
10
1522
16197
50
119
1330
15616
80
370
928
12785
Alcoholic hepatic failure
K70.4 [45586729]
—
—
1.0e+50
1.0e+50
—
4.9e+00
4.9e+00
—
—
—
—
cases:0.92%
controls:0.00%
cases:1.42%
controls:0.00%
—
—
cases:3.91%
controls:0.03%
cases:5.06%
controls:0.04%
—
—
15
0
1610
16232
23
0
1602
16232
—
54
5
1326
15730
51
5
957
13150
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
1.5e+00
2.5e+00
1.0e+50
—
—
3.2e+00
2.7e+00
cases:1.42%
controls:0.33%
cases:1.66%
controls:0.14%
cases:0.43%
controls:0.00%
—
—
—
—
cases:2.68%
controls:0.11%
cases:5.06%
controls:0.37%
23
53
1601
16170
27
23
1598
16209
7
0
1618
16232
—
—
37
18
1343
15717
51
49
957
13106
Intravenous
ZX120 [2001311495]
1.2e+00
1.6e+00
1.6e+00
1.0e+50
1.4e+00
2.1e+00
1.9e+00
cases:3.39%
controls:1.07%
cases:2.03%
controls:0.41%
cases:0.55%
controls:0.12%
cases:0.49%
controls:0.00%
cases:0.65%
controls:0.15%
cases:3.33%
controls:0.41%
cases:5.85%
controls:0.97%
55
174
1569
16049
33
67
1592
16165
9
19
1616
16213
8
0
1617
16232
10
25
1524
16182
46
65
1334
15670
59
127
949
13028
Very extensive body CT
JN4CD [2001310902]
1.2e+00
2.5e+00
—
—
—
3.1e+00
2.9e+00
cases:1.29%
controls:0.40%
cases:0.92%
controls:0.07%
—
—
—
—
—
—
cases:1.74%
controls:0.08%
cases:3.97%
controls:0.23%
21
65
1603
16158
15
12
1610
16220
—
—
—
24
12
1356
15723
40
30
968
13125
Neutrophil count
30630007 [4148615]
1.8e+00
2.5e+00
—
—
—
2.6e+00
2.9e+00
cases:0.43%
controls:0.07%
cases:0.43%
controls:0.04%
—
—
—
—
—
—
cases:0.58%
controls:0.04%
cases:0.99%
controls:0.05%
7
12
1617
16211
7
6
1618
16226
—
—
—
8
7
1372
15728
10
7
998
13148
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
1.5e+00
2.5e+00
1.0e+50
—
—
3.1e+00
2.6e+00
cases:1.60%
controls:0.36%
cases:1.78%
controls:0.15%
cases:0.49%
controls:0.00%
—
—
—
—
cases:2.68%
controls:0.12%
cases:5.16%
controls:0.41%
26
59
1598
16164
29
24
1596
16208
8
0
1617
16232
—
—
37
19
1343
15716
52
54
956
13101
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
8.9e-01
1.5e+00
1.8e+00
1.0e+50
3.4e+00
2.1e+00
1.8e+00
cases:2.40%
controls:1.00%
cases:1.54%
controls:0.34%
cases:0.31%
controls:0.05%
cases:1.17%
controls:0.00%
cases:1.43%
controls:0.05%
cases:3.41%
controls:0.42%
cases:8.73%
controls:1.56%
39
163
1585
16060
25
56
1600
16176
5
8
1620
16224
19
0
1606
16232
22
8
1512
16199
47
66
1333
15669
88
205
920
12950
Abdominal CT examination both without and with contrast
JN3CD [2001305561]
1.2e+00
2.2e+00
—
1.0e+50
—
3.3e+00
2.9e+00
cases:1.11%
controls:0.33%
cases:0.86%
controls:0.09%
—
—
cases:0.86%
controls:0.00%
—
—
cases:1.74%
controls:0.06%
cases:3.57%
controls:0.21%
18
53
1606
16170
14
15
1611
16217
—
14
0
1611
16232
—
24
10
1356
15725
36
27
972
13128
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
7.4e-01
1.3e+00
1.6e+00
1.0e+50
3.7e+00
2.1e+00
1.8e+00
cases:1.85%
controls:0.89%
cases:1.42%
controls:0.39%
cases:0.37%
controls:0.07%
cases:1.11%
controls:0.00%
cases:1.50%
controls:0.04%
cases:3.19%
controls:0.40%
cases:8.53%
controls:1.48%
30
144
1594
16079
23
64
1602
16168
6
12
1619
16220
18
0
1607
16232
23
6
1511
16201
44
63
1336
15672
86
195
922
12960
Hepatitis B virus core IgM Ab [Presence] in Serum
31204-1 [3013527]
1.8e+00
2.8e+00
—
—
—
2.9e+00
2.2e+00
cases:1.48%
controls:0.26%
cases:2.40%
controls:0.15%
—
—
—
—
—
—
cases:2.68%
controls:0.15%
cases:3.97%
controls:0.45%
24
42
1600
16181
39
25
1586
16207
—
—
—
37
23
1343
15712
40
59
968
13096
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
1.1e+00
1.7e+00
2.0e+00
—
2.7e+00
1.3e+00
8.9e-01
cases:1.60%
controls:0.55%
cases:1.54%
controls:0.28%
cases:0.37%
controls:0.05%
—
—
cases:0.46%
controls:0.03%
cases:0.87%
controls:0.25%
cases:1.98%
controls:0.82%
26
89
1598
16134
25
46
1600
16186
6
8
1619
16224
—
7
5
1527
16202
12
39
1368
15696
20
108
988
13047
Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
1777-2 [3001467]
2.0e+00
2.8e+00
—
—
—
2.3e+00
2.4e+00
cases:1.11%
controls:0.15%
cases:1.05%
controls:0.06%
—
—
—
—
—
—
cases:0.58%
controls:0.06%
cases:1.69%
controls:0.15%
18
24
1606
16199
17
10
1608
16222
—
—
—
8
9
1372
15726
17
20
991
13135
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
1.4e+00
2.5e+00
1.0e+50
—
—
3.1e+00
2.6e+00
cases:1.42%
controls:0.36%
cases:1.72%
controls:0.15%
cases:0.49%
controls:0.00%
—
—
—
—
cases:2.68%
controls:0.12%
cases:5.16%
controls:0.40%
23
58
1601
16165
28
24
1597
16208
8
0
1617
16232
—
—
37
19
1343
15716
52
52
956
13103
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
1.3e+00
2.0e+00
—
1.0e+50
—
3.3e+00
3.0e+00
cases:1.72%
controls:0.49%
cases:1.97%
controls:0.27%
—
—
cases:0.37%
controls:0.00%
—
—
cases:4.49%
controls:0.17%
cases:8.63%
controls:0.48%
28
79
1596
16144
32
44
1593
16188
—
6
0
1619
16232
—
62
27
1318
15708
87
63
921
13092
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
1.0e+00
1.8e+00
2.4e+00
—
—
2.4e+00
2.0e+00
cases:1.05%
controls:0.39%
cases:0.80%
controls:0.14%
cases:0.55%
controls:0.05%
—
—
—
—
cases:1.01%
controls:0.10%
cases:2.68%
controls:0.39%
17
63
1607
16160
13
22
1612
16210
9
8
1616
16224
—
—
14
15
1366
15720
27
51
981
13104
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
8.5e-01
1.5e+00
2.1e+00
—
2.6e+00
1.2e+00
1.2e+00
cases:5.48%
controls:2.42%
cases:2.89%
controls:0.66%
cases:0.68%
controls:0.09%
—
—
cases:0.52%
controls:0.04%
cases:2.68%
controls:0.79%
cases:8.63%
controls:2.73%
89
392
1535
15831
47
107
1578
16125
11
14
1614
16218
—
8
6
1526
16201
37
124
1343
15611
87
359
921
12796
Respiratory and circulatory monitoring
WX700 [2001310817]
7.4e-01
1.1e+00
2.3e+00
1.0e+50
2.4e+00
1.6e+00
1.3e+00
cases:4.99%
controls:2.45%
cases:2.71%
controls:0.91%
cases:0.68%
controls:0.07%
cases:0.55%
controls:0.00%
cases:0.52%
controls:0.05%
cases:3.19%
controls:0.64%
cases:7.54%
controls:2.17%
81
397
1543
15826
44
147
1581
16085
11
11
1614
16221
9
0
1616
16232
8
8
1526
16199
44
100
1336
15635
76
285
932
12870
Thorax X-ray examination
GD1AA [2001303617]
7.6e-01
1.4e+00
1.9e+00
—
2.0e+00
1.8e+00
1.6e+00
cases:18.35%
controls:9.51%
cases:13.48%
controls:3.59%
cases:3.20%
controls:0.47%
—
—
cases:2.80%
controls:0.39%
cases:17.10%
controls:3.43%
cases:34.23%
controls:9.90%
298
1542
1326
14681
219
582
1406
15650
52
76
1573
16156
—
43
64
1491
16143
236
540
1144
15195
345
1303
663
11852
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
9.8e-01
1.8e+00
2.4e+00
—
—
2.3e+00
1.9e+00
cases:1.05%
controls:0.39%
cases:0.80%
controls:0.14%
cases:0.55%
controls:0.05%
—
—
—
—
cases:1.01%
controls:0.10%
cases:2.68%
controls:0.40%
17
64
1607
16159
13
22
1612
16210
9
8
1616
16224
—
—
14
16
1366
15719
27
52
981
13103
Base excess in Blood by calculation
11555-0 [3012501]
9.8e-01
1.8e+00
2.4e+00
—
—
2.3e+00
1.9e+00
cases:1.05%
controls:0.39%
cases:0.80%
controls:0.14%
cases:0.55%
controls:0.05%
—
—
—
—
cases:1.01%
controls:0.10%
cases:2.68%
controls:0.40%
17
64
1607
16159
13
22
1612
16210
9
8
1616
16224
—
—
14
16
1366
15719
27
52
981
13103
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
3.7e-01
9.6e-01
1.2e+00
3.2e+00
1.8e+00
1.1e+00
8.6e-01
cases:8.68%
controls:6.14%
cases:6.28%
controls:2.50%
cases:1.17%
controls:0.37%
cases:0.74%
controls:0.03%
cases:1.83%
controls:0.31%
cases:7.39%
controls:2.56%
cases:18.55%
controls:8.80%
141
996
1483
15227
102
405
1523
15827
19
60
1606
16172
12
5
1613
16227
28
51
1506
16156
102
403
1278
15332
187
1157
821
11998
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
1.9e+00
2.3e+00
—
—
—
2.7e+00
2.5e+00
cases:1.85%
controls:0.28%
cases:2.15%
controls:0.22%
—
—
—
—
—
—
cases:2.25%
controls:0.15%
cases:4.27%
controls:0.38%
30
45
1594
16178
35
35
1590
16197
—
—
—
31
24
1349
15711
43
50
965
13105
Disorders of iron metabolism
E83.1 [45552418]
1.9e+00
2.3e+00
—
—
—
2.7e+00
2.5e+00
cases:0.43%
controls:0.06%
cases:0.49%
controls:0.05%
—
—
—
—
—
—
cases:0.72%
controls:0.05%
cases:0.99%
controls:0.08%
7
10
1617
16213
8
8
1617
16224
—
—
—
10
8
1370
15727
10
11
998
13144
Benign neoplasm: Colon, unspecified
D12.6 [45576377]
1.4e+00
1.5e+00
—
1.0e+50
2.6e+00
2.5e+00
1.3e+00
cases:2.16%
controls:0.55%
cases:0.98%
controls:0.22%
—
—
cases:0.31%
controls:0.00%
cases:0.52%
controls:0.04%
cases:2.32%
controls:0.19%
cases:2.98%
controls:0.81%
35
90
1589
16133
16
35
1609
16197
—
5
0
1620
16232
8
6
1526
16201
32
30
1348
15705
30
106
978
13049
linagliptin; oral
A10BH05 [40251691]
1.4e+00
1.4e+00
1.6e+00
—
1.8e+00
1.6e+00
1.5e+00
cases:2.89%
controls:0.70%
cases:2.77%
controls:0.73%
cases:1.23%
controls:0.26%
—
—
cases:1.50%
controls:0.25%
cases:3.91%
controls:0.79%
cases:5.75%
controls:1.31%
47
114
1577
16109
45
118
1580
16114
20
42
1605
16190
—
23
41
1511
16166
54
124
1326
15611
58
172
950
12983
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
1.3e+00
2.0e+00
—
1.0e+50
—
3.2e+00
2.8e+00
cases:1.60%
controls:0.45%
cases:1.78%
controls:0.24%
—
—
cases:0.37%
controls:0.00%
—
—
cases:3.99%
controls:0.17%
cases:7.34%
controls:0.46%
26
73
1598
16150
29
39
1596
16193
—
6
0
1619
16232
—
55
27
1325
15708
74
61
934
13094
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4.6e-01
1.1e+00
1.8e+00
2.8e+00
1.4e+00
1.0e+00
6.9e-01
cases:27.71%
controls:19.48%
cases:24.92%
controls:10.00%
cases:8.25%
controls:1.43%
cases:0.80%
controls:0.05%
cases:5.93%
controls:1.52%
cases:24.42%
controls:10.31%
cases:41.07%
controls:25.97%
450
3161
1174
13062
405
1624
1220
14608
134
232
1491
16000
13
8
1612
16224
91
246
1443
15961
337
1623
1043
14112
414
3417
594
9738
hydroxyzine; oral, parenteral
N05BB01 [21604590]
8.9e-01
1.7e+00
1.8e+00
—
1.8e+00
1.7e+00
1.4e+00
cases:4.06%
controls:1.71%
cases:3.75%
controls:0.70%
cases:0.55%
controls:0.09%
—
—
cases:0.85%
controls:0.14%
cases:4.06%
controls:0.74%
cases:6.75%
controls:1.82%
66
277
1558
15946
61
114
1564
16118
9
15
1616
16217
—
13
23
1521
16184
56
116
1324
15619
68
239
940
12916
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
6.2e-01
1.6e+00
2.7e+00
—
—
2.7e+00
2.3e+00
cases:0.92%
controls:0.50%
cases:0.98%
controls:0.20%
cases:0.55%
controls:0.04%
—
—
—
—
cases:2.46%
controls:0.17%
cases:5.36%
controls:0.56%
15
81
1609
16142
16
33
1609
16199
9
6
1616
16226
—
—
34
27
1346
15708
54
74
954
13081
Addiction caused by alcohol UNS
F10.29 [2000501684]
2.2e+00
2.5e+00
—
—
—
2.7e+00
1.8e+00
cases:1.91%
controls:0.21%
cases:1.11%
controls:0.09%
—
—
—
—
—
—
cases:0.65%
controls:0.04%
cases:2.08%
controls:0.33%
31
34
1593
16189
18
15
1607
16217
—
—
—
9
7
1371
15728
21
44
987
13111
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
2.7e-01
8.1e-01
1.4e+00
3.4e+00
1.5e+00
9.7e-01
8.7e-01
cases:20.63%
controls:16.58%
cases:16.98%
controls:8.35%
cases:4.68%
controls:1.22%
cases:1.11%
controls:0.04%
cases:5.22%
controls:1.16%
cases:20.43%
controls:8.85%
cases:40.48%
controls:22.20%
335
2690
1289
13533
276
1356
1349
14876
76
198
1549
16034
18
6
1607
16226
80
188
1454
16019
282
1392
1098
14343
408
2921
600
10234
IgG subclass 4 [Mass/volume] in Serum
2469-5 [3024980]
2.4e+00
2.6e+00
—
—
—
2.6e+00
1.6e+00
cases:2.52%
controls:0.23%
cases:2.03%
controls:0.15%
—
—
—
—
—
—
cases:1.88%
controls:0.14%
cases:1.79%
controls:0.38%
41
37
1583
16186
33
25
1592
16207
—
—
—
26
22
1354
15713
18
50
990
13105
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.5e-01
5.8e-01
1.8e+00
4.1e+00
1.8e+00
7.2e-01
2.7e-01
cases:33.62%
controls:30.40%
cases:36.12%
controls:24.08%
cases:23.69%
controls:5.01%
cases:12.74%
controls:0.25%
cases:23.40%
controls:4.88%
cases:40.94%
controls:25.26%
cases:50.10%
controls:43.36%
546
4931
1078
11292
587
3909
1038
12323
385
813
1240
15419
207
40
1418
16192
359
791
1175
15416
565
3974
815
11761
505
5704
503
7451
Transplant complication
127 [2001600125]
—
—
—
—
—
4.4e+00
4.8e+00
—
—
—
—
—
—
—
—
—
—
cases:3.12%
controls:0.04%
cases:6.65%
controls:0.06%
—
—
—
—
—
43
6
1337
15729
67
8
941
13147
Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
40724-7 [3040363]
2.3e+00
3.7e+00
—
—
—
—
3.1e+00
cases:1.72%
controls:0.17%
cases:1.78%
controls:0.04%
—
—
—
—
—
—
—
—
cases:1.69%
controls:0.08%
28
28
1596
16195
29
7
1596
16225
—
—
—
—
17
10
991
13145
Anaemia other/unspecified
B82 [2002000293]
1.5e+00
3.5e+00
—
—
—
2.8e+00
1.4e+00
cases:0.99%
controls:0.23%
cases:0.98%
controls:0.03%
—
—
—
—
—
—
cases:1.23%
controls:0.08%
cases:1.49%
controls:0.38%
16
37
1608
16186
16
5
1609
16227
—
—
—
17
12
1363
15723
15
50
993
13105
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
1.3e+00
2.5e+00
—
—
—
3.1e+00
2.2e+00
cases:1.66%
controls:0.47%
cases:1.66%
controls:0.14%
—
—
—
—
—
—
cases:2.54%
controls:0.11%
cases:4.96%
controls:0.56%
27
76
1597
16147
27
23
1598
16209
—
—
—
35
18
1345
15717
50
74
958
13081
Other extensive ultrasound examination of artery
PG1DE [2001309713]
1.6e+00
2.2e+00
—
—
—
2.6e+00
2.6e+00
cases:1.35%
controls:0.27%
cases:0.74%
controls:0.09%
—
—
—
—
—
—
cases:1.74%
controls:0.13%
cases:3.67%
controls:0.28%
22
43
1602
16180
12
14
1613
16218
—
—
—
24
20
1356
15715
37
37
971
13118
ERCP
UJK02 [2001305365]
2.5e+00
2.2e+00
—
—
—
2.6e+00
1.7e+00
cases:1.91%
controls:0.17%
cases:0.92%
controls:0.10%
—
—
—
—
—
—
cases:0.87%
controls:0.06%
cases:1.39%
controls:0.26%
31
27
1593
16196
15
16
1610
16216
—
—
—
12
10
1368
15725
14
34
994
13121
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
4.7e-01
2.0e+00
—
—
2.7e+00
2.4e+00
2.0e+00
cases:0.68%
controls:0.43%
cases:0.86%
controls:0.12%
—
—
—
—
cases:0.46%
controls:0.03%
cases:1.52%
controls:0.15%
cases:5.06%
controls:0.71%
11
69
1613
16154
14
20
1611
16212
—
—
7
5
1527
16202
21
23
1359
15712
51
94
957
13061
enoxaparin; parenteral
B01AB05 [21600976]
5.3e-01
9.0e-01
2.1e+00
—
2.9e+00
1.6e+00
1.0e+00
cases:7.51%
controls:4.54%
cases:3.57%
controls:1.48%
cases:1.91%
controls:0.25%
—
—
cases:2.74%
controls:0.15%
cases:6.23%
controls:1.31%
cases:11.31%
controls:4.49%
122
737
1502
15486
58
241
1567
15991
31
40
1594
16192
—
42
25
1492
16182
86
206
1294
15529
114
591
894
12564
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
8.0e-01
1.1e+00
2.1e+00
—
2.4e+00
1.4e+00
1.1e+00
cases:6.77%
controls:3.16%
cases:4.55%
controls:1.52%
cases:1.60%
controls:0.19%
—
—
cases:1.50%
controls:0.14%
cases:5.65%
controls:1.40%
cases:13.59%
controls:5.07%
110
513
1514
15710
74
246
1551
15986
26
31
1599
16201
—
23
22
1511
16185
78
220
1302
15515
137
667
871
12488
Supplier / Service Provider
OMOP5117446 [33004]
-4.0e-01
-1.5e-01
6.4e-01
—
3.3e+00
2.8e+00
3.3e+00
cases:19.27%
controls:26.30%
cases:7.69%
controls:8.80%
cases:1.48%
controls:0.78%
—
—
cases:1.89%
controls:0.07%
cases:9.49%
controls:0.64%
cases:24.21%
controls:1.20%
313
4266
1311
11957
125
1428
1500
14804
24
127
1601
16105
—
29
11
1505
16196
131
101
1249
15634
244
158
764
12997
ABO and Rh group [Type] in Blood
882-1 [3003694]
4.5e-01
1.1e+00
2.2e+00
1.0e+50
2.8e+00
1.5e+00
9.8e-01
cases:7.45%
controls:4.86%
cases:4.80%
controls:1.63%
cases:1.48%
controls:0.16%
cases:2.15%
controls:0.00%
cases:1.43%
controls:0.09%
cases:5.51%
controls:1.33%
cases:12.90%
controls:5.28%
121
789
1503
15434
78
265
1547
15967
24
26
1601
16206
35
0
1590
16232
22
15
1512
16192
76
209
1304
15526
130
694
878
12461
Other specified anaemias
D64.8 [45595771]
1.8e+00
1.9e+00
—
1.0e+50
—
3.4e+00
1.9e+00
cases:0.62%
controls:0.10%
cases:0.62%
controls:0.09%
—
—
cases:0.31%
controls:0.00%
—
—
cases:0.94%
controls:0.03%
cases:1.39%
controls:0.22%
10
16
1614
16207
10
15
1615
16217
—
5
0
1620
16232
—
13
5
1367
15730
14
29
994
13126
Multidisciplinary treatment meeting
WZC20 [2001310890]
9.2e-01
1.4e+00
2.1e+00
—
2.8e+00
2.2e+00
1.6e+00
cases:1.23%
controls:0.49%
cases:1.11%
controls:0.27%
cases:0.31%
controls:0.04%
—
—
cases:0.52%
controls:0.03%
cases:1.16%
controls:0.13%
cases:2.58%
controls:0.54%
20
80
1604
16143
18
44
1607
16188
5
6
1620
16226
—
8
5
1526
16202
16
20
1364
15715
26
71
982
13084
pH of Serum or Plasma
2753-2 [3018418]
8.2e-01
1.3e+00
1.8e+00
—
2.1e+00
1.7e+00
1.3e+00
cases:11.82%
controls:5.60%
cases:10.83%
controls:3.26%
cases:3.45%
controls:0.60%
—
—
cases:3.85%
controls:0.51%
cases:15.58%
controls:3.20%
cases:27.28%
controls:9.05%
192
908
1432
15315
176
529
1449
15703
56
98
1569
16134
—
59
83
1475
16124
215
504
1165
15231
275
1190
733
11965
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
D37.6 [45586102]
3.1e+00
2.7e+00
1.0e+50
1.0e+50
—
—
3.2e+00
cases:1.05%
controls:0.05%
cases:0.80%
controls:0.06%
cases:0.55%
controls:0.00%
cases:0.49%
controls:0.00%
—
—
—
—
cases:2.48%
controls:0.11%
17
8
1607
16215
13
9
1612
16223
9
0
1616
16232
8
0
1617
16232
—
—
25
14
983
13141
Idiopathic thrombocytopenic purpura
D69.3 [45537929]
3.1e+00
—
—
—
—
2.9e+00
2.9e+00
cases:0.92%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.03%
cases:0.69%
controls:0.04%
15
7
1609
16216
—
—
—
—
8
5
1372
15730
7
5
1001
13150
Leukocytes [#/volume] in Peritoneal fluid
26468-9 [3023487]
3.8e+00
—
1.0e+50
1.0e+50
1.0e+50
—
5.1e+00
cases:1.35%
controls:0.03%
—
—
cases:1.17%
controls:0.00%
cases:0.43%
controls:0.00%
cases:2.15%
controls:0.00%
—
—
cases:6.94%
controls:0.05%
22
5
1602
16218
—
19
0
1606
16232
7
0
1618
16232
33
0
1501
16207
—
70
6
938
13149
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
1.1e+00
2.0e+00
2.6e+00
—
—
2.3e+00
9.5e-01
cases:2.46%
controls:0.82%
cases:2.46%
controls:0.36%
cases:0.49%
controls:0.04%
—
—
—
—
cases:2.10%
controls:0.22%
cases:2.18%
controls:0.86%
40
133
1584
16090
40
58
1585
16174
8
6
1617
16226
—
—
29
35
1351
15700
22
113
986
13042
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
4.6e-01
1.2e+00
1.8e+00
—
3.1e+00
1.4e+00
1.3e+00
cases:1.29%
controls:0.82%
cases:1.35%
controls:0.41%
cases:0.43%
controls:0.07%
—
—
cases:0.65%
controls:0.03%
cases:1.81%
controls:0.43%
cases:3.47%
controls:0.93%
21
133
1603
16090
22
66
1603
16166
7
12
1618
16220
—
10
5
1524
16202
25
68
1355
15667
35
122
973
13033
Unspecified diabetes mellitus, without complications
E14.9 [45605408]
1.7e+00
2.0e+00
—
—
—
2.9e+00
2.2e+00
cases:0.99%
controls:0.17%
cases:0.49%
controls:0.07%
—
—
—
—
—
—
cases:0.58%
controls:0.03%
cases:1.59%
controls:0.18%
16
28
1608
16195
8
11
1617
16221
—
—
—
8
5
1372
15730
16
24
992
13131
Gastritis, unspecified
K29.7 [45591583]
1.5e+00
1.8e+00
—
1.0e+50
—
3.2e+00
2.3e+00
cases:1.23%
controls:0.28%
cases:0.68%
controls:0.11%
—
—
cases:3.63%
controls:0.00%
—
—
cases:1.96%
controls:0.08%
cases:2.68%
controls:0.27%
20
46
1604
16177
11
18
1614
16214
—
59
0
1566
16232
—
27
13
1353
15722
27
35
981
13120
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
1.2e+00
1.8e+00
2.5e+00
—
2.4e+00
1.1e+00
9.6e-01
cases:1.54%
controls:0.47%
cases:1.35%
controls:0.23%
cases:0.37%
controls:0.03%
—
—
cases:0.33%
controls:0.03%
cases:0.51%
controls:0.18%
cases:1.59%
controls:0.62%
25
76
1599
16147
22
37
1603
16195
6
5
1619
16227
—
5
5
1529
16202
7
28
1373
15707
16
81
992
13074
General Practice
1 [38004446]
6.5e-01
1.3e+00
1.9e+00
—
2.3e+00
1.4e+00
1.1e+00
cases:21.98%
controls:12.79%
cases:16.86%
controls:5.13%
cases:4.80%
controls:0.73%
—
—
cases:7.04%
controls:0.76%
cases:19.28%
controls:5.41%
cases:36.90%
controls:15.99%
357
2075
1267
14148
274
833
1351
15399
78
118
1547
16114
—
108
123
1426
16084
266
851
1114
14884
372
2104
636
11051
Essential (primary) hypertension
I10 [45591453]
3.8e-01
7.2e-01
1.1e+00
4.4e+00
1.4e+00
7.5e-01
1.8e-01
cases:27.77%
controls:20.83%
cases:19.88%
controls:10.75%
cases:4.98%
controls:1.71%
cases:8.55%
controls:0.11%
cases:6.52%
controls:1.77%
cases:21.09%
controls:11.17%
cases:31.65%
controls:27.80%
451
3380
1173
12843
323
1745
1302
14487
81
277
1544
15955
139
18
1486
16214
100
287
1434
15920
291
1757
1089
13978
319
3657
689
9498
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
6.2e-01
9.1e-01
2.3e+00
1.0e+50
3.0e+00
1.4e+00
1.1e+00
cases:2.16%
controls:1.17%
cases:1.23%
controls:0.50%
cases:0.62%
controls:0.06%
cases:0.98%
controls:0.00%
cases:1.11%
controls:0.06%
cases:2.17%
controls:0.55%
cases:5.65%
controls:1.93%
35
190
1589
16033
20
81
1605
16151
10
10
1615
16222
16
0
1609
16232
17
9
1517
16198
30
86
1350
15649
57
254
951
12901
Ultrasound elastography of liver
JJ1LE [2001305253]
2.5e+00
—
1.0e+50
—
—
3.3e+00
2.9e+00
cases:0.74%
controls:0.06%
—
—
cases:0.49%
controls:0.00%
—
—
—
—
cases:1.01%
controls:0.04%
cases:1.29%
controls:0.07%
12
10
1612
16213
—
8
0
1617
16232
—
—
14
6
1366
15729
13
9
995
13146
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
5.0e-01
1.4e+00
1.6e+00
—
2.8e+00
1.5e+00
1.4e+00
cases:1.85%
controls:1.13%
cases:2.58%
controls:0.64%
cases:0.62%
controls:0.12%
—
—
cases:0.91%
controls:0.06%
cases:3.19%
controls:0.74%
cases:7.04%
controls:1.92%
30
183
1594
16040
42
104
1583
16128
10
20
1615
16212
—
14
9
1520
16198
44
117
1336
15618
71
253
937
12902
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
5.1e-01
1.5e+00
1.7e+00
—
2.7e+00
1.4e+00
1.4e+00
cases:1.85%
controls:1.12%
cases:2.34%
controls:0.55%
cases:0.62%
controls:0.11%
—
—
cases:0.72%
controls:0.05%
cases:2.54%
controls:0.65%
cases:6.05%
controls:1.56%
30
181
1594
16042
38
89
1587
16143
10
18
1615
16214
—
11
8
1523
16199
35
102
1345
15633
61
205
947
12950
Erysipelas
A46 [45561706]
8.2e-01
1.2e+00
2.1e+00
1.0e+50
1.9e+00
1.4e+00
1.2e+00
cases:4.19%
controls:1.89%
cases:2.15%
controls:0.68%
cases:0.55%
controls:0.07%
cases:0.37%
controls:0.00%
cases:0.52%
controls:0.08%
cases:2.39%
controls:0.58%
cases:7.54%
controls:2.31%
68
306
1556
15917
35
110
1590
16122
9
11
1616
16221
6
0
1619
16232
8
13
1526
16194
33
91
1347
15644
76
304
932
12851
Inpatient Visit
IP [9201]
5.1e-01
1.0e+00
1.7e+00
—
2.5e+00
1.7e+00
1.2e+00
cases:10.59%
controls:6.63%
cases:7.57%
controls:2.85%
cases:2.15%
controls:0.38%
—
—
cases:3.85%
controls:0.33%
cases:13.33%
controls:2.78%
cases:24.90%
controls:9.09%
172
1076
1452
15147
123
463
1502
15769
35
62
1590
16170
—
59
54
1475
16153
184
437
1196
15298
251
1196
757
11959
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.6e+00
1.7e+00
—
—
—
2.5e+00
2.8e+00
cases:1.66%
controls:0.34%
cases:1.42%
controls:0.26%
—
—
—
—
—
—
cases:2.83%
controls:0.23%
cases:8.73%
controls:0.59%
27
55
1597
16168
23
42
1602
16190
—
—
—
39
36
1341
15699
88
77
920
13078
Iron deficiency anaemia
B80 [2002000291]
1.6e+00
3.0e+00
—
—
—
2.1e+00
1.9e+00
cases:0.74%
controls:0.15%
cases:0.74%
controls:0.04%
—
—
—
—
—
—
cases:0.87%
controls:0.11%
cases:1.79%
controls:0.27%
12
24
1612
16199
12
6
1613
16226
—
—
—
12
17
1368
15718
18
35
990
13120
Thrombin time
3243-3 [3036489]
1.1e+00
1.9e+00
—
1.0e+50
—
3.1e+00
2.5e+00
cases:1.72%
controls:0.55%
cases:1.91%
controls:0.30%
—
—
cases:0.43%
controls:0.00%
—
—
cases:4.20%
controls:0.19%
cases:7.34%
controls:0.66%
28
90
1596
16133
31
49
1594
16183
—
7
0
1618
16232
—
58
30
1322
15705
74
87
934
13068
One hour or less
ZXE00 [2001311394]
6.0e-01
1.1e+00
1.5e+00
—
2.0e+00
2.0e+00
1.4e+00
cases:10.53%
controls:6.08%
cases:4.68%
controls:1.63%
cases:0.80%
controls:0.17%
—
—
cases:0.98%
controls:0.14%
cases:7.39%
controls:1.09%
cases:13.29%
controls:3.53%
171
986
1453
15237
76
265
1549
15967
13
28
1612
16204
—
15
22
1519
16185
102
172
1278
15563
134
464
874
12691
insulin (beef); parenteral
A10AD02 [21600730]
1.3e+00
1.4e+00
1.5e+00
-1.0e+50
1.3e+00
1.6e+00
1.5e+00
cases:11.27%
controls:3.30%
cases:11.57%
controls:3.21%
cases:3.45%
controls:0.83%
cases:0.00%
controls:0.07%
cases:2.93%
controls:0.80%
cases:14.86%
controls:3.36%
cases:17.66%
controls:4.44%
183
535
1441
15688
188
521
1437
15711
56
134
1569
16098
0
11
1625
16221
45
129
1489
16078
205
529
1175
15206
178
584
830
12571
insulin glargine; parenteral
A10AE04 [21600739]
1.3e+00
1.4e+00
1.5e+00
-1.0e+50
1.3e+00
1.6e+00
1.5e+00
cases:11.27%
controls:3.30%
cases:11.57%
controls:3.21%
cases:3.45%
controls:0.83%
cases:0.00%
controls:0.07%
cases:2.93%
controls:0.80%
cases:14.86%
controls:3.36%
cases:17.66%
controls:4.44%
183
535
1441
15688
188
521
1437
15711
56
134
1569
16098
0
11
1625
16221
45
129
1489
16078
205
529
1175
15206
178
584
830
12571
liraglutide; parenteral
A10BJ02 [1123630]
1.3e+00
1.3e+00
1.7e+00
—
1.6e+00
1.4e+00
1.2e+00
cases:2.46%
controls:0.66%
cases:1.78%
controls:0.47%
cases:0.92%
controls:0.17%
—
—
cases:0.72%
controls:0.14%
cases:1.74%
controls:0.44%
cases:2.88%
controls:0.87%
40
107
1584
16116
29
77
1596
16155
15
28
1610
16204
—
11
23
1523
16184
24
69
1356
15666
29
114
979
13041
pH of Capillary blood
2745-8 [3009343]
5.1e-01
1.4e+00
1.6e+00
—
2.7e+00
1.5e+00
1.4e+00
cases:1.85%
controls:1.12%
cases:2.40%
controls:0.63%
cases:0.62%
controls:0.12%
—
—
cases:0.85%
controls:0.06%
cases:3.19%
controls:0.72%
cases:6.94%
controls:1.84%
30
182
1594
16041
39
102
1586
16130
10
20
1615
16212
—
13
9
1521
16198
44
114
1336
15621
70
242
938
12913
Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
49376-7 [3029536]
2.2e+00
—
—
—
—
3.2e+00
3.1e+00
cases:0.55%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.80%
controls:0.03%
cases:1.69%
controls:0.08%
9
10
1615
16213
—
—
—
—
11
5
1369
15730
17
10
991
13145
Karyotype in Bone marrow
81861-7 [21494434]
1.7e+00
2.5e+00
—
—
—
2.4e+00
1.8e+00
cases:0.86%
controls:0.15%
cases:0.62%
controls:0.05%
—
—
—
—
—
—
cases:0.58%
controls:0.05%
cases:0.89%
controls:0.14%
14
25
1610
16198
10
8
1615
16224
—
—
—
8
8
1372
15727
9
19
999
13136
Sepsis due to Staphylococcus aureus
A41.0 [45532832]
1.6e+00
1.8e+00
—
—
1.0e+50
2.9e+00
2.2e+00
cases:0.68%
controls:0.14%
cases:0.55%
controls:0.09%
—
—
—
—
cases:0.33%
controls:0.00%
cases:1.30%
controls:0.08%
cases:1.69%
controls:0.18%
11
22
1613
16201
9
15
1616
16217
—
—
5
0
1529
16207
18
12
1362
15723
17
24
991
13131
Ethanol [Moles/volume] in Serum or Plasma
14719-9 [3020191]
1.8e+00
2.8e+00
—
—
—
2.5e+00
1.4e+00
cases:0.74%
controls:0.12%
cases:0.62%
controls:0.04%
—
—
—
—
—
—
cases:1.16%
controls:0.10%
cases:1.29%
controls:0.33%
12
20
1612
16203
10
6
1615
16226
—
—
—
16
15
1364
15720
13
44
995
13111
Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
55774-4 [40758895]
1.7e+00
2.4e+00
—
—
—
2.3e+00
2.0e+00
cases:0.49%
controls:0.09%
cases:0.49%
controls:0.04%
—
—
—
—
—
—
cases:0.58%
controls:0.06%
cases:1.09%
controls:0.14%
8
15
1616
16208
8
7
1617
16225
—
—
—
8
9
1372
15726
11
19
997
13136
Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
55776-9 [40758897]
1.7e+00
2.4e+00
—
—
—
2.3e+00
2.0e+00
cases:0.49%
controls:0.09%
cases:0.49%
controls:0.04%
—
—
—
—
—
—
cases:0.58%
controls:0.06%
cases:1.09%
controls:0.14%
8
15
1616
16208
8
7
1617
16225
—
—
—
8
9
1372
15726
11
19
997
13136
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
3.7e-01
6.9e-01
1.1e+00
3.5e+00
1.4e+00
8.2e-01
5.9e-01
cases:14.35%
controls:10.38%
cases:11.38%
controls:6.04%
cases:2.89%
controls:0.99%
cases:0.98%
controls:0.03%
cases:3.65%
controls:0.89%
cases:13.99%
controls:6.69%
cases:28.77%
controls:18.36%
233
1684
1391
14539
185
981
1440
15251
47
161
1578
16071
16
5
1609
16227
56
145
1478
16062
193
1053
1187
14682
290
2415
718
10740

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
908
2603
6.55
323.01
3.8
2.7
12.17
12.99
umol/l
2.31
869
2440
646
372
27.94
307.65
1.5
1.2
713.33
1982.22
titre
—
21
9
705
1131
10.15
307.65
2.5
3.2
13.93
10.67
g/l
32.78
660
1047
285
48
71.60
307.65
2.9
2.2
266.15
871.38
e6/l
2.03
207
40
824
1718
8.60
307.65
11.7
2.8
19.18
8.43
umol/l
12.79
793
1547
191
28
77.04
307.65
1.4
1.5
17.81
27.89
g/l
2.40
121
22
874
2270
7.08
307.65
3.7
2.7
23.67
22.98
%
0.48
842
2133
1020
1496
16.30
307.65
6.6
2.2
0.15
0.21
g/l
90.46
935
1406
655
379
28.04
307.65
1.5
1.2
87.95
115.59
titre
0.60
78
34
234
42
64.78
307.65
2.0
1.2
8.78
13.48
g/l
2.46
158
32
670
904
11.81
307.65
1.7
2.0
1.60
1.36
g/l
1.50
626
835
412
196
27.70
307.65
1.2
1.1
1.61
1.51
g/l
2.48
384
181
238
38
73.05
307.65
2.6
2.2
—
—
—
0
0
897
2444
6.87
307.65
3.7
2.6
2.27
2.28
g/l
0.21
841
2276
263
97
32.08
307.65
2.7
1.4
—
—
—
0
0
650
198
53.60
307.65
4.2
2.2
2226.94
233.61
u/ml
0.76
643
193
492
616
10.97
307.65
3.1
1.7
0.37
0.35
mg/l
0.20
209
296
759
341
40.45
307.65
7.7
2.2
47.40
35.72
umol/l
3.88
741
293
252
39
76.12
307.65
2.6
2.0
1315.18
4664.35
e6/l
1.31
142
26
761
1546
8.30
307.65
1.7
1.6
—
—
—
0
0
717
1393
8.35
307.65
1.7
1.6
—
—
—
0
0
246
116
24.76
307.65
1.1
1.1
286.32
285.14
mg/l
0.05
228
105
724
1832
6.27
290.38
1.6
1.3
474.07
493.78
titre
0.10
162
386
620
1512
5.97
254.75
13.5
7.8
10.42
10.23
mmol/l
0.23
604
1455
203
119
19.32
250.92
1.4
1.1
217.78
138.57
titre
0.39
27
21
327
413
9.63
250.39
4.9
2.8
2.61
3.65
g/l
22.17
321
393
149
45
36.31
236.07
4.8
3.0
0.58
0.61
mmol/l
1.70
149
45
194
123
17.75
230.40
1.4
1.1
—
—
—
0
0
169
84
22.31
224.58
1.2
1.0
—
—
—
0
0
1127
4854
5.19
224.40
13.9
3.2
50.87
37.78
u/l
3.63
1094
4589
176
98
19.99
222.41
1.2
1.1
—
—
—
0
0
368
610
7.48
222.02
3.6
3.5
106.46
876.61
u/ml
2.48
326
533
944
3802
4.48
198.30
21.1
4.2
66.05
87.62
%
107.21
920
3739
761
2649
4.48
194.24
6.2
3.8
0.76
0.82
mmol/l
27.42
741
2518
1303
6765
5.44
191.78
19.4
5.2
31.66
35.51
g/l
97.28
1276
6356
939
3849
4.35
190.50
4.2
2.3
4.10
2.81
mg/l
29.13
881
3313
673
2173
4.55
189.11
9.1
6.3
1.06
1.04
mmol/l
0.61
648
2023
218
235
10.54
186.51
1.1
1.1
—
—
—
0
0
671
2185
4.50
185.95
3.4
2.1
—
—
—
0
0
746
2638
4.34
184.64
2.0
1.6
4.82
2.60
g/l
53.28
623
1597
641
2026
4.54
184.62
1.6
1.2
—
—
—
0
0
212
237
10.12
176.36
1.2
1.1
—
—
—
0
0
125
58
23.24
170.30
1.7
5.4
—
—
—
0
0
402
927
5.41
169.64
1.4
1.5
—
—
—
0
0
128
68
20.33
164.57
42.6
36.7
6.96
7.27
ug/l
0.60
114
57
593
1918
4.27
162.70
3.2
2.7
2.29
1.76
%
17.24
541
1716
1293
7229
4.68
157.68
30.3
14.6
1.36
1.26
inr
12.37
1150
6025
278
489
6.64
155.95
7.1
5.1
1.81
1.57
mg/l
3.65
268
440
127
75
18.27
155.34
39.2
35.7
132.07
134.48
ug/l
0.08
108
66
523
1606
4.31
152.86
4.0
4.4
5.46
22.12
ug/l
2.29
464
1333
99
34
30.92
150.11
4.2
3.1
630.29
107.41
ug/l
0.61
99
34
273
496
6.40
147.97
4.0
2.3
23.47
21.27
s
6.69
263
452
660
2442
3.84
147.17
4.3
2.1
32.17
29.68
s
14.65
642
2384
203
273
8.34
145.24
1.5
1.5
139.18
153.14
au/ml
0.54
46
87
204
277
8.27
144.76
1.4
1.4
374.55
261.59
u/ml
2.89
128
156
1330
7859
4.61
143.27
28.9
6.8
26.68
11.96
umol/l
42.30
1317
7530
210
300
7.88
142.59
1.5
1.5
—
—
—
0
0
974
4714
3.61
141.80
6.4
2.6
57.96
61.29
u/l
1.02
933
4383
329
745
5.27
140.11
2.0
1.7
0.98
1.59
g/l
26.96
282
645
474
1446
4.20
138.31
5.3
2.5
32.34
76.69
u/l
0.73
427
1218
201
283
7.95
138.11
1.3
1.2
—
—
—
0
0
386
1022
4.63
135.66
5.9
4.6
23.04
24.14
mmol/l
7.85
378
1010
104
54
20.49
134.78
1.0
1.0
—
—
—
0
0
104
54
20.49
134.78
1.0
1.1
—
—
—
0
0
141
143
10.69
125.09
2.4
2.4
42.97
46.71
iu/ml
0.07
19
18
140
141
10.76
124.81
1.2
1.2
—
—
—
0
0
1112
6172
3.47
123.31
5.9
3.0
157.47
157.96
ug/l
0.01
1064
5739
459
1488
3.89
121.29
3.0
2.8
81.74
68.91
e9/l
8.24
351
1109
460
1508
3.85
119.40
14.5
10.1
—
—
—
0
0
217
393
6.21
117.07
1.4
1.3
—
—
—
0
0
490
1749
3.57
110.95
6.4
4.1
5.36
5.81
kpa
18.85
476
1698
449
1530
3.66
108.98
11.7
9.0
1.98
1.35
mmol/l
8.73
435
1503
874
4427
3.08
108.92
7.4
4.3
—
—
—
0
0
948
5025
3.09
108.85
11.0
6.5
—
—
—
0
0
489
1774
3.50
107.54
6.5
4.2
7.37
7.38
ph
0.98
302
1026
476
1703
3.53
106.93
6.4
4.1
0.51
1.71
mmol/l
8.02
396
1464
906
4746
3.02
105.12
5.6
2.5
—
—
—
0
0
490
1838
3.37
101.43
1.8
1.7
—
—
—
0
0
494
1952
3.19
92.71
12.3
8.7
4.75
5.09
kpa
11.24
479
1886
494
1953
3.19
92.62
12.3
8.7
12.12
12.13
kpa
0.03
479
1888
493
1952
3.18
92.13
12.3
8.7
7.42
7.41
ph
1.00
234
1049
461
1770
3.23
90.60
12.5
9.0
95.90
95.43
%
0.78
452
1716
1106
6822
2.89
88.69
14.3
7.2
1.18
1.21
mmol/l
30.63
1065
6287
1103
6813
2.88
87.85
12.4
6.8
10.14
9.08
%
21.27
1065
6348
1158
7360
2.93
86.90
12.0
6.4
0.57
0.61
e9/l
5.04
1028
6219
1099
6804
2.85
86.61
12.3
6.6
3.16
2.89
%
3.53
1059
6336
835
4502
2.73
86.58
7.4
4.4
7.41
7.40
ph
6.24
670
3238
482
1946
3.09
86.38
12.3
8.6
-0.37
0.83
mmol/l
6.20
411
1617
1159
7383
2.93
86.35
12.0
6.4
0.04
0.04
e9/l
8.48
1027
6246
324
1028
3.68
85.90
14.1
11.3
23.15
24.24
mmol/l
5.48
318
1013
1093
6800
2.81
84.36
11.9
6.5
59.33
57.65
%
5.02
1061
6478
1166
7504
2.90
84.18
12.0
6.5
1.43
1.91
e9/l
10.99
1052
6516
1106
6944
2.81
83.45
12.3
6.6
23.82
27.03
%
20.29
1073
6546
1091
6809
2.79
83.18
12.5
6.7
0.73
0.68
%
2.04
1053
6346
1169
7564
2.88
82.94
15.4
7.9
1.18
1.21
mmol/l
24.56
1054
6513
1171
7593
2.88
82.56
12.5
6.7
0.17
0.20
e9/l
8.21
1053
6545
362
1351
3.15
73.09
1.8
2.9
65.15
66.59
g/l
2.20
342
1246
63
41
15.94
72.86
1.1
1.0
—
—
—
0
0
299
1000
3.43
72.28
13.0
11.5
14.10
16.00
%
19.00
294
965
591
2916
2.60
69.93
1.4
1.3
3.79
1.66
u/ml
0.97
108
756
1200
8283
2.66
67.57
16.4
9.8
3.63
4.21
e9/l
12.84
1092
7121
1045
6779
2.48
67.01
6.2
2.8
—
—
estimate
—
0
0
125
230
5.80
65.55
2.1
1.8
0.82
0.86
g/l
0.14
100
189
726
4094
2.38
62.65
4.6
3.3
—
110.87
estimate
—
0
23
152
346
4.74
62.54
2.9
3.4
164.67
1134.34
u/ml
0.72
143
324
575
2938
2.47
61.73
3.7
3.0
513.51
546.96
mosm/kgh2o
3.00
507
2570
518
2535
2.52
60.92
2.1
1.7
1246.80
1159.46
nmol/l
1.16
431
1945
747
4305
2.35
60.83
4.8
3.4
0.85
0.40
e6/l
3.11
593
3193
358
1471
2.83
59.75
5.7
3.6
4.78
4.54
kpa
1.14
343
1426
1275
9330
2.63
58.94
16.2
3.3
162.89
54.04
u/l
71.33
1245
8727
54
42
13.26
56.46
1.1
1.0
16.25
16.51
umol/l
0.10
47
35
64
69
9.61
53.89
6.3
2.1
39.39
9.87
umol/l
3.55
55
43
811
5038
2.20
52.86
4.9
3.5
190.20
93.48
e6/l
0.32
658
3878
497
2527
2.38
52.50
3.8
3.2
2.82
1.65
e6/l
1.36
273
1289
525
2747
2.34
51.81
3.6
3.1
1.22
1.03
e6/l
0.64
305
1516
538
2883
2.29
49.86
3.0
1.7
3.10
1.22
mg/l
8.31
472
2252
1204
8894
2.32
49.22
15.1
5.5
7.62
6.85
mmol/l
20.72
1180
8510
729
4436
2.15
49.00
2.3
1.7
18.06
19.97
nmol/l
3.32
663
3746
612
3485
2.20
48.63
3.7
2.7
5.58
4.63
e6/l
1.07
562
3186
847
5606
2.05
43.97
5.9
4.0
137.36
112.15
e6/l
0.19
665
4049
372
1794
2.39
43.24
2.1
1.5
—
—
—
0
0
171
550
3.35
43.05
1.5
1.2
—
—
—
0
0
669
4147
2.03
40.78
3.8
3.2
—
—
—
0
0
960
6769
2.00
40.36
2.9
2.2
94.02
94.70
pmol/l
0.15
550
3655
651
4013
2.03
40.16
5.2
2.9
386.22
354.05
umol/l
8.65
584
3532
350
1708
2.33
39.22
2.0
1.7
—
—
—
0
0
285
1279
2.49
38.46
1.8
1.4
—
—
—
0
0
177
641
2.97
36.30
1.8
1.5
20.26
22.91
iu/ml
—
7
15
141
452
3.32
35.55
2.4
3.9
62.13
61.65
%
0.07
133
443
77
161
4.97
34.87
1.2
1.1
—
—
—
0
0
163
587
2.97
33.70
2.5
2.2
1293.85
577.97
ug/l
0.53
149
562
1362
11217
2.24
33.69
32.5
8.3
127.31
80.56
u/l
98.30
1337
10675
129
405
3.37
33.60
4.3
3.4
2.22
2.05
index
0.14
78
219
106
296
3.76
32.97
1.4
1.3
46.89
64.22
mmol/l
4.29
73
244
90
225
4.17
32.63
5.2
5.9
11.73
11.88
mg/l
0.10
82
210
134
447
3.17
31.59
1.4
1.4
271.79
277.05
ug/g
0.09
86
271
213
912
2.53
31.43
4.2
3.2
1.41
1.25
%
1.37
213
906
101
282
3.75
31.41
1.4
1.7
—
—
—
0
0
155
565
2.92
31.31
1.6
3.7
52.83
45.66
mg/l
0.46
131
485
155
565
2.92
31.31
1.6
3.7
64.95
62.25
mg/l
0.09
131
482
62
118
5.42
31.21
1.9
1.3
0.81
1.17
promille
0.99
55
92
321
1647
2.18
31.20
1.5
1.4
—
—
—
0
0
243
1122
2.37
30.35
6.9
4.0
4.79
5.14
kpa
8.15
233
1074
238
1092
2.38
30.15
7.0
4.0
7.42
7.42
ph
0.11
204
904
887
6469
1.80
29.69
26.3
11.7
0.00
0.00
e9/l
0.15
751
5270
216
967
2.42
28.85
6.0
4.9
—
—
—
0
0
141
510
2.93
28.84
1.6
3.5
1.34
2.31
ratio
2.49
77
296
1161
9230
1.88
28.81
6.4
4.5
344.77
1225.41
e6/l
0.89
13
145
67
147
4.71
28.65
1.1
1.3
—
—
—
0
0
270
1339
2.22
28.37
2.3
2.2
361.65
376.83
nmol/l
0.33
255
1244
71
165
4.45
28.28
1.8
1.5
—
—
—
0
0
863
6342
1.76
27.22
4.1
2.4
70.83
77.06
nmol/l
8.08
796
5671
649
4423
1.77
26.41
11.9
6.5
—
—
—
0
0
105
347
3.16
25.09
4.9
4.3
—
—
—
0
0
762
5502
1.72
24.77
5.4
4.3
13.61
8.05
mg/mmol
2.19
524
3573
35
47
7.59
24.66
1.7
1.5
3136.00
3264.00
titre
—
5
5
771
5592
1.71
24.60
4.6
3.5
7.03
7.92
mmol/l
7.06
658
4716
255
1307
2.13
24.42
6.4
4.2
0.88
0.65
%
0.89
124
410
97
312
3.24
24.24
5.7
5.2
2.39
2.54
mmol/l
0.20
60
212
690
4871
1.72
24.19
3.6
3.2
1603.89
1395.07
ng/l
0.47
616
4193
264
1378
2.09
24.08
6.6
4.4
0.89
0.85
%
0.12
133
442
162
693
2.48
23.75
2.5
2.0
3.26
1.84
ug/l
0.78
147
618
78
221
3.66
23.73
1.8
1.6
26.97
32.22
g/l
2.64
70
195
211
1021
2.22
23.31
1.2
1.2
—
—
—
0
0
231
1160
2.15
23.26
5.8
4.2
93.98
93.17
ng/l
0.04
209
1016
73
202
3.74
22.99
1.9
1.5
969.28
1768.56
e6/l
2.07
50
139
673
4789
1.69
22.43
2.6
2.3
218.39
244.90
u/l
0.31
644
4546
65
169
3.96
22.35
1.8
1.4
—
—
—
0
0
59
147
4.13
21.50
1.1
1.1
—
—
—
0
0
585
4049
1.69
21.39
1.6
1.3
—
—
—
0
0
324
5122
0.54
21.17
4.5
3.4
—
—
—
0
0
99
349
2.95
21.16
1.2
1.8
—
—
—
0
0
205
1023
2.15
20.88
8.8
6.9
23.28
24.32
mmol/l
2.68
200
978
731
5399
1.64
20.52
4.4
3.6
76.57
45.77
mg/l
2.25
514
3594
77
239
3.33
20.39
2.3
2.3
1.03
0.90
%
1.12
62
176
60
159
3.88
20.11
1.7
1.6
—
—
—
0
0
385
5736
0.57
20.03
3.2
4.5
21.95
21.78
%
0.07
143
2856
63
174
3.72
19.91
1.8
1.4
62237.47
85876.87
e6/l
0.20
38
101
136
582
2.46
19.86
4.0
3.0
22.86
24.63
mmol/l
4.23
130
577
132
568
2.44
19.04
1.6
2.4
13.95
10.38
g/l
7.00
119
510
165
785
2.22
18.88
8.0
4.1
—
—
—
0
0
159
745
2.26
18.88
7.6
5.1
1.78
1.63
%
1.61
152
706
97
360
2.80
18.87
1.2
1.6
0.80
0.85
nmol/l
0.32
79
300
464
3102
1.69
18.87
8.1
4.8
—
—
—
0
0
62
176
3.62
18.84
1.3
1.2
1.81
1.60
nmol/l
0.48
57
156
145
655
2.33
18.76
1.6
2.4
6.95
7.37
g/l
2.01
133
601
145
655
2.33
18.76
1.6
2.4
4.31
4.17
g/l
0.98
133
601
65
192
3.48
18.61
1.4
1.4
—
—
—
0
0
138
614
2.36
18.48
1.6
2.4
3.01
2.92
g/l
0.53
126
560
148
679
2.30
18.47
7.8
5.4
0.84
0.87
%
0.51
142
641
144
655
2.31
18.33
1.6
2.4
4.38
3.72
g/l
4.61
132
601
35
65
5.48
18.11
1.4
2.6
44.61
69.04
mg/l
2.21
28
51
130
570
2.39
17.99
1.5
1.6
7.93
6.99
iu/ml
0.16
24
129
237
1315
1.94
17.90
7.1
4.7
0.69
0.09
%
0.47
101
341
508
3532
1.63
17.51
4.7
3.6
0.00
0.08
—
6
39
27
40
6.85
17.44
1.2
1.3
12.71
9.11
ug/l
1.51
27
40
1232
13720
0.59
17.25
6.9
5.4
4.04
4.51
mmol/l
48.82
1155
12764
135
613
2.31
17.24
8.0
4.2
24.02
24.91
mmol/l
2.57
129
566
54
149
3.71
17.12
3.4
3.5
12.46
11.82
index
0.22
46
92
234
1313
1.91
17.05
7.1
4.5
0.04
0.13
%
2.56
102
376
101
405
2.59
16.90
1.4
1.6
1.03
1.19
g/l
4.47
95
386
1262
13949
0.59
16.67
7.4
6.2
2.29
2.63
mmol/l
37.81
1175
12929
99
396
2.60
16.65
1.4
1.6
0.20
0.24
g/l
4.07
92
377
1226
13638
0.60
16.40
6.7
5.3
1.27
1.41
mmol/l
24.92
1137
12607
42
100
4.28
16.27
1.1
1.1
—
—
—
0
0
40
92
4.43
16.19
1.2
1.1
—
—
—
0
0
443
3050
1.62
15.57
4.8
4.0
209.32
500.56
ng/l
2.63
378
2517
107
459
2.42
15.54
1.8
1.6
29.21
17.50
u/ml
0.69
19
103
95
386
2.55
15.48
2.3
2.3
78.55
70.32
ug/min
0.09
50
224
57
175
3.34
15.40
1.4
1.2
2.31
4.69
u/ml
1.31
35
88
280
4312
0.58
15.39
2.4
3.2
0.74
0.76
ug/l
0.06
190
2831
75
272
2.84
15.26
1.1
1.3
287.97
214.31
miu/ml
0.57
12
101
38
90
4.30
14.84
1.4
1.4
1.30
1.12
nmol/l
0.41
27
67
450
3141
1.60
14.82
2.0
1.8
562.55
26771185.50
pmol/l
2.63
379
2626
204
1159
1.87
14.20
6.4
4.2
1.20
1.22
mmol/l
4.30
195
995
150
769
2.05
14.10
7.1
4.4
36.94
36.90
°c
0.43
150
762
57
191
3.06
13.37
1.5
4.5
9.08
10.92
%
1.87
57
191
1395
14912
0.58
13.24
76.0
25.5
3.98
4.52
e12/l
151.13
1363
14547
1395
14911
0.58
13.21
75.8
25.4
30.64
30.48
pg
1.76
1379
14745
1396
14914
0.58
13.05
77.0
25.8
118.73
136.53
g/l
192.92
1382
14747
1396
14914
0.58
13.05
76.0
25.6
6.24
6.81
e9/l
9.35
1367
14547
1396
14912
0.58
12.99
78.7
26.2
35.79
40.62
%
156.47
1380
14736
1396
14910
0.58
12.93
76.1
25.6
161.39
244.24
e9/l
216.13
1368
14594
1396
14909
0.58
12.89
75.8
25.5
92.39
91.38
fl
8.59
1381
14742
113
539
2.18
12.82
3.0
3.8
279.40
405.17
mg/l
0.51
78
234
209
1234
1.79
12.80
3.7
3.1
192.62
211.70
ng/l
0.37
193
1131
29
1033
0.27
12.79
1.5
1.4
—
—
—
0
0
554
7084
0.67
12.61
3.8
5.5
1.52
2.92
ug/l
6.82
477
6458
1199
10513
1.52
12.33
7.5
4.4
23.33
12.33
mm/h
55.24
1147
9801
60
218
2.82
12.21
2.0
2.5
—
—
—
0
0
21
35
6.06
12.14
1.1
1.1
—
—
—
0
0
81
344
2.42
12.06
4.2
2.9
91.33
89.55
%
1.64
76
331
142
755
1.96
12.04
6.2
3.2
23.44
25.13
mmol/l
5.67
135
725
47
1259
0.35
11.96
1.4
2.2
3.61
3.59
ratio
0.04
40
1038
748
6013
1.45
11.91
4.4
3.4
6.25
6.20
ph
0.57
368
3377
50
167
3.06
11.82
5.9
4.5
—
—
—
0
0
54
192
2.87
11.45
1.9
2.3
1.02
1.53
g/24h
0.65
34
113
62
240
2.65
11.20
3.1
2.0
1.84
1.69
mmol/l
0.48
62
231
100
480
2.15
11.18
8.8
6.1
1.67
1.39
mmol/l
1.96
90
416
74
322
2.36
10.47
9.9
7.3
11.83
11.65
mmol/l
0.16
69
290
74
322
2.36
10.47
10.0
7.3
105.03
105.75
mmol/l
0.49
69
290
78
350
2.29
10.29
3.7
2.2
111.71
130.19
g/l
6.56
63
278
42
138
3.10
10.24
1.5
2.5
778.17
1172.37
e6/l
2.43
36
118
639
5089
1.42
10.23
4.7
3.6
2.29
2.35
mmol/l
14.74
587
4596
40
128
3.18
10.19
1.7
1.3
10.96
6.43
g/l
3.25
25
97
1198
13114
0.68
10.14
5.8
4.5
1.38
1.32
mmol/l
0.54
1109
12007
285
1940
1.57
10.02
1.4
1.3
—
—
—
0
0
44
151
2.97
9.97
1.3
1.2
—
—
—
0
0
40
130
3.13
9.94
2.5
2.3
—
—
—
0
0
68
293
2.38
9.85
4.5
3.3
57.10
58.81
%
0.49
68
293
680
5509
1.40
9.72
2.7
2.2
—
—
—
0
0
82
387
2.18
9.60
1.2
1.2
5.29
3.83
u/ml
—
7
34
64
272
2.41
9.56
1.1
1.1
226.96
51.66
iu/ml
—
9
41
39
128
3.10
9.54
1.7
1.3
3.31
2.80
g/l
0.63
25
97
39
128
3.10
9.54
1.7
1.3
0.61
0.38
g/l
1.64
25
94
46
166
2.82
9.53
1.2
1.4
279.13
278.36
mosm/kgh2o
0.05
30
123
38
123
3.14
9.52
2.2
2.3
756.24
667.50
ml
0.68
25
72
45
162
2.83
9.37
1.3
2.1
—
—
—
0
0
39
130
3.05
9.30
1.5
1.3
—
—
—
0
0
31
899
0.33
9.28
1.5
1.9
3.06
3.47
mmol/l
1.14
24
668
715
5877
1.38
9.22
5.7
3.9
34.25
72.70
ng/l
1.74
617
4407
888
7565
1.38
9.16
5.2
3.8
32.67
1.10
estimate
1.51
210
1595
120
666
1.86
8.96
1.3
1.3
—
—
—
0
0
53
214
2.53
8.85
1.9
1.6
—
—
—
0
0
53
214
2.53
8.85
1.9
1.6
—
—
—
0
0
53
214
2.53
8.85
1.9
1.6
—
—
—
0
0
53
214
2.53
8.85
1.9
1.6
—
—
—
0
0
1393
14734
0.64
8.74
62.5
22.2
88.82
81.80
umol/l
6.69
1381
14568
43
160
2.73
8.45
1.3
1.2
—
—
—
0
0
45
172
2.66
8.40
6.3
3.7
62.64
55.46
%
1.15
40
148
259
1793
1.53
8.36
3.7
3.5
5.90
4.98
e9/l
0.43
224
1544
1252
13495
0.70
8.34
7.0
5.4
6.73
6.07
mmol/l
31.37
1166
12317
872
7476
1.35
8.28
5.2
3.8
0.00
0.00
estimate
-0.00
206
1581
884
7600
1.35
8.21
5.3
3.8
0.00
0.22
estimate
0.54
186
1479
31
99
3.17
7.97
1.4
2.7
381.44
577.45
e6/l
0.89
25
77
497
3925
1.38
7.89
3.5
3.0
0.00
0.03
—
7
100
21
52
4.08
7.81
1.7
1.5
2.00
1.52
%
0.32
16
46
85
445
1.96
7.59
5.0
4.1
3.97
3.94
mmol/l
0.16
85
439
18
28
6.49
7.41
1.1
1.1
1466.67
614.29
titre
—
6
7
69
341
2.07
7.24
1.4
1.1
—
—
—
0
0
28
91
3.11
7.02
1.9
2.7
40.36
39.94
%
0.03
12
48
28
91
3.11
7.02
1.3
1.4
7.42
7.41
ph
0.08
19
65
170
1114
1.59
6.97
5.5
3.8
—
—
—
0
0
11
8
13.83
6.89
1.8
1.0
—
—
—
0
0
206
1417
1.52
6.81
6.6
4.4
7.37
7.36
ph
0.41
174
1025
223
1584
1.47
6.29
3.1
2.5
142.30
153.10
ug/g
0.26
187
1289
18
47
3.86
6.26
1.7
1.3
1.51
26.86
ug/l
—
9
18
20
57
3.54
6.16
1.1
1.0
1904.55
1382.14
miu/ml
1.46
20
57
15
24
6.30
6.16
2.4
2.8
47.18
30.56
mg/l
—
5
7
21
62
3.42
6.15
1.3
1.8
—
—
—
0
0
1254
13367
0.74
6.01
11.7
6.9
42.53
39.96
mmol/mol
10.51
1202
12462
17
44
3.89
5.99
13.5
1.7
—
—
—
0
0
120
750
1.65
5.98
2.5
2.4
—
—
—
0
0
44
197
2.27
5.95
1.4
1.3
—
—
—
0
0
1387
14547
0.70
5.92
38.9
12.5
35.02
27.20
u/l
33.46
1370
14131
11
424
0.25
5.66
1.3
1.7
—
—
—
0
0
101
614
1.69
5.61
1.2
1.3
—
—
—
0
0
199
1416
1.46
5.56
1.5
1.6
—
—
—
0
0
14
24
5.87
5.53
1.3
1.2
—
—
—
0
0
11
409
0.26
5.34
1.1
1.2
1.51
1.49
g/l
0.05
11
409
9
8
11.30
5.29
2.0
1.4
—
—
—
0
0
13
22
5.95
5.22
1.1
1.1
—
—
mmol/l
—
0
0
5
0
+∞
5.21
15.0
0.0
9.06
—
ug/l
—
5
0
15
40
3.78
5.09
1.1
1.3
—
—
—
0
0
26
98
2.68
5.09
3.2
2.8
13.38
16.35
%
4.92
26
98
65
358
1.85
5.08
1.2
1.1
—
—
—
0
0
20
65
3.10
5.07
1.2
1.9
72.17
93.79
umol/l
—
6
39
375
3026
1.31
4.81
3.9
3.1
2.48
2.46
mmol/l
2.28
332
2718
24
90
2.69
4.75
2.2
2.2
484.94
500.52
min
0.25
18
60
8
8
10.04
4.52
1.0
1.1
—
—
—
0
0
8
8
10.04
4.52
2.3
2.8
138.00
213.50
ug/g
—
8
8
15
36
4.20
4.51
1.5
1.3
31.47
28.22
s
1.61
15
36
193
1420
1.41
4.50
2.3
2.4
5.88
8.34
ug/l
1.30
170
1286
12
23
5.25
4.46
1.7
2.0
9.50
10.27
%
—
6
11
33
150
2.22
4.38
5.6
2.2
—
—
—
0
0
22
85
2.61
4.14
1.2
1.9
—
—
—
0
0
493
4220
1.24
3.79
5.7
3.9
0.00
0.00
estimate
1.15
176
1425
7
8
8.78
3.77
1.1
1.3
—
—
—
0
0
19
72
2.66
3.73
1.0
1.9
—
—
—
0
0
17
61
2.81
3.69
1.1
1.2
—
—
—
0
0
21
472
0.44
3.67
1.1
1.2
—
—
—
0
0
20
80
2.52
3.55
3.4
2.8
1099.70
1104.11
u/ml
0.00
20
80
20
82
2.46
3.39
1.2
1.3
129.70
141.79
nmol/l
0.46
20
82
13
42
3.11
3.37
1.8
3.8
0.12
0.18
e9/l
—
8
16
23
101
2.30
3.36
2.8
2.4
9.01
8.10
mmol/l
0.66
23
101
21
454
0.46
3.34
1.1
1.7
—
—
—
0
0
33
169
1.97
3.30
1.2
1.2
—
—
—
0
0
22
96
2.31
3.27
1.6
2.1
147.00
145.95
ug/min
—
5
22
62
963
0.63
3.22
1.2
1.4
—
—
—
0
0
51
305
1.69
3.13
2.8
3.3
0.79
0.80
nmol/l
0.06
27
245
541
6103
0.83
3.10
2.6
2.0
1.39
1.38
mmol/l
0.06
484
5068
56
350
1.62
2.93
1.4
1.5
12.64
7.61
u/l
0.92
37
271
19
82
2.33
2.91
1.0
1.0
—
—
—
0
0
9
22
4.11
2.88
1.8
1.5
—
—
—
0
0
7
13
5.40
2.87
2.0
1.5
—
—
—
0
0
7
13
5.40
2.87
1.1
1.1
—
—
—
0
0
17
73
2.34
2.65
2.6
2.4
—
—
—
0
0
72
491
1.49
2.61
2.7
3.6
153.21
99.70
u/ml
0.64
72
474
8
20
4.01
2.57
10.6
6.4
5.63
5.32
mmol/l
—
8
20
132
1709
0.75
2.54
2.0
2.3
14.47
13.76
nmol/l
0.39
109
1549
1212
12656
0.84
2.49
5.4
4.9
2.26
1.97
mu/l
7.16
1122
11575
16
69
2.33
2.48
1.8
2.8
2105.00
1841.89
ml
0.83
16
61
8
21
3.82
2.46
1.0
1.0
—
—
—
0
0
14
57
2.47
2.45
1.1
1.1
287.43
223.71
iu/ml
0.18
14
57
1392
14333
0.81
2.34
61.4
20.6
4.02
4.00
mmol/l
1.81
1375
14047
40
245
1.65
2.32
4.8
2.5
—
—
—
0
0
9
29
3.11
2.22
2.2
2.0
—
—
—
0
0
23
121
1.91
2.21
1.6
2.0
2.13
1.22
u/field
0.60
15
69
20
100
2.01
2.21
2.8
1.2
94.35
107.37
pmol/l
0.32
20
100
39
609
0.63
2.16
1.1
1.1
—
—
—
0
0
18
88
2.06
2.11
3.2
1.9
—
—
—
0
0
12
49
2.46
2.10
1.6
1.9
22.83
33.59
%
1.73
12
49
9
31
2.91
2.07
5.3
4.1
51.67
93.87
u/l
—
9
31
1392
14305
0.83
2.06
60.9
20.4
137.97
139.69
mmol/l
69.23
1375
14043
6
16
3.76
1.93
1.8
1.6
—
—
—
0
0
32
197
1.64
1.87
3.5
2.4
—
—
—
0
0
45
301
1.51
1.86
6.1
1.8
—
—
—
0
0
42
277
1.53
1.85
1.5
1.5
—
—
—
0
0
12
53
2.27
1.81
1.7
1.3
8.79
7.81
mmol/l
0.25
12
53
28
171
1.65
1.71
1.1
1.1
—
—
—
0
0
10
40
2.51
1.66
2.6
1.7
—
—
—
0
0
40
271
1.49
1.59
1.7
1.3
—
—
—
0
0
19
106
1.80
1.59
3.8
2.7
34.15
37.12
mg/l
0.08
13
77
16
85
1.89
1.55
1.9
1.7
—
—
—
0
0
46
324
1.43
1.52
6.1
1.7
—
—
—
0
0
46
325
1.43
1.50
6.1
1.7
—
—
—
0
0
19
109
1.75
1.47
1.3
1.4
22.78
28.97
u/l
0.37
13
87
7
28
2.51
1.45
1.3
1.9
—
—
—
0
0
114
928
1.25
1.43
1.2
1.3
—
—
—
0
0
45
321
1.41
1.41
6.3
1.6
—
—
—
0
0
13
67
1.95
1.38
1.2
1.1
—
—
—
0
0
45
325
1.40
1.33
1.5
1.7
—
—
—
0
0
9
45
2.01
1.23
4.2
7.3
6.99
5.43
kpa
—
9
45
163
1403
1.18
1.19
2.3
2.1
0.00
0.01
estimate
0.50
26
287
52
394
1.33
1.17
1.6
1.6
16444.15
13815.12
e6/l
0.24
33
278
5
20
2.50
1.15
1.2
1.4
0.87
1.35
umol/l
—
5
12
87
713
1.23
1.08
2.3
2.2
0.00
1.16
estimate
0.50
17
216
29
408
0.71
1.07
1.1
1.1
—
—
—
0
0
1166
11320
1.10
1.05
63.8
20.9
15.42
13.68
%
140.10
1160
11160
77
934
0.82
0.98
2.4
2.5
29.93
18.47
au/ml
—
6
77
11
62
1.78
0.94
1.1
2.1
38.85
40.05
g/l
0.28
11
62
6
28
2.15
0.91
1.0
1.4
—
—
—
0
0
37
483
0.76
0.88
2.1
1.9
187.41
213.79
pmol/l
1.30
37
454
16
103
1.56
0.87
1.3
1.6
0.25
0.23
nmol/l
0.08
16
78
6
30
2.00
0.87
1.2
1.2
—
—
—
0
0
46
361
1.28
0.86
5.6
4.6
—
—
—
0
0
361
3352
1.10
0.85
6.1
3.9
1.02
1.02
kg/l
0.14
270
2246
1004
10347
0.92
0.84
4.2
4.0
14.63
14.89
pmol/l
2.69
908
9419
1390
13677
1.10
0.77
50.2
16.8
21.67
26.57
mg/l
10.99
1346
11337
1105
11322
0.93
0.75
65.1
22.0
331.08
332.95
g/l
7.25
1095
11265
24
324
0.74
0.75
1.6
2.1
2.58
4.05
iu/l
—
9
135
20
142
1.41
0.72
1.3
1.4
535623.69
151567.23
e6/l
0.64
13
97
40
318
1.26
0.71
1.6
1.4
27.79
23.95
iu/l
0.28
30
255
18
126
1.43
0.70
1.2
1.1
—
—
titre
—
0
0
22
161
1.37
0.68
1.3
1.6
75.43
66.41
%
0.90
14
102
258
2386
1.10
0.68
1.2
1.3
85.76
33.70
iu/ml
1.60
87
733
590
5642
1.07
0.67
5.6
3.8
0.00
0.04
estimate
1.45
173
1311
14
94
1.49
0.66
1.7
1.5
674.33
265.26
mu/l
—
9
69
73
845
0.86
0.62
1.3
1.3
32.80
61.68
au/ml
—
5
68
0
22
0.00
0.59
0.0
1.5
—
7.43
—
0
9
19
140
1.36
0.58
1.3
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
75
654
1.15
0.55
1.8
1.6
—
—
—
0
0
15
206
0.73
0.55
1.2
1.3
0.18
0.35
nmol/l
—
5
17
37
449
0.82
0.54
19.6
10.2
—
—
—
0
0
6
96
0.62
0.52
1.5
2.2
1.53
2.95
ug/l
—
6
89
12
83
1.45
0.51
1.7
1.5
—
—
—
0
0
19
247
0.77
0.50
1.3
1.3
—
—
—
0
0
85
761
1.12
0.45
4.3
3.6
1.02
1.02
ratio
0.22
80
702
15
196
0.76
0.43
1.2
1.3
0.80
9.59
nmol/l
0.49
15
190
5
33
1.52
0.41
2.2
1.2
—
—
—
0
0
14
105
1.34
0.41
1.7
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
3.8
—
41.83
—
0
18
0
18
0.00
0.40
0.0
7.7
—
8.94
—
0
18
1012
10298
0.96
0.40
5.2
4.4
0.43
3885.54
—
7
26
0
19
0.00
0.39
0.0
1.5
—
43.79
—
0
19
62
690
0.89
0.35
2.0
1.9
—
—
—
0
0
6
43
1.40
0.35
3.0
1.5
—
—
—
0
0
9
126
0.71
0.35
1.0
1.5
134.69
166.98
pmol/l
—
9
126
14
175
0.80
0.31
1.1
1.7
—
—
—
0
0
7
53
1.32
0.31
4.0
2.4
55.89
51.62
umol/l
—
7
46
404
3912
1.04
0.30
4.7
3.3
0.00
0.03
estimate
0.86
164
1221
8
62
1.29
0.28
1.3
1.3
151.75
183.98
mmol/24h
—
8
62
9
116
0.77
0.27
1.4
1.3
2.26
2.09
mmol/l
—
9
109
14
172
0.81
0.27
1.2
1.3
0.21
0.19
nmol/l
0.45
14
141
9
73
1.23
0.25
1.3
1.5
12.76
7.31
ug/l
—
9
65
19
162
1.17
0.23
1.5
2.0
—
—
—
0
0
28
315
0.89
0.21
1.1
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
37.33
—
0
6
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.7
—
1.48
—
0
5
14
164
0.85
0.18
1.2
1.3
—
—
nmol/l
—
0
0
31
342
0.90
0.18
1.3
1.7
44.77
758.76
e6/l
1.09
22
258
177
1830
0.96
0.17
4.8
5.2
32.13
32.35
%
0.09
140
1170
5
70
0.71
0.16
1.2
1.3
—
—
—
0
0
106
1108
0.95
0.16
3.1
2.6
5.89
6.06
ph
1.51
89
769
79
751
1.05
0.15
1.1
1.2
117.30
143.31
u/ml
0.17
24
268
31
338
0.92
0.15
1.2
1.7
12.79
55.38
e6/l
0.90
19
244
7
86
0.81
0.14
1.1
1.2
—
—
—
0
0
11
95
1.16
0.11
2.5
1.5
96.36
84.22
umol/l
0.60
11
95
221
2257
0.98
0.11
1.2
1.3
11.25
11.93
u/ml
0.06
65
850
15
134
1.12
0.11
3.1
2.4
—
—
—
0
0
14
156
0.90
0.10
1.3
2.1
—
—
—
0
0
77
742
1.04
0.10
2.6
3.6
3.93
4.48
pmol/l
3.26
67
650
71
683
1.04
0.10
2.5
2.8
—
—
—
0
0
5
44
1.14
0.10
1.0
1.2
—
12.14
—
0
7
5
48
1.04
0.09
1.6
1.2
49.60
61.26
%
—
5
43
20
185
1.08
0.08
1.1
1.2
—
—
—
0
0
10
89
1.12
0.07
3.3
2.1
104.54
115.49
ng/l
—
10
89
12
109
1.10
0.06
1.7
4.0
20.08
66.01
u/ml
1.21
12
109
21
219
0.96
0.03
1.3
1.8
17.50
25.56
ug/l
0.65
21
213
14
147
0.95
0.01
1.3
1.2
—
—
—
0
0
19
194
0.98
0.00
1.3
1.1
—
—
—
0
0
19
194
0.98
0.00
1.3
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
4.6
—
0.70
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
4.66
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
172.00
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
3.39
—
0
9
5
49
1.02
-0.00
1.0
1.1
0.16
3.09
u/ml
—
5
14
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
5
52
0.96
-0.00
1.2
1.0
—
—
—
0
0
5
52
0.96
-0.00
1.2
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
484.06
—
0
9
0
9
0.00
-0.00
0.0
1.2
—
112.67
—
0
9
0
7
0.00
-0.00
0.0
1.4
—
2.50
—
0
7
8
79
1.01
-0.00
1.1
1.0
—
—
—
0
0
5
52
0.96
-0.00
1.2
1.0
—
—
—
0
0
5
59
0.85
-0.00
2.4
2.9
—
—
—
0
0
6
65
0.92
-0.00
4.0
2.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
394.50
—
0
6
9
90
1.00
-0.00
1.8
1.4
19.76
8.60
u/l
—
9
78

Mortality – FinRegistry

↥

Association

Association between endpoint I9_VARICVEOES and mortality.

Females

Parameter HR [95% CI] p-value
I9_VARICVEOES 8.066 [6.74, 9.65] < 0.001
Birth year 0.99 [0.98, 1.0] 0.022

During the follow-up period (1.1.1998 — 31.12.2019), 1624 out of 2914 females with I9_VARICVEOES died.

Males

Parameter HR [95% CI] p-value
I9_VARICVEOES 9.18 [7.92, 10.63] < 0.001
Birth year 0.984 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 3955 out of 6272 males with I9_VARICVEOES died.

Mortality risk

Mortality risk for people of age

years, who have I9_VARICVEOES.

N-year risk Females Males
1 0.878% 1.631%
5 4.186% 9.69%
10 10.017% 21.728%
15 18.217% 37.731%
20 30.053% 54.018%

Relationships between endpoints

↥

Index endpoint: I9_VARICVEOES – Oesophageal varices

GWS hits: 5

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data